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AA - arachidonic acid
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BHT - butylated hydroxytoluene
BZP - benzoyl peroxide
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FIO(-HX) - Ham's Flo medium lacking hypoxanthine 
FA - fluocinolone acetonide 
HCHO - formaldehyde
HGPRT - hypoxan thine-guanine phosphoribosyl transferase (E.G. 2.4.2.8) 
3hPDBu - phorbol 12,13 dibutyrate 
HX - hypoxanthine
LETS - large-external-transformation-sensitive protein
MAM - methylazoxymethanol
MGBG - methylglyoxal bis(guanylhydrazone)
MMS - methylmethane sulphonate
MNNG - N-methyl-N '-nitro-N-nitrosoguanidine
MNU - N-methyl-N-nitrosourea
MT - O^ methylguanine DNA methyl transferase (E.G. 2.1.1.66) 
Na'̂ -K'*‘-Mg2+-ATPase - sodium-potassium-magnesium-dependent adenosine
triphosphatase (E.G. 3.6.1.3)
OAG - l-oleoyl-2-acetylglycerol
ODG - ornithine decarboxylase (E.G. 4,1.1.17)
O^ MeG - O^ methylguanine
o4 MeT - O^ methylthymine
4-OMeTPA - 4-0 methylTPA
Oua - ouabain
Pĵ - inorganic phosphate
PA - plasminogen activator
PDD - phorbol 12,13 didecanoate
PG - prostaglandin (s)
PGE - prostaglandin E 
PGF - prostaglandin F
PKG - Ga2+-phospholipid-dependent protein kinase G 
PMN - polymorphonuclear leucocyte 
Rb - rubidium
SAMD - S-adenosyl-L-methionine decarboxylase (E.G. 4.1.1.50)
SGE - sister chromatid exchange(s)
STS - skin tumour sensitive 
TG - 6-thioguanine
TPA - 12-0-tetradecanoylphorbol-13-acetate 
UDS - unscheduled DNA synthesis 
UV - ultraviolet light
ABBREVIATIONS - CELL LINES
3t3 - established Swiss mouse fibroblasts 
Balb/c 3T3 - mouse fibroblasts 
C3H/10T^ - established mouse fibroblasts 
CEF - chick embryo fibroblasts
CHO - established Chinese hamster ovary cell line(s)
CHO-Kl - subclone(s) of CHO
HEF - hamster embryo fibroblasts
HL-60 - human promyelocytic leukaemia cells
HTC - established rat hepatoma cell line
L5178Y - established mouse lymphoma cell line
MDCK - established dog kidney cell line
SHE - Syrian hamster embryo cells
V79 - established Chinese hamster lung fibroblasts (embryonic) 
WI-38 - diploid human fibroblasts
SUMMARY
The introduction to this thesis reviews examples and characteristics 
of two-stage carcinogenesis, with particular reference to the promotion 
of mouse skin tumours by 12-0-tetradecanoyIphorbol- 13-acetate (TPA).
The effects of TPA and other tumour promoters on mammalian cells in 
culture is also discussed together with current evidence for the 
existence of specific phorbol diester receptors on the membranes of 
target cells. Chapter 2 lists the materials and methods basic to the 
cell culture procedures used in succeeding chapters.
The experimental work is presented in four parts. In Chapter 3, 
the effect of TPA on the frequency of both spontaneous and chemical- 
induced drug-resistant mutsints of the Chinese hamster ovary cell line, 
CHO-Kl, is described. The mutagen-specificity of the mutagenesis 
enhancing activity of TPA at the ouabain resistance (Oua^) locus in 
these cells is confirmed. Using this Oua^/CHO-Kl system the hypothesis 
that tumour promoting agents may act as 'in vitro mutagenesis enhancing 
agents via a free radical mechanism is investigated in Chapter 4. The 
influence of free radical scavenging compounds present in cell culture 
medium on the mutagenesis enhancing activity of TPA, benzoyl peroxide, 
formaldehyde and linear alkanes is examined. In Chapter 5 the effect 
of TPA on induced Oüa^ mutation in other Chinese hamster cells in culture 
is described.
Chapter 6 comprises a preliminary investigation into the survival 
of CHO-Kl cells irradiated in suspension with monochromatic ultraviolet 
light (UV). With reference to its membrane activity the effect of TPA 
on cell survival following UV irradiation is also examined.
A summary of findings is presented at the end of each experimental 
chaipter. These are discussed in Chapter 7 in the light of recent 
hypotheses for in vitro mutagenesis enhancing activity.
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Considering their possible importance in human carcinogenesis little 
attention has been given to the detection of tumour promoting agents 
among endogenous and synthetic chemicals. Primarily, this has been due 
to the expense, both in terms of expenditure and time, that would be 
required to test environmental chemicals in currently available in vivo 
models of two-stage carcinogenesis. There is, therefore, an urgent need 
for a rapid screening test for compounds possessing tumour promoting 
activity.
The initiation of two-stage carcinogenesis is generally accepted 
to be a mutation event. As the majority of carcinogens are also mutagens 
(McCann et al., 1975), an attractive possibility is that tumour promoters 
may act in part to enhance mutagenesis at the gene level. The demonstration 
of such a mutagenesis enhancing activity might provide the basis of a 
screening test.
Mammalian cell mutation assays have been adapted to assess the 
mutagenesis enhancing activity of the potent tumour promoting agent TPA, 
but the data obtained have been conflicting. TPA has been found to enhance 
both chemical- and UV-induced gene mutations in Chinese hamster V79 
fibroblasts (Lankas et al., 1977, 1980; Trosko et al., 1977). In cultured 
Chinese hamster ovary (CHO) cells, it has been suggested that TPA may 
only enhance the expression of specific MNNG-induced lesions (Dewdney 
and Sdper, 1984). Conversely, Thompson et al. (1980) and Kinsella (1981) 
have reported no enhancement of UV-induced mutagenesis by TPA in either 
CHO orV79 cells, respectively. That different results are observed in 
different cell lines, even from the same species, is not surprising as 
in vivo tumour promoting agents are known to be tissue as well as species
specific (Table 1.1). A lack of reproducibility between laboratories 
employing the same cell line, however, questions the applicability of 
this as a valid screening method.
The purpose of this study was to investigate the influence of 
various factors implicated to explain these differences, the mutagen 
used, the cell culture conditions and the cell lines employed. It was 
envisaged that the results obtained may provide not only an explanation 
for the discordant results but also an insight into the mechanism of 
mutagenesis enhancement by TPA, and other tumour promoting agents.
CHAPTER 1. INTRODUCTION
1.1 Two Stage Carcinogenesis
In 1944 Mottram described an experimental model of carcinogenesis 
that provided conclusive evidence that tumour induction could be divided 
into two distinct treatment stages. The discovery of this 'initiation- 
promotion' protocol of tumour induction led to the proposal of the two- 
stage theory of carcinogenesis (Friedewald and Rous, 1944; Berenblum and 
Shubik, 1947). In the first stage, initiation, exposure of mouse skin to 
a single subthreshold dose of a carcinogen is postulated to cause 
changes resulting in the formation of latent tumour cells. During the 
second stage, promotion, repeated treatment of these 'initiated' cells 
with a tumour enhancing agent allows the expression of a neoplastic 
phenotype, and proliferation to a visible tumour. Inherent in the 
theory, and distinguishing promotion from other forms of carcinogenesis 
is that neither treatment alone is sufficient for tumour induction.
In the first experiments initiation was produced by a single 
application of benz [a]pyrene and promotion by repeated treatments with 
croton oil, the seed oil of Croton tigliim L. Until recently this 
remained the primary experimental model for the investigation of tumour 
promotion, principally because croton oil is an extremely potent 
promoter of mouse skin tumours (Boutwell, 1964). The identification of 
the active principles of croton oil as 12,13 diesters of phorbol, and 
the development of methods for their synthesis, made it possible to 
study the effects of chemically pure promoters (Van Duuren, 1969;
Hecker, 1971).'The availability of this homologous series of compounds, 
with a full range of tumour promoting potency, has prompted studies in 
vivo and in vitro aimed at the identification of the critical target 
sites in promotion. The most abundant and most potent of the series.
12-0-tetradecanoylphorbol-13-acetate (TPA), has now superceded croton 
oil as the promoter of choice. The phorbol diesters remain the most 
potent mouse skin tumour promoters, although a wide variety of other 
compounds ha/e also been shown to possess tumour-promoting activity.
The molecular mechanisms underlying initiation and promotion are, 
as yet, undefined. There are, however, unique and distinct properties 
associated with each process. The initiation stage of skin tumour in­
duction requires only a single subthreshold application of a carcinogen 
and is presumed to be a rapid process (Diamond et al., 1980). It is 
accomplished with no apparent morphological changes (Boutwell, 1964; Van 
Duuren, 1969), and initiated cells show no autonomy of growth (Farber, 
1984a, 1984b). Furthermore, initiation appears to be irreversible. The 
time between initiation and promotion can be extended for up to a year, 
with little or no reduction in tumour yield (Boutwell, 1964, 1974; Van 
Duuren, 1969). This, despite the continued division of the epidermal 
cells from which the tumours eventually develop (Boutwell, 1974). It is 
now accepted that initiation involves the induction of genetic changes 
(Slaga et al., 1978a, 1982b; Diamond et al., 1980; Slaga, 1983), 
followed by fixation of these mutation events (Armuth and Berenblum, 
1982; Trosko and Chang, 1984), which explains the irreversibility of the 
process. An important characteristic of initiators, inherent in the 
irreversible nature of the process, is that their effects are additive 
(Boutwell, 1964). If applied in sufficiently high single or cumulative 
doses the majority of initiators are also complete carcinogens. This is 
encompassed in the two stage theory of carcinogenesis by assumimg that 
these compounds possess both initiating and promoting properties 
(Boutwell, 1964, 1974; Farber, 1984a). The efficiency of the 
experimental initiation-promotion model can be attributed to croton oil, 
and TPA, being much more potent promoters them the complete carcinogens.
which at the low doses used for initiation lose their promoting 
activities (Boutwell, 1976). This may be an oversimplification. It is 
now becoming apparent that the nature of the 'promoting' component in 
complete carcinogenesis may differ from that in TPA promotion (Scribner 
and Scribner, 1982; Verma, 1982).
Promotion in marked contrast to initiation, is a slow process 
requiring prolonged exposure to the promoting agent (Mottram, 1944; 
Boutwell, 1964). Promotion itself may also be a two stage process 
(Boutwell, 1964; Slaga et al., 1980; Furstenberger et al., 1981), the 
first involving the 'conversion' of initiated cells into dormant tumour 
cells, and the second 'propagation' of these cells into visible tumours 
by means of cellular proliferation. This subdivision was originally 
proposed after it was found that a point was reached, after prolonged 
promotion of mouse skin, when the promoter could be replaced by a 
non-specific proliferative stimulus, e.g. turpentine, and tumours would 
still develop (Boutwell, 1964). The finding that a single application of 
TPA, followed by repeated treatments with a non-promoting hyperplastic 
agent is sufficient for tumour development after initiation further 
supports a two-stage promotion process (Furstenberger et al., 1981).
There is evidence that at least some part of the promotion process 
is reversible. When the interval between promoter applications is in­
creased beyond an optimal time the promoting effect is greatly reduced 
or eliminated, even if the total promoting dose is kept constant 
(Boutwell, 1964). Reversibility is most probably related to the 
propagation stage in promotion with the first application of TPA 
inducing the obligatory effect for promotion (Furstenberger and Marks, 
1983).
Promoters have been shown to elicit occasional tumours when 
applied repeatedly to mouse skin (Boutwell, 1964), and in some strains
of mice TPA appears to be a weak carcinogen (Astrup and Iversen, 1983). 
This apparent carcinogenic activity can be accounted for by the 
occurrence of a background of initiated cells or precancerous lesions, 
as a result of the actions of environmental carcinogens and spontaneous 
mutations (Van Duuren, 1969; Goerttler et al., 1982). It has been 
suggested that this property of tumour promotion could be used to detect 
background levels of initiation (Boutwell et al., 1982). It has, 
however, been demonstrated experimentally that tumour promoters are not 
just weak carcinogens. When repeated doses of promoters are followed by 
a single dose of an initiator no tumours result (Berenblum and Haran, 
1955; Roe, 1959).
Despite conclusive evidence for two stages in mouse skin tumori- 
genesis, the relevance of the initiation-promotion protocol to general 
carcinogenesis remained in doubt for a considerable time. Using the 
same treatment schedule on the skin of other species of rodents 
negative results were obtained (Shubik, 1950). However, it is now 
becoming apparent, provided an appropriate experimental protocol is 
employed (Goerttler et al., 1982) that similar stages of tumour 
induction can be demonstrated in other species and tissues (Table 
1.1). Other models of two-stage carcinogenesis are currently under 
evaluation, including a growing number of in vitro transformation 
systems. These have been reviewed by Hecker et al. (1982). An 
important finding in these studies is that a potential tumour promoter 
in one system may have no promoting activity in another. For example, 
both phorbol (Hecker, 1981) and phenobarbitone (Grube et al., 1975) 
are inactive in mouse skin but are active in other models (see 
Table 1.1). This suggests that different mechanisms of promotion are 
operating in different tissues.
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Table 1.1 Animal models of two-stage carcinogenesis other than mouse 
skin.
TISSUE INITIATOR METHOD OF 
APPLICATION





DMN Sc injection Phorbol Ip injection , 1
DMN Sc injection Saccharin Diet 2
Rat liver AAF Diet Phenobarbitone Diet 3
AAF Diet Steroid drugs Diet 4











Rat colon MNNG Intrarectal Bile acids Diet 6
Mouse
forestomach
DMBA Intragastric TPA Intragastric 7
Rat mammary 
gland
DMBA Intragastric High fat Diet 8
DMBA Intragastric Progesterone Im injection 9
Mouse skin and 
other organs
DMBA Transplacental TPA Sc injection 1 0
Abbreviations
Im, intramuscular Ip, intraperitoneal Sc, subcutaneous 
AAF, 2-acetylaminofluorene BHT, butylated hydroxytoluene 
DMBA, 7,12-dimethylbenzanthracene DMN, dimethyInitrosamine 
MNNG, N-methyl-N'-nitro-N-nitrosoguanidine MNU, methylnitrosourea
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The diversity of compounds shown to have promoting activity in 
mouse skin, and other tissues suggests that there may be similar 
stages in human carcinogenesis. Significantly, the experimental models 
in which promotion has been shown to occur represent the sites of 
major cancer mortality in man (Sivak, 1978). A growing number of 
epidemiological studies have indicated that 60-90% of human cancers 
are induced by factors present in the environment (Doll, 1977; Wynder 
and Gori, 1977; Doll and Peto, 1981). The risk to man is probably from 
multiple exposures to a wide variety of chemicals resulting in complex 
interactions between initiators, cocarcinogens and tumour promoters 
(Diamond et al., 1980; Hecker, 1984). What cannot be distinguished 
from epidemiological studies is whether these environmental factors 
represent true promotion events or other forms of cocarcinogenesis.
For one cancer, human lung cancer, there is circumstantial evidence
rA.p'î
for the role of promoting agents. The^decline in lung cancer risk in 
ex-smokers, compared to the risk in people who continue to smoke, 
suggests that some part of the tumour induction process is reversible 
(Doll, 1978; Wynder et al., 1978), and could result from the activity 
of promoting elements in the tobacco smoke. The role of promoting 
agents in other human cancers is now suspected. Apart from tobacco 
use, other factors particularly implicated are dietary constituents 
(Day, 1982; Hicks, 1982) and alcohol consumption (Wynder et al.,
1978).
As promotion may be important in the induction of human cancer, 
it is a process that warrants further investigation. An understanding 
of the mechanisms involved may prove useful in the provision of more 
rational approaches to both cancer treatment eind cancer prevention.
1.2 Chemistry of Tumour Promoting Agents
1.2.1 Structure-Activity Relationships
In biological processes where a number of agonists are available 
elucidation of their mechanism of action and their critical site of 
interaction has often been aided by the establishment of 
structure-activity relationships. For the tumour promoting agents such 
studies have been hampered not by a lack of agonists, but by the 
structural diversity of those available. The phorbol 12,13 diester 
promoting agents, however, provide a unique series of compounds for 
this type of study.
The general structure of these compounds was identified 
independently by Van Duuren (1969) and Hecker (1971) and is given in 
Fig. 1.1a. They are 12,13 diesters of the polyfunctional diterpene 
alcohol phorbol, with various aliphatic carboxylic acids.
Phorbol diesters are amphiphilic molecules consisting of a 
hydrophilic phorbol moiety, and a hydrophobic region, the saturated 
fatty acid chains at C-12 and C-13. The presence of the hydrophobic 
region appears to be essential for promoting activity in mouse skin, 
probably by assisting the passage of the molecule through a lipid 
environment to its site of action (Hecker, 1978). Phorbol, which lacks 
fatty acid side chains, is inactive as a mouse skin promoting agent 
(Hecker, 1971) except in the STS strain of mice (Baird and Boutwell, 
1971). That the actual size of the hydrophobic region is important was 
shown by Thielmann sind Hecker (1969), using a number of symmetrical 
12,13 diesters. The promoting activity of these symmetrical diesters 
increased with increasing chain length up to 8 carbons but then, 
beginning with the 1 2-carbon diester the activity decreases markedly. 
For both symmetrical and asymmetrical diesters those having a combined 
carbon chain length of 14 to 20 are the most active (Hecker, 1978).
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Phorbol R-i= R_= Ro= H 













Fig. 1.1 Chemical structures of (a) Phorbol 12,13 diesters
(b) 4yg Phorbol 12,13 diesters (c) 4oc Phorbol 12,13 
diesters (d) Anthralin.
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Phorbol diesters with aromatic side chains are less active than 
straight chain diesters containing the same numbers of carbons 
(Thielmann and Hecker, 1969).
The tumour promoting activity of the phorbol diesters is 
profoundly effected by alterations in the configuration of the phorbol 
moiety. In the active, 4 3 diesters, the 5- and 7-membered rings are 
trans-linked. Fig. 1.1b, conferring conformational rigidity on the 
molecule. On inversion of the C-4 hydroxyl group, producing the 
4a. diesters. Fig. 1.1.c, these rings become cis-linked. The molecule 
acquires flexibility, with a consequent loss of activity (Hecker, 
1971). Loss of the C-4 hydroxyl group, however, does not significantly 
affect biological activity (Hecker, 1978). Méthylation of the C-4 
hydroxyl group leads to a great reduction in promoting activity, the 
TPA analogue 4-OMeTPA being only weakly promoting (Hecker, 1978). It 
has been suggested that 4-OMeTPA may be a useful negative control in 
promotion experiments (Hecker, 1978). However, it may not be the most 
appropriate compound for this use since it appears that its mechanism 
of action as a skin mitogen is different from that of TPA 
(Furstenberger et al., 1979, 1982a).
The presence of a free allylic hydroxyl group at C-20 is 
essential for high promoting activity (Hecker, 1968, 1971). 
Estérification of the 12,13 diesters at this position leads to 
production of 'cryptic' promoters, which require cleavage of the C-20 
ester group to yield the active promoting species (Hecker, 1978).
The importance of the other functional groups on the phorbol 
moiety is less certain. It appears that the double bond at C1,C2, 
although not that at C6,C7, is required for skin tumour promoting 
activity. The cyclopropane ring system can also be opened without 
significant loss of activity (Hecker, 1978).
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Limited studies on the structural requirements for biological 
activity have been performed for other tumour promoting agents. 
Diterpene ester promoting agents of the parent alcohols, resiniferonol 
and ingenol, exhibit similar structure activity requirements to those 
of the phorbol diesters (Evans and Soper, 1978; Fujiki et al., 1982a). 
All show the need for both hydrophobic and hydrophilic regions within 
the molecule. Furthermore, the triesters of ingenol appear to possess 
the cryptic promoting activity shown by the phorbol triesters (Fujika 
et al., 1982a).
For the non-diterpene ester-type promoting agents the structural 
requirements for activity are more diverse. The most potent of these 
compounds in routine use is the phenolic compound anthralin. Fig. 
l.ld. Compared with TPA, it is much less active as a mouse skin 
promoter and needs to be applied in approximately 1 0 0 0-fold higher 
doses to elicit a comparable tumour yield (Boutwell, 1974). For 
anthralin and its analogues the presence of the keto-phenol moiety is 
a pre-requisite for promoting activity (Van Duuren et al., 1978). For 
the phenol analogues shown to have weak promoting activity, no simple 
structural relationships could be determined, although over 50 
compounds were studied (Boutwell and Bosch, 1959). Some of these 
phenolic compounds are thought to be responsible for the promoting 
activity of tobacco smoke condensate (Van Duuren et al., 1973). Carbon 
chain length is important for the linear alksine and alkanol promoting 
agents. Promoting activity for these resides solely in the compounds 
with 10-16 carbon chain length (Sice, 1966). While, the weak promoting 
activity of some long chain unsaturated fatty acids (Holsti, 1959), is 
increased in the methyl esters of the free acids (Arffmann and 
Glavind, 1971).
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Considering the structural diversity of the mouse skin tumour 
promoting agents it seems impossible that any one mechanism will 
explain tumour promotion. On the basis of the potencies of the various 
tumour promoters it has been suggested that the mechanism of action of 
the phorbol diesters may be unique (Blumberg, 1981). The recent 
isolation of the indole alkaloids teleocidin from Streptomyces fungi 
(Fujiki et al., 1982b) and lyngbyatoxin A and debromoaplysiatoxin from 
blue-green algae (Fujiki et al., 1983) may confirm this. These 
compounds are chemically dissimilar from the phorbol diesters, yet 
appear to potentiate the same effects on mouse skin at similar doses 
(Sugimura et al., 198 2).
1.2.2 Physical Properties of Phorbol Diesters
The physical properties of the phorbol diesters are a reflection 
of their amphiphilic nature. By measuring interfacial tensions of 
aqueous solutions of the diesters at 25°C Jacobson et al., (1975) 
obtained apparent solubility limits for TPA and phorbol didecanoate 
(PDD) of 2 X 10  ̂M and 5 x 10 ^ M respectively. This estimate for TPA 
is in close agreement with that of 3.7 x 10  ̂M obtained by a 
spectrophotometric method (Van Duuren et al., 1976). As it is a 
surface-active agent, TPA also forms micelles. These have been 
detected in aqueous solution at 10 ^ M (Edelman and Wang, 1978). The 
phorbol diesters interact with lipid structures in vitro (Jacobson et 
al., 1975). When introduced into the aqueous subphase, TPA, PDD or its 
inactive stereoisomer 4a PDD insert into phosphatidylcholine 
monolayers at the air-water interface, increasing surface pressure. 
Both TPA and 4 a PDD also reduce the enthalpy of the minor transition 
of dipalmitoylphosphatidylcholine liposomes (Jacobson et al., 1975). 
This decrease was associated with a change in the orientation of the
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acyl side chain of the phospholipid molecule. The ability to interact 
with phospholipid bilayers analogous to cellular membranes could be 
important to the tumour promoting activity of the phorbol diesters.
The phorbol esters are susceptible to autooxidation (Hecker, 
1971). To prevent this Schmidt and Hecker (1975) have recommended that 
TPA, either as a solid or in solution should be stored at -20°C in the 
dark. Under these conditions these authors report no degradation of 
TPA for at least 6 months. In cell-free culture medium containing 10% 
foetal bovine serum both TPA and PDD have been found to be stable for 
at least 96 hours at 37°C (Berry et al., 1982).
1.2.3 Metabolism of Phorbol Diesters
As the phorbol diesters are capable of producing rapid effects 
both in vivo and in vitvo (see below) it seems reasonable to expect 
that they do not require conversion to an active metabolite (Diamond 
et al., 1980; Blumberg, 1980). Experimental evidence has come to 
support this from studies both in mouse skin and in cell cultures.
3Segal et al. (1975) failed to detect any metabolism of HTPA 
during the first 24 hours after application to mouse skin. Similarly,
3Hecker (1978) found that up to 72 hours after administration of HTPA 
to mouse skin the promoter molecule remained largely unchanged. In 
this study minor amounts of two metabolites, as opposed to 
autooxidation products (Schmidt and Hecker, 1975) were detected. Both 
were less active than TPA either as irritants or as promoters (Hecker, 
1978). In vivo it is possible that some metabolites are not detected 
because of their rapid removal (Evans and Soper, 1978). This problem 
can be overcome by the use of in vitro systems, where metabolites 
accumulate in culture medium. In cell cultures TPA and other phorbol 
diesters are metabolised much more rapidly than in vivo (Diamond et
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al., 1980). Different metabolites are produced by cells from different 
species (O'Brien and Diamond, 1978a; O'Brien and Saladik, 1980; Berry 
et al., 1982). In all cases the products of metabolism are of much 
lower activity than the original molecule. Information currently 
available indicates that any metabolism that does occur leads to 
inactivation rather than activation of TPA and other phorbol diesters.
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1.3 Effects of Promoters on Mouse Skin
Mammalian skin consists of two distinct structures. The outer 
layer, the epidermis, is avascular and alymphatic, eind serves to 
exclude harmful substances and micro-organisms. The inner layer, the 
dermis, is relatively acellular comprised largely of connective 
tissues with a few blood vessels. The dermis is responsible for the 
tensile strength of the skin. Malignant skin tumours are known to 
develop from epidermal cells (Boutwell, 1974). Consequently the 
majority of the studies on mouse skin have concentrated solely on the 
epidermis as the target for both initiators and promoters.
The application of phorbol diester tumour promoters to mouse 
skin leads to a number of alterations in epidermal morphology and
metabolism (Raick, 1973a, 1973b). Similar changes have also been
reported following the application of the non-phorbol promoting agents 
benzoyl peroxide (BZP) (Klein-Szanto and Slaga, 1982) and teleocidin 
(Fujika et al., 1982b). These changes appear to be the same whether or 
not the skin has been previously initiated (Argyris, 1983c).
The most conspicuous morphological events are an acute epidermal 
hyperplasia and cell proliferation (Raick, 1973a; Argyris, 1980 ). 
Associated with this stimulation of cell division are profound effects 
on macromolecular synthesis. A 0.016 yg application of TPA causes a 
sequential increase in tritiated precursor uptake into RNA, protein 
and, following an initial depression, DNA in both epidermis (Baird et
al., 1971) or mouse whole skin (Raick, 1973a). The majority of these
responses can also be elicited by other inflammatory hyperplasiogenic 
agents that are not promoting (Raick, 1974; Argyris, 1983b), although 
there may be some differences in the magnitude and onset of the 
responses (Raick, 1974; Nelson et al., 1982). Repeated applications of 
non-promoting hyperplastic agents are unable to maintain the diffuse
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hyperplasia evident after repeated TPA treatments (Argyris, 1983a, 
1983b). After a single application, promoters increase macromolecular 
synthesis above basal levels for 3-4 days. For the hyperplasiogenic 
agents this increase is not sustained longer than 24 hours (Baird et 
al., 1971). The induction of events associated with the preparation 
for cell division are not generally regarded as specific for 
promotion.
Tumour promotion in mouse skin, however, does seem inseparably 
linked to epidermal hyperproliferation. All the promoting agents so 
far studied have a strong mitogenic activity (Blumberg, 1981). For the 
phorbol diesters irritancy has been correlated with tumour promoting 
potency (Slaga et al., 1974). There are only a few exceptions, most 
notably, phorbol dibutyrate (Thielmann and Hecker, 1969) and the 
retinoyl derivative 12-0-retinoylphorbol-13-acetate (Furstenberger et 
al., 1981), which are both highly irritant but non-promoting. In 
addition, for TPA the threshold for the hyperplastic response is at 
least 1000-fold lower than that required for promotion (Boutwell, 
1974). For the non-phorbol promoters, the association with 
hyperproliferation is not so clear, as many highly irritant compounds, 
such as acetic acid and turpentine, are at best only weakly promoting 
(Boutwell, 1964; Argyris, 1983b). Taken together,the weight of 
evidence seems to support the long held view that hyperplasia, though 
necessary for promotion, is not sufficient alone to completely explain 
the process (Gywnn and Salaman, 1953).
This complex set of tissue reactions evoked during the induction 
of hyperplasia creates a high background of changes in mouse skin. 
Thus, it has been difficult to determine the critical changes that 
distinguish the promoters from irritants in general. There are some 
changes, however, that cannot be simply ascribed to cell division or 
hyperplasia.
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The induction of ornithine decarboxylase (ODC), the 
rate-limiting enzyme in polyamine biosynthesis, by promoters was first 
reported by O'Brien et al. (1975a). A 0.016 yg application of TPA 
stimulated ODC activity in mouse epidermis by more than 200-fold. The 
sharp peak of enzyme activity at 5-6 hours was followed by a return to 
low basal levels 12 hours after treatment (O'Brien et al., 1975a). 
Following this increase in ODC activity, epidermal levels of the 
polyamines, putrescine and spermidine, but not spermine, were elevated 
(O'Brien et al., 1976). The activity of another enzyme in polyamine 
biosynthesis, S-adenosyl-L-methionine decarboxylase (SAMD) was also 
increased by the application of tumour promoters to mouse skin 
(O'Brien et al., 1975a). This is not a specific event in promotion, as 
hyperplasiogenic agents also produce similar effects (O'Brien et al., 
1975a).
The importance of ODC induction in promotion is suggested by 
other observations. Papillomas and carcinomas induced in mouse skin by 
the two stage protocol have elevated levels of ODC (O'Brien et al.,
1976). Unlike many other regenerating systems, activation of this 
enzyme is not generally associated with cellular proliferation in 
mouse skin (O'Brien et al., 1975b). For TPA, the extent of ODC 
induction is dose-related (O'Brien et al., 1975b). In addition, and 
most significantly, for both phorbol and non-phorbol promoters the 
ability to induce ODC correlates well with skin tumour promoting 
activity (O'Brien et al., 1975b). The exception to this is the weakly 
promoting diterpene,mezerein which has been found to induce ODC levels 
comparable to those induced by TPA (Mufson et al., 1979). However, as 
prior treatment of mouse skin with cycloheximide abolishes TPA 
induction of ODC (O'Brien et al., 1975a), de novo protein synthesis is
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required for its expression. Activation of this enzyme, though 
necessary cannot therefore be the initial event in promotion.
A distinct morphological feature of promoter treated epidermis 
is the appearance of an increased number of keratinized cells, which 
reach a peak 4 days after the promoter treatment (Raick, 1973a; 
Klein-Szanto and Slaga, 1982). These 'dark' basal cells Eire 
distinguishable from normal epidermal cells by their smaller size and 
larger mitochondria (Evans and Soper, 1978). Non-promoting 
hyperplasiogenic agents such as ethylphenylpropiolate (EPP) seem 
unable to induce dark cells (Raick, 1974). The efficiency of dark cell 
induction correlates well with tumour promoting ability for both 
phorbol and non-phorbol promoters (Klein-Szanto and Slaga, 1981). The 
most potent mouse skin promoter TPA, increases dark cell numbers from 
2-3% of basal cells to 15-20% (Klein-Szanto et al., 1982). The notable 
exception to this correlation is the weakly promoting 4-OMeTPA, which 
is an extremely good inducer of dark cells (Klein-Szanto and Slaga,
1981). A large number of these cells are found in papillomas and 
carcinomas induced in the two-stage protocol (Raick, 1974). Thus, dark 
cell induction has been considered the critical factor in the process 
of promotion (Bohrman, 1983). It has even been suggested that the 
failure of TPA to promote tumours in guinea pig skin is related to its 
inability to induce dark cells (Bourin et al., 1982). However, the 
relevance of dark cell induction to the promotion process remains 
uncertain.
There are some responses in mouse skin preceding those described 
above, which point to a membrane interaction as the initial event in 
promotion. Within 3 hours of 0.016 yg application of TPA the synthesis 
of phosphatidylcholine and phosphatidyl ethanol amine in mouse -skin is 
markedly increased above control levels (Rohrschneider et al., 1972).
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This 'early' stimulation of phospholipid metabolism by various phorbol 
esters correlates with their tumour promoting ability, and is not 
evoked by hyperplasiogenic agents (Rohrschneider et al., 1972). 
Significantly this prompt response is independent of protein synthesis 
(Rohrschneider and Boutwell, 1973a). Concurrent with this effect on 
phospholipid synthesis, TPA also causes an increased release of the 
prostaglandins, PGE and PGF, from cell membranes (Ashendel and 
Boutwell, 1979). This response has been reported to start within 15 
minutes of promoter treatment (Furstenberger and Marks, 1980).
Although PGs are known mediators of inflammation, their release may 
also be important to promotion. Pretreatment of mouse skin with 
indomethacin, an inhibitor of PG synthesis, abolishes promoter-induced 
ODC activity and DNA synthesis, as well as oedema (Verma et al.,
1980). In addition, phorbol diesters have a known affinity for 
phospholipid bilayers and exhibit strict structural requirements for 
their biological activity, suggesting that they might interact with 
specific membrane sites. Promoter-membrane interactions could trigger 
conformational changes at receptor sites that may explain the reduced 
receptiveness of epidermal cells to endogenous growth inhibitors such 
as G1 chalone (Grimm and Marks, 1974) and g-adrenergic stimulation 
(Mairks et al., 1978). Conformational changes may also be responsible 
for the selective activation of plasma membrane bound enzymes 
eventually leading to the nuclear events resulting in cell division 
(Rohrschneider et al., 1972). ODC induction by TPA is inhibited by 
colchicine, which implicates myotubules in the transmission of the 
signals from the cell membranes that effect gene expression (O'Brien 
et al., 1976).
It is possible that the targets for tumour promoters may not be 
confined to the epidermis. Little is known about promoter induced
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effects in the dermis (Aldaz et al., 1985). The dermal changes that 
have been studied are those characteristic of inflammation. Increased 
vascular permeability, resulting in marked oedema, is seen within an 
hour of promoter application to mouse ear (Janoff et al., 1970). 
Accompanying these vascular changes, leucocytes have been shown to 
infiltrate the dermis within 24 hours (Frei and Stephens, 1968). This 
leucocyte infiltration may be important to promotion. When treated 
with TPA in vitro leucocytes are known to produce an 'inflammatory 
burst' of activity resulting in the release of proteolytic enzymes and 
reactive oxygen radicals (Goldstein et al., 1979; Witz et al., 1980). 
Interest in these reactive species has been increased with the finding 
that TPA and other promoting agents, but not hyperplasiogenic agents, 
decrease epidermal levels of superoxide dismutase (SOD) and catalase 
(Solanki et al., 1981). These enzymes are psirt of the major cellular 
defence mechanism against reactive oxygen species (Fridovich, 1974).
As the dermis has an essential role in epidermal physiology, these 
changes should not be disregarded, and may play a significant, but as 
yet undefined, role in promotion (Aldaz et al., 1985).
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1.4 Inhibition of Mouse Skin Tumour Promotion
Various modifiers of tumour promotion have been very useful in 
increasing the understanding of the cellular events critical to the 
process of promotion. The anti-inflammatory steroids, such as 
fluocinolone acetonide (FA), are the most potent inhibitors of mouse 
skin tumour promotion (Schwarz et al., 1977; Slaga et al, 1978b). The 
repeated application of as little as 0.01 yg of FA almost completely 
inhibits phorbol ester-mediated tumour promotion, cellular 
proliferation and dark cell induction in mouse skin (Schwarz et al., 
1977; Slaga et al., 1980). FA does not, however, inhibit promoter 
induced ODC activity (Slaga et al, 1983). Certain retinoids are also 
potent inhibitors of phorbol diester tumour promotion (Verma et al.,
1979). In contrast to FA, the active retinoids inhibited promoter- 
induced epidermal ODC activity, but are ineffective against the 
production of hyperplasia and dark cells (Verma et al., 1979). The 
application of a combination of FA and retinoids to mouse skin, 
concurrently with TPA, acts synergistically to completely inhibit 
tumour promotion (Weeks et al., 1979).
The differential spectrum of activity of these inhibitors 
supports the subdivision of promotion into two stages (Boutwell, 1964; 
Furstenberger et al., 1981) and indicates that different cellular 
events are critical to each stage. Dark cell induction is correlated 
with Stage I (conversion) activity, while ODC activation is correlated 
with Stage II (propagation) activity (Slaga et al., 1982). The 
association of different critical effects within these stages can be 
used to explain the anomaly of the weak promoters 4-OMeTPA and 
mezerein. 4-OMeTPA, a potent inducer of dark cells, is now classified 
as a Stage I promoting agent, requiring only a single application to 
accomplish the conversion of an initiated cell to a dormsint tumour
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cell (Furstenberger et al., 1982a). Mezerein, a potent stimulator of 
ODC activity is classified as a Stage II promoter. Multiple 
applications of mezerein are required following a single application 
of a Stage I promoter for tumours to become visible (Slaga et al., 
1983).
The effects of other inhibitors, although less impressive, do 
indicate that other promoter-mediated effects may be of some 
importance. Various protease inhibitors, including the chloromethyl 
ketones, antipain and leupeptin, suppress mouse skin tumour promotion 
(Troll et al., 1978). As there is no clear evidence that tumour 
promoters stimulate protease activity in mouse skin, these agents may 
not be specifically inhibiting the action of proteases (Diamond et 
al., 1980). The prostaglandin synthesis inhibitor, indomethacin, is 
only a weak inhibitor at low doses (Viaje et al., 1977). However, this 
lack of inhibitory effect may be due to its low lipophilicity 
preventing percutaneous absorption (Slaga et al., 1978b). Other 
metabolites of arachidonic acid may be important in tumour promotion. 
Fischer et al. (1982) have shown that phospholipase A^ inhibitors and 
thromboxane synthesis inhibitors also suppress TPA-mediated tumour 
promotion.
Recently, the antioxidants butylated hydroxyanisole (BHA) and 
butylated hydroxytoluene (BHT) have been found to be potent inhibitors 
of skin tumour promotion by both TPA and BZP (Slaga et al., 1983). 
Their mechanism of action remains to be elucidated, but it is possible 
that free radicals are of importance and these agents may prevent 
promotion by their free radical scavenging potential.
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1.5 Effects of Tumour Promoters on Cells in Culture
In the study of tumour promotion, cell culture systems offer 
the advantages of being better defined and more flexible than in 
vivo systems. As they are also simpler, the experimental results 
obtained are more easily interpreted. The effects of tumour promoters 
have been investigated on
a) primary cultures - cultures initiated directly from an organism;
b) primary cell lines - cell populations derived at the first or 
subsequent subcultures from primary cultures, which can only be 
passaged a finite number of times; and
c) established cell lines - which demonstrate the ability to be 
subcultured indefinitely.
All of these especially established cell lines, represent cells 
somewhat altered from the original cells in vivo» The extrapolation of 
results to the in vivo situation, consequently, must be undertaken 
with caution. However, the findings of in vitro studies are useful 
because they often reflect, and extend, the observations made in mouse 
skin.
The majority of in vitro studies have employed the phorbol 
diesters, in particular TPA. The use of other non-phorbol promoting 
agents has been restricted by their toxicity to cells in culture.
Many studies with tumour promoting agents have attempted to 
mimic two-stage carcinogenesis in vitro. These have usually employed 
established rodent cell lines, which undergo malignant transformation 
following exposure to oncogenic viruses and chemicals (Pienta et al., 
1983). This is characterised by the loss of the contact-dependent 
inhibition of cell division, which normally limits their saturation 
density in monolayer culture, and the formation of piled-up 
criss-crossed foci (Paul, 1975; Heidelberger, 1976). Concurrently,
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they undergo morphological changes and acquire the capacity to grow in 
soft agar and to give rise to tumours when injected into an 
appropriate animal host (Heidelberger, 1976).
In 1974 Lasne and coworkers described what appeared to be 
two-stage malignant transformation of cells in culture. They reported 
the acceleration of the time required for the transformation of rat 
embryo fibroblasts when they were treated with benzo [ajpyrene and 
subsequently grown in TPA-containing medium (Lasne et al., 1974). 
However, on further investigation transformation of this cell line was 
found to occur in most experimental groups, including those with 
carcinogen alone, TPA alone and untreated cells (Lasne et al., 1977).
Of the other transformation systems in which TPA is active the 
most convincing and best studied example of two-stage carcino­
genesis in vitro employs the established C3H/10T% mouse fibroblast
cell line. In cultures of this cell line continuous exposure to a
—7non-toxic, non-transforming concentration of TPA (1.6 x 10 M),
following treatment with a subtransforming dose of either a 
carcinogenic hydrocarbon or ultraviolet light, produces a substantial 
number of transformed foci (Mondai et al., 1976; Mondai and 
Heidelberger, 1976). For transformation to occur the promoters must be 
given after the 'initiator', and for a series of phorbol diesters 
their potency in this system parallels their in vivo promoting 
activity (Mondai et al., 1976). Furthermore, a number of non-phorbol 
promoters have also been shown to promote transformation of this cell 
line (Heidelberger and Mondai, 1982; Hirakawa et al., 1982; Kaibara et 
al., 1984).
Another transformation system which may become useful to 
promoter research uses Syrian hamster embryo (SHE) fibroblasts (Poiley 
et al., 1979). With this cell line, in addition to transformation.
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which can be demonstrated after only 7 days (Di Paolo et al., 1982), 
parallel mutagenesis studies can be performed at two genetic loci 
(Barrett et al., 1983).
Although the systems described above are operationally analogous 
to in vivo studies they all utilize cells of a fibroblastic origin, 
rather than epithelial cells from which the majority of tumours are 
known to develop. No clear cut model of two-stage transformation has 
yet been documented in epithelial cell cultures, despite extensive 
efforts. This is principally because of the technical difficulties 
involved in maintaining epidermal cells in culture (Bohrman, 1983; 
Yuspa et al., 1983).
In addition to the effects observed in transformation systems, 
promoting agents have also been shown to evoke pleiotropic effects in 
diverse cell types. It must be emphasised that these effects represent 
the responses of 'uninitiated' cells, and that effects observed in one 
particular cell type may not be common to others. However, when a 
series of phorbol diesters have been tested for a specific effect in 
vitro a positive correlation has generally been found between 
promoting activity in mouse skin and the ability to induce that 
effect in vitro (Diamond et al., 1980).
TPA can have striking reversible effects on the morphology and 
size of cells in monolayer culture. These effects are most apparent in 
sparse, growing cultures, although similar changes do occur in 
confluent cultures (Diamond et al., 1980).
Primary cultures of newborn mouse epidermis can be maintained in 
culture (Yuspa et al., 1976a; Fusenig and Samsel, 1978). These cells 
differentiate in vitro and produce keratin proteins that are identical 
to those of the outer horny layer of the skin. Addition of TPA (10 ^ 
- 10  ̂M) to these cells alters their morphology, shifting them to a
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less differentiated state, with wider intercellular spaces (Yuspa et 
al., 1976a; Fusenig and Samsel, 1978); changes resembling those seen 
in mouse skin treated with TPA (Raick, 1973a). Similar morphological 
changes have also been reported in cultured human epidermal 
kératinocytes exposed to TPA (10  ̂- 10 ^ M) (Parkinson and Emmerson,
1982).
The treatment of primary fibroblast cultures with TPA also 
results in morphological changes. The cells of growing cultures of 
WI-38 diploid human fibroblasts (Diamond et al., 1974), or chick 
embryo fibroblasts (CEF) (Driedger and Blumberg, 1977) become 
elongated on exposure to low concentrations of TPA (1.6 x 10 M and 5 
X 10 ^ M, respectively). Concurrently, the number of cytoplasmic 
processes is increased, and the nuclear and cytoplasmic membranes show 
more distinctly than in control cultures. During exposure to TPA,
WI-38 cells retain a normal well-orientated growth pattern (Diamond et 
al., 1974) while CEF assume a criss-crossed disorientated arrangement 
(Driedger and Blumberg, 1977). For CEF this change in growth pattern 
is similar to, but distinguishable from that induced by transformation 
with Rous sarcoma virus (RSV) (Wilson and Reich, 1979). In contrast to 
the phorbol diesters, non-phorbol promoting agents do not induce 
morphological changes in CEF (Driedger and Blumberg, 1978).
-8In established Swiss 3T3 mouse fibroblasts treated with 8 x 10 
M TPA changes in cellular morphology are similar to those reported for 
WI-38 fibroblasts (Diamond et al., 1974). With continuous TPA exposure 
sparse cultures ofJWI-38, 3T3 or CEF all achieve higher saturation 
densities than control cultures (Diamond et al., 1974; Driedger and 
Blumberg, 1977). This is probably the result of a decrease in cell 
volume, associated with TPA treatment, which delays the onset of 
contact-dependent growth inhibition (Diamond et al., 1974).
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The induction of epidermal macromolecular synthesis and cellular 
proliferation are characteristic actions of tumour promoters in 
vivo. TPA is capable of stimulating these events in vitroi partic­
ularly in cells which have become quiescent. It has been proposed that 
this is an effect mediated through the cell membrane (Jazwinski et 
al., 1978; Tsien et al., 1982), with TPA, or other phorbol diesters, 
directly stimulating cell replication mechanisms and/or interrupting 
endogenous growth controls (such as contact-inhibition).
When contact-inhibited cultures of Swiss 3T3 mouse fibroblasts 
were exposed to TPA (8 x 10 M) a sequential stimulation of RNA and 
DNA synthesis was produced (Sivak and Van Duuren, 1970). The amount of 
protein per culture also increased after 4 days continuous exposure to 
TPA. Similar observations have been made using confluent, 
contact-inhibited Balb/c3T3 mouse fibroblasts (Sivak, 1977) and human 
fibroblasts (O'Brien et al., 1979). In quiescent cultures of hamster 
embryo fibroblasts (HEF), however, DNA synthesis was not stimulated in 
response to phorbol diesters (O'Brien and Diamond, 1977).
DNA synthesis and cell proliferation can also be elevated by TPA 
in several growing cell culture sytems. In many cases, however, it 
appears that the observed effects on growth parameters may be a 
rebound phenomenon, due entirely to the synchronisation of cells 
during an initial inhibition of DNA synthesis by TPA (Peterson et al.,
1977). However, this explanation may not be applicable to all cases.
In primary cultures of newborn mouse epidermal cells, following an 
initial depression, TPA causes a pronounced and sustained stimulation 
of DNA synthesis (Fusenig and Samsel, 1978). As TPA also increases the 
proliferative compartment of the cell population this response is not 
merely an overshoot reaction following the preceding block (Fusenig 
and Samsel, 1978). The stimulation of DNA synthesis by TPA in this
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system is dose-dependent over the range 10  ̂- 10 ^ M, and for a 
series of phorbol diesters there is a good correlation between the 
ability to stimulate DNA synthesis and tumour promoting ability (Yuspa 
et al., 1976b). The similarity of the results in this in vitro model 
with those in vivo (Raick, 1973a) suggests that the enhancement of 
epidermal cell growth by phorbol diesters is caused by a direct 
interaction with the target cells, and is not simply part of a non­
specific inflammatory response.
A similar response is shown by growing C3H/10T% cells to 
promoter treatment (Weinstein et al., 1978). TPA (4.8 x 10 ^ M) causes 
an initial transient inhibition of exponential growth, which is 
followed by a return to the original growth rate, rather than a 
stimulation of growth. TPA-treated C3H/10T% cultures do, however, go 
on to achieve a 4-fold increase over controls in saturation density 
(Weinstein et al., 1978); analogous to the promoter-induced 
hyperplasia in mouse skin.
A large number of studies have examined specific biochemical 
effects of phorbol diesters in cells in culture. As in adult mouse 
epidermis in vivo TPA increases ODC activity in primary newborn mouse 
epidermal cell cultures. TPA (1.6 x 10  ̂M) induces a 5-fold increase 
in ODC-activity, with peak induction at 9 hr (Yuspa et al., 1976b).
For TPA and five other phorbol diesters a rank-order correlation of 
ODC stimulation with promoting activity has been demonstrated (Yuspa 
et al., 1976b). O'Brien and Diamond (1978b) have shown that phorbol 
diester tumour promoters also induce ODC in HEF cell cultures, and 
that the extent of this induction was greater-in cells which had 
undergone malignant transformation than in normal HEF. In contrast to 
mouse epidermal cells in vitro and in vivo, the induction of ODC by 
TPA in HEF is not followed by an increase in DNA synthesis. Enhanced
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ODC activity is not, therefore, simply a prelude to promoter-induced 
cell proliferation (O'Brien and Diamond, 1978b).
An effect of tumour promoters of particular importance is the 
production of reversible changes in a number of specific cellular 
proteins normally associated with the transformed phenotype. The most 
extensively studied of these are the loss of the major cell surface 
protein, LETS (large-external-transformation-sensitive) protein, and 
the induction of plasminogen activator.
The function of the LETS protein is not known (Hynes, 1976), 
although its loss from the cell surface correlates well with malignant 
transformation in a wide variety of cell types (Blumberg, 1981). The 
treatment of exponentially growing cultures of CEF with TPA 
(1.6 X 10 ^ M) leads to a decrease in the amount of LETS protein on 
the cell surface, with the total amount being decreased by 80% after 3 
days (Blumberg et al., 1976). Within 3 days of subculture into medium 
without TPA the treated cells regain normal levels of LETS.
Plasminogen activators (PA), which act in the fibrinolytic 
system to convert plasminogen to plasmin, are detected in many tissues 
in the body. In most cell types in vitro malignant transformation is 
accompanied by a marked increase in PA levels (Blumberg, 1981) and in 
vivo increased PA secretion may be associated with the metastatic 
behaviour of tumour cells (Wang et al., 1980). The observation that 
TPA is a reversible inducer of PA in a number of cell types including 
CEF, HeLa cells and HTC rat hepatoma cells (Wigler and Weinstein,
1976) is therefore of importance. In CEF, PA is induced by 
concentrations of TPA as low as 5 x 10  ̂M and requires de novo RNA 
and protein synthesis (Wigler and Weinstein, 1976). The effect is 
observed as early as 3 hr after exposure to TPA, and is sustained 
provided TPA remains in the medium. PA returns to normal levels within
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12 hr of the removal of TPA. For a series of phorbol diesters, and 
related diterpenes, the induction of PA correlates with tumour- 
promoting potency (Weinstein et al., 1978).
The involvement of PA in tumour promotion has, however, been 
questioned. Several agents known to inhibit mouse skin tumour 
promotion, including retinoic acid and dexamethasone, fail to block 
the elevation of PA levels by TPA in CEF or HeLa cell cultures 
(Weinstein et al., 1978). Additionally, non-diterpene ester-type 
promoters do not induce PA in CEF (Weinstein et al., 1978).
As carcinogenesis is likely to involve major disturbance of cell 
differentiation (Sporn, 1978; Weinstein et al., 1979), the actions of 
the phorbol diesters on various programmes of cellular different­
iation in vitro has drawn considerable attention (Tables 1.2a and 
1.2b). At first sight, this dual effect of the tumour promoters 
appears confusing. However, the observations that the phorbol diesters 
inhibit terminal differentiation is in agreement with indications in 
vivo that TPA inhibits differentiation (keratinization) in mouse 
epidermis (Raick, 1973a; Marks et al., 1978), This action may be of 
importance with regard to the tumour-promoting activity of these 
compounds (Yamasaki et al., 1982). The induction of differentiation by 
the phorbol diesters in other cell culture systems (Table 1.2b) may 
partially explain why some of these compounds have an antileukaemic 
action (Evans and Soper, 1978; Hecker, 1978),
Studies on mouse skin suggest that the cell membrane is the 
major target for the action of the phorbol diesters (1.3). The effect 
of these compounds on isolated membrane preparations (Kubinski et al., 
1973; Van Duuren et al., 1976) indicate that they may also be capable 
of disrupting membrane integrity. The effects of TPA on cell culture 
systems, described above, e.g. changes in cellular morphology and
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Table 1.2 Examples of the modulation of cell differentiation in vitro 
by phorbol diesters.












Erythroid Yamasaki et al., 
1977




Myogenesis Cohen et al., 
1977
b) Induction
Rauscher virus-transformed Erythroid Miao et al..
murine erythroleukaemia 1978




Myeloid Huberman and 
Callahan, 1979
Human melanoma Melanogenesis Huberman et al., 
1979
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orientation, loss of contact-inhibition of growth, and loss of LETS 
proteins, support this hypothesis. In addition, promoters induce 
changes in certain physical parameters, which are most probably due to 
direct effects on cell membranes. Wenner et al. (1974) observed that 
TPA (10 ^ M) caused a decrease of 15% in the electrophoretic mobility 
of Erhlich-Lettre ascites tumour cells in culture, while the 
non-promoting 4a PDD did not. This decrease in mobility could be 
reversed by washing the cells. Also, the fluorescence polarization of 
1,6-diphenyl-l,3,5-hexatriene, embedded in the cell membranes of 
lymphoblastoid and rat embryo cells, is decreased following treatment 
with promoters (Castagna et al., 1979; Fisher et al., 1979). As this 
decrease was not observed with non-promoters it has been proposed that 
in the presence of promoting agents the lipid moieties of cell 
membranes may become more fluid (Fisher et al., 1979).
A number of biochemical effects induced by phorbol diester 
tumour promoters on cells in culture are almost certainly the result 
of membrane modifications. The rapidity of onset of these changes, and 
the fact that they do not require de novo RNA and protein synthesis 
indicates that they are the direct result of exposure to phorbol 
diesters.
As in mouse epidermis in vivo, the phorbol diesters stimulate 
phospholipid synthesis in certain cell cultures. TPA treatment of HeLa 
cells (Suss et al., 1971) and bovine lymphocytes (Wertz and Mueller,
31978) increases the incorporation of H-choline into their membrane 
phospholipids. In bovine lymphocytes, the ability of several phorbol
3
diesters to stimulate H-choline incorporation correlates with their 
potency as tumour promoters (Wertz eind Mueller, 1978).
The effects of TPA on the membrane transport of low molecular 
weight compounds is dependent on the system examined. These effects
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are of particular interest because they can be easily measured and are
among the earliest effects observed following treatment with TPA. The
uptake of ^^Rb^, a analogue, and ^^P^ into quiescent Swiss 3T3
mouse fibroblasts in serum-free medium is increased within 5-10 min of
the addition of TPA (5 x 10 ^ M) (Moroney et al., 1978). In this cell
line stimulation of uptake is ouabain-sensitive, suggesting that
membrane-bound Na^/K^-ATPase is the target for phorbol diesters. The
rate of transport of a glucose analogue, 2-deoxyglucose, is also
increased in several cell types (Blumberg, 1980). In resting CEF
cultures, TPA and other active phorbol diesters have been shown to
stimulate 2-deoxyglucose transport within 30 min of addition to the
culture medium (Driedger and Blumberg, 1977). TPA was maximally
-8effective at 2 x 10 M, and a good correlation was demonstrated 
between the activity of the phorbol diesters in this system and 
their in vivo tumour-promoting activity. For the non-phorbol promoters 
inconsistent effects have been noted (Driedger and Blumberg, 1978). In 
contrast, TPA (1.6 x 10  ̂M) inhibits 2-deoxyglucose uptake in human 
lymphocytes in culture (De Chatelet et al., 1976). This may indicate 
that the effects of TPA on membrane transport are not simply a 
reflection of altered membrane permeability.
Ohuchi and Levine (1978a) have shown that TPA stimulates 
synthesis of prostaglandins (PGs) in the canine kidney cell line,
MDCK, by causing déacylation of membrane phospholipids. The release of 
free arachidonic acid, the precursor of PGs, into the culture medium 
was also stimulated by TPA. However, the release of free linoleic acid 
from membranes into culture medium was not affected (Ohuchi and 
Levine, 1978b). TPA may, therefore, specifically increase the activity 
of a phospholipase A^ which has a greater affinity for arachidonate 
than for linoleic acid ester bonds (Ohuchi and Levine, 1978b). The
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release of arachidonic acid induced by TPA can be inhibited by 
indomethacin (Ohuchi and Levine, 1978b), and this may explain the weak 
anti-promoting activity of this compound. The stimulation of PG 
synthesis may be a general response of cells to promoter treatment. 
Similar effects are induced by TPA in cultured mouse epidermal cells, 
CEFs and other cell types (Weinstein et al., 1979; Furstenberger et 
al., 1982b). Non-promoting diterpene esters are unable to affect the 
rate of PG synthesis (Weinstein et al., 1979).
It is generally accepted that TPA does not form covalent adducts 
with cellular DNA (Boutwell, 1974; Poirier et al., 1975) and it is 
non-mutagenic (Lankas et al., 1977; Soper and Evans, 1977). However, 
there have been conflicting reports on the capacity of TPA to induce 
sister chromatid exchanges (SCE) in various cell types. The role of 
SCE in carcinogenesis has not been clearly identified, although they 
certainly reflect a type of damage or rearrangement of the genetic 
material (Nagasawa et al., 1983). Cells from patients with various 
hereditary 'cancer-prone' syndromes are known to have elevated levels 
of this type of chromosome damage (Chaganti et al., 1974; Raj and 
Heddle, 1980; Shiloh et al., 1985).
TPA has been reported to increase the frequency of spontaneous 
SCE in Chinese hamster V79 cells (Kinsella and Radman, 1978), and in 
mouse C3H/10T%, mouse 3T3 and Chinese hamster ovary (CHO) cells 
(Nagasawa and Little, 1981). That the elevation of SCE may be involved 
in tumour promotion was supported by the finding that 4-OMeTPA, the 
weakly promoting analogue of TPA had no effect on SCE levels in V79 
cells (Kinsella and Radman, 1978). Conversely, other investigators 
have been unable to demonstrate this effect for TPA in either V79 or 
CHO cells (Loveday and Latt, 1979; Thompson et al., 1980; Dewdney and 
Soper, 1984).
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In V79 cells, unusually, SCE induction by TPA was not 
accompanied by an increase in structural chromosomal damage 
(chromosome aberrations, CA) (Kinsella and Radman, 1978). However, in 
cultured human lymphocytes TPA (1.6 x 10 ^ M and 1.6 x 10 ^ M) has 
been shown to induce both CA and SCE (Emerit and Cerutti, 1981). Most 
chemicals and physical agents capable of causing CAs in mammalian 
cells are also carcinogens (Auerbach, 1976; Carrano et al., 1978). 
Furthermore, CAs are found in many types of cancerous growth and in an 
increasing number of cases there is a specific chromosomal abnormality 
associated with a particular form of neoplastic growth (Rowley, 1984). 
Thus, the observation of the induction of chromosomal damage by TPA 
could have implications with respect to the possible mechanism(s) of 
tumour promotion.
A model to explain how promoters might produce chromosomal 
damage has been proposed by Emerit and Cerutti (1981, 1982), and 
depends on the production of activated forms of oxygen. Support for 
this hypothesis has come from other observations. TPA has been shown 
to stimulate radical production in human polymorphonuclear leucocytes 
(PMN), by evoking a typical phagocytic burst of activity (Goldstein et 
al., 1979; Witz et al., 1980; Kensler and Trush, 1981). This effect 
is rapid, with the peak response occurring within 5 min of TPA (1.6 x 
10  ̂M) addition (Kensler and Trush, 1981). The ability of a series of 
phorbol diesters to stimulate free radical production by PMNs corr­
elates with their tumour promoting activity in mouse skin (Goldstein 
et al., 1981). The hon-phorbol tumour promoters teleocidin and 
lyngbyatoxin À are also capable of eliciting this rapid response 
(Formisano et al., 1983). Since leucocytes are pairt of the 
inflammatory state induced by TPA in mouse skin (1.3), their ability 
to generate free radicals may contribute to promotion. However, as
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recently TPA has been shown to stimulate radical production in 
cultured mouse epidermal cells(Fischer and Adams, 1985), it may be not 
be necessary to include leucocytes in a free radical mechanism of 
tumour promotion.
Concurrent with the stimulation of free radical production and 
the induction of chromosome damage, TPA has been shown to reduce the 
levels of superoxide dismutase (SOD) in both cultured mouse epidermal 
cells (Colburn et al., 1979) and human leucocytes (Kinsella et al., 
1983). As SOD is part of the cellular defence against free radicals, 
these findings increase the possibility that promoters may induce 
damage through an indirect mechanism (Emerit and Cerutti, 1981).
It is difficult to envisage a reversible mechanism of promotion 
including these permanent changes in chromosomes. However, it has been 
suggested that the initial effects of the increase in free radicals 
and the lowering of protective enzyme levels are on cell proliferation 
(Oberley et al., 1981) and on cell differentiation (Oberley et al.,
1980). It is more likely that this combination of effects is more 
important to the late or final stages of promotion (Cerutti, 1985), a 
view supported by inhibitor studies. Effective inhibitors of Stage II 
promotion (1.4) suppress both TPA-induced chromosomal damage, and free 
radical production (Witz et al., 1980; Kensler and Trush, 1981; Slaga 
et al., 1982). Additionally, Cu DIPS, a low molecular weight copper 
complex with SOD-mimetic activity, has been shown to inhibit both 
TPA-induced ODC activation and tumour promotion in mouse skin (Kensler 
et al., 1983).
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1.6 Phorbol Diester Receptor Sites
The phorbol diester tumour promoters induce a large number of
biological and biochemical changes both in vivo (1.3) and in
vitro (1.5). In contrast, one target, the cell surface membrane, is 
proposed as the site of the interaction for these compounds with 
cells. Circumstantial evidence also suggests that these compounds may 
act by binding to specific receptor sites. Only extremely low doses
are required for the induction of their responses, 10 - 10~ M in
vitro and 1.7 x 10 ^ M per application in vivo. While small structural 
modifications in the TPA molecule can markedly affect its activity 
(Hecker, 1978).
Initial attempts to demonstrate specific binding for the phorbol
3 3diesters using radioactive ligands, such as HTPA and HPDD, were 
unsuccessful (Helmes et al., 1974; Kubinski et al., 1974), probably 
due to the high lipophilicity of these particular diesters (Jacobson
3et al., 1975). The introduction of a less lipophilic derivative, H
3phorbol 12,13 dibutyrate ( HPDBu) has now permitted the demonstration
of specific phorbol diester binding to cultured cells (Driedger and
Blumberg, 1980) and to other tissues (Delclos et al., 1980; Dunphy et
al., 1980; Shoyab and Todaro, 1980). Consistent with their effects in
cell culture systems, specific phorbol diester binding sites have been
found in virtually all tissues with the exception of erythrocytes
(Shoyab et al., 1981).
In contrast to the behaviour of carcinogens, the binding of
the phorbol diesters is reversible (Driedger and Blumberg, 1980).
Depending on ph'e system, the dissociation constant for their binding
ranges from 7-50 nM, and the number of binding sites ranges from
1.5-2.0 pmol/mg protein or 0.5-10 x 10^ sites/cell (Blumberg et al.,
1983). As in all the systems examined, TPA has a higher binding 
3affinity than HPDBu, the receptor being measured should, perhaps be 
regarded as a TPA receptor (Blumberg et al., 1983).
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3The pharmacological evidence that the binding detected by HPDBu 
mediates both tumour promotion in mouse skin and the biological 
response in vitro is strong. Excellent quantitative agreements have 
been demonstrated between the potency of the phorbol diesters to
3induce specific effects and their ability to inhibit HPDBu binding in 
a variety of cell systems (Blumberg et al., 1984). Additionally, 
teleocidin and lyngbyatoxin, potent mouse skin tumour promoters
3structurally dissimilar to the phorbol diesters, also inhibit HPDBu 
binding with nanomolar affinity (Umezawa et al., 1981; Collins and 
Rozengurt, 1982). However, as anthralin and other phenols with weak
3promoting activity fail to inhibit HPDBu binding (Blumberg et al.,
1983) this may not provide a general assay for tumour-promoting 
agents. Mezerein, the potent Stage II promoter, shows a markedly lower 
affinity for the receptor than does TPA in most systems (Driedger and 
Blumberg, 1980). This implies that additional targets may exist which 
elicit the responses important to the Stage II of promotion.
3HPDBu binding is not significantly affected by hydroxyurea, 
cycloheximide or sodium fluoride (Shoyab and Todaro, 1980). It does 
not, therefore, require DNA, RNA or protein synthesis or metabolic 
energy. Inhibitors of mouse skin tumour promotion, including retinoic 
acid and dexamethasone, also have no effect (Shoyab and Todaro, 1980). 
They must induce their inhibitory actions through mechanisms other 
than the inhibition of phorbol diester binding.
Various workers have attempted to identify the endogenous 
compound(s) usually interacting with these receptors. Structural 
analogies have been proposed between the phorbol diesters and cortisol 
(Wilson and Huffman, 1976), prostaglandins (Symthies et al., 1975) and 
polyunsaturated fatty acid methyl esters (Rohrschneider and Boutwell, 
1973b). In none of these cases has an analogue of comparable potency
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and with the ability to mimic the range of action of the phorbol 
diesters been identified. As the effects of phorbol diesters on cells 
closely resembles those of a number of naturally occurring 
polypeptides such as thrombin, epidermal growth factor (EGF) and 
platelet-derived growth factor, these have also been proposed as the 
endogenous activators usurped by the phorbol diesters (Mufson, 1984). 
Again, all of the actions of TPA are not shared by any of these 
factors (Lee and Weinstein, 1978), and there are cell types which 
appear to lack EGF receptors that still respond to TPA (Pruss and 
Herschman, 1977; Greenbaume et al., 1983). The binding studies of 
Dunphy et al. (1980) suggest that the phorbol diester receptor is not 
analogous to a hormone receptor. These authors showed that the levels
3of HPDBu binding in the mouse brain (30 pmol/mg protein) were 
markedly higher than those for the neurotransmitters ( ~ 2 pmol/mg 
protein) or for other hormones. Furthermore, in mouse fibroblasts EGF
3does not compete with HPDBu for its binding sites (Shoyab and Todaro,
1980).
Based on the similarity in the phenotypes induced by Rous 
sarcoma virus (RSV) and TPA in CEF (Driedger and Blumberg, 1977) it 
has been proposed that the immediate response of the phorbol diester 
receptor interaction could be a change in kinase or phosphatase 
activity or specificity (Blumberg, 1981). The mechanism of 
transformation by RSV has been identified to be by the introduction 
into the cell of a tyrosine kinase, apparently analogous to a normal 
cellular enzyme but expressed at an enhanced level (Erikson et al.,
1981). Indeed the properties of the phorbol diester receptor shows 
marked similarities to those of protein kinase C (PKC) described by 
Takai et al. (1979a, 1979b). This is a Ca^*- and 
phospholipid-dependent protein kinase for which diacylglycerol,
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transiently produced during phosphatidylinositol breakdown in a 
signal-dependent manner, is the endogenous activator (Takai et al., 
1979a, 1979b).
There are a growing number of reports to suggest that some, if 
not all, of the pleiotropic actions of the tumour promoting phorbol 
diesters may be mediated through PKC. TPA and other phorbol diesters 
have been shown to directly activate PKC both in vivo and in vitro by 
substituting for diacylglycerol, without eliciting the breakdown of 
phosphatidylinositol (Castagna et al., 1982; Yaminishi et al., 1983). 
The ability of a series of phorbol diesters to activate PKC correlates 
with their tumour promoting activity (Castagna et al., 1982). Other 
promoters, such as teleocidin and lyngbyatoxin, previously shown to
3inhibit HPDBu binding also activate PKC, while anthralin and other
weak promoters have no effect (Kikkawa et al., 1983). In vitro, the
3 2+binding of HPDBu to PKC has an absolute requirement for both Ca and
phospholipid. This has led to the proposal that the specific phorbol
diester receptor is a quarternary complex involving Ca^^,
phospholipid, PKC and an active phorbol diester (Kikkawa et al.,
1983). Of a series of phospholipids tested, phosphatidylserine was
shown to be the most effective (Kikkawa et al., 1983). This is
identical to the phospholipid requirement of PKC activated in vivo by
diacylglycerol (Kaibuchi et al., 1981). In vivo, Ashendel et al.
3(1983) have shown that the binding of HPDBu to its receptors in
2+various mouse tissues also required Ca and phospholipid.
3There are other similarities between the HPDBu receptor and PKC 
which suggest that they may be the same. The tissue distribution of
3the HPDBu binding protein has been found to parallel that of PKC 
(Nishizuka et al., 1979; Shoyab et al., 1981). Both have been found in 
inactive forms in the cytosol of mammalian cells, and are activated by
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reversible association with membrane phospholipids in the presence of 
Ca^^ (Takai et al., 1979b; Kraft and Anderson, 1983). Additionally, in
3subcellular fractionation studies, the HPDBu binding protein from rat 
brain has been shown to copurify with PKC (Neidel et al., 1983). In
3kinetic studies the apparent dissociation constant of HPDBu binding,
8 nM, is identical to its apparent activation constant for PKC in 
homogenised rat brain preparations (Kikkawa et al., 1983). One 
difference, however, is apparent. Phorbol diester activation of PKC in 
vivo is sustained and not subject to feedback control by the cyclic 
nucleotides (Yaminishi et al., 1983). This is probably because the 
phorbol diesters intercalate into the cell membrane (Castagna et al., 
1982; Delclos et al., 1983), and are metabolized at a much slower rate 
than diacylglycerol (Nishizuka, 1983).
The physiological role of PKC is as yet unknown, although it may 
be involved in cellular proliferation (Nishizuka, 1984). It has a 
broad substrate specificity, and has been found to phosphorylate seryl 
and threonyl residues but not tyrosyl residues in many endogenous 
proteins. Perhaps of most importance are the recent reports that PKC 
activation causes phosphorylation of the EGF receptor (Cochet et al.,
1984) and the 3-subunit of the insulin receptor (Takayama et al.,
1984), preventing the binding of the endogenous activators. Similarly, 
TPA has been reported to induce phosphorylation of EGF receptors in 
cultured human epidermoid cells (Iwashita and Fox, 1984) and insulin 
receptors in cultured human B-lymphocytes (Jacobs et al., 1983).
Consistent with the diacylglycerols being the endogenous 
analogues of the phorbol diesters, they have been shown to competi-
3tively inhibit HPDBu binding to its receptor site (Sharkey et al.,
1984). TPA has a diacylglycerol-like structure (Nishizuka, 1984) 
and in vitro the synthetic diacylglycerol derivative, l-oleoyl-2-
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acetylglycerol (OAG) has been shown to induce similar, rapid bio­
chemical reponses to the phorbol diesters in several systems. OAG 
induces ODC activity in cultured rodent cells (Jetten et al., 1985), 
and terminal differentiation of HL-60 cells (Ebeling et al., 1985; 
Kreutter al., 1985). PKC activation may also be involved in the 
production of free radicals by PMNs treated with phorbol diesters. OAG 
has been shown to both induce phosphorylation of marker proteins and 
stimulate superoxide anion production in human neutrophils (Robinson 
et al., 1984; Fujita et al., 1985). Superoxide radicals generated in a 
xanthine-xanthine oxidase system did not induce phosphorylation of 
these marker proteins (Fujita et al., 1985). A number of phorbol 
diester-induced changes can thus be explained by activation of PKC. 
However, the critical protein changes in promotion are yet to be 
identified.
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1.7 Mutations and Mutagens
1.7.1 Gene Mutations and Their Detection
The material of inheritance of almost all living organisms is 
deoxyribonucleic acid (DNA). The normal DNA molecule is a double 
helix, consisting of a pair of polynucleotide strands coiled around 
each other. These are held together by hydrogen bonds between pairs of 
complementary purine (adenine (A) and guanine (G)) and pyrimidine 
(cytosine (C) and thymine (T)) bases. The only base pairs usually 
permitted by hydrogen bonding and steric hindrance are A-T and G-C. In 
all cells, prior to division, DNA is replicated in a semi-conservative 
manner. The two strands separate and each serves as a template for the 
formation of a new daughter strand by normal AT and GO base pairing.
The order of bases on one strand of the cells DNA constitutes a 
genetic message which contains all the information necessary to 
determine the specific structure and functions of that cell. This 
genetic information is translated into polypeptide chains (proteins) 
in a complex process involving messenger RNA, ribosomes aind transfer 
RNA (Watson, 1976). Each amino acid component of a particular 
polypeptide is specified by a triplet of successive bases (a codon). A 
segment of DNA in which the order of bases ultimately determines the 
sequence of amino acids in a single polypeptide chain is called a 
gene.
Gene mutations are heritable alterations to DNA affecting a 
single gene. This may occur spontaneously or be caused by external 
agents - mutagens,. In molecular terms gene mutations consist of the 
substitution, addition or deletion of one or more base-pairs in DNA. 
Mutations due to substitutions are known as base-pair substitutions 
and those due to additions or deletions as frameshifts.
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A base-pair substitution mutation occurs when a wrong base is 
inserted which then pairs with its natural partner during DNA 
replication. In this way, a new pair of incorrect bases is inserted 
into DNA. On translation, this results in the alteration of only one 
amino acid within a particular protein. In contrast, when a frameshift 
mutation occurs the subsequent genetic message becomes disrupted, 
leading to the formation of an altered polypeptide. As they cause 
alterations in the structure of proteins, gene mutations can bring 
about profound changes in the anatomical and metabolical functions of 
cells. Certain gene mutations affecting dispensible, enzymatic 
functions can be detected if the resultant mutant organism possesses a 
phenotypic trait which allows it to be distinguished from normal 
(wild-type) members of a population.
Mutations of specific sites arise in either a 'reverse' (mutant 
to wild-type) or a 'forward' (wild-type to mutant) direction. Reverse 
mutation is generally studied in mutant cells containing known 
base-pair substitution or frameshift mutations. In these cells, normal 
functional activity can be restored following a new substitution, or a 
second addition or deletion close to the first. Thus, a reverse 
mutation requires a highly specific type of DNA interaction. The Ames 
test (Ames et al., 1973), which is used to screen environmental 
chemicals for mutagenicity, is the best known assay system measuring 
reverse mutations. It is based on the reversion of histidine- 
requiring Salmonella typhimuri-vm bacteria to prototrophy (growth 
factor independence).
Forward mutations may arise from substitutions, additions or 
deletions of the bases of a gene, or from the deletion of an entire 
gene and/or neighbouring genes. These can be detected when there is a 
change in an enzymatic function resulting in auxotrophy (growth factor
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dependence), or in resistance to veirious chemical or physical agents. 
Numerous genetic markers, based on forward mutations to drug 
resistance, are employed in mammalian cell mutation assays (Puck and 
Ham, 1968; Gupta and Singh, 19 82; Adair and Carver, 1983). However, 
the most commonly used markers are resistance to the antimetabolite 
6-thioguanine (Arlett, 1977b; Bradley et al., 1981; Hsie et al.,
1981), to the steroid compound ouabain (Baker et al., 1974; Cole and 
Arlett, 1976; Gupta and Siminovitch, 1980), or to high concentrations 
of the nucleoside thymidine (Anderson and Fox, 1974; Clive, 1977).
Whatever the cell type employed, mutation assays always comprise 
the same three basic steps - cell treatment, mutation expression and 
mutant selection. During the cell treatment a standardised cell 
population is exposed to a mutagen under a well defined and 
reproducible set of conditions. The expression time is the period 
between the initiation of cell treatment and the addition of the 
selecting agent. This period is necessary to allow induced DNA lesions 
to yield mutations and for the transcription of mutated genes. It also 
provides time for the disappearance of existing gene products from 
mutant cells, by dilutions at successive cell divisions and by normal 
degradation. Specific mutants are selected in the final step, by 
imposing growth conditions on the cell populations which kill or 
inhibit normal cells but which permit mutants to give rise to 
macroscopic colonies.
The densities of the cells on the plates during mutant selection 
is an important factor in mammalian cell mutation assays. Many 
mammalian cell mutsints engage in metabolic cooperation when they are 
in contact with normal cells. This is a process whereby mutant cells 
can receive certain substances from normal cells. In the case of 
enzyme deficient mutants these substances are presumed to be enzyme
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products which render the cells phenotypically normal and, therefore, 
unselectable as mutants (Simons, 1974; Abbondandolo, 1977). In 
mutation assays this leads to a reduced yield of mutant colonies and a 
consequence low value for the mutation frequency. This problem can be 
overcome by selecting for mutants at cell densities at which cell-cell 
contacts are not permitted.
The biochemical bases of the drug resistance markers to be 
employed during these investigations are detailed later.
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The alkylating agents represent the largest class of mutagens present 
in man's environment (Fishbein et al., 1970). The four agents used in 
these investigations are all monofunctional alkylators, i.e. they only
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donate a single alkyl group to a nucleophilic site within a biological 
macromolecule. The positions of the normal DNA bases susceptible to 
alkylation are the Nl, N̂ , N3, 0̂ , N7 and CB of guanine ; the Nl, N3, 
N̂ , N7 and CB of adenine; the N3 and N^ of cytosine and the N3 and 
of thymine (Drake and Baltz, 1976). The superscript notation signifies 
exocyclic sites and the nonsuperscript notation endocyclic sites. The 
spectrum of DNA alkylation produced by these agents varies with their 
chemical nature. Reagents of low nucleophilicity (classed as SNl 
agents), typified by MNNG and MNU, react relatively more extensively 
at 0-atom sites than do those of high nucleophilicity (SN2 agents), 
such as MMS (Lawley, 1974). EMS, which is classified as a borderline 
SN1/SN2 agent (Sega, 1984) fills an intermediate position in this 
respect. The agents used in these investigations thus represent a 
broad range of reactivities.
Alkylation of DNA can produce both potentially miscoding 
(mutagenic) lesions and potentially lethal lesions. 0^ alkylG and 0^ 
alkylT probably represent the most important DNA lesions with respect 
to the induction of gene mutations, and cancer, by simple alkylating 
agents (Lawley, 1974; Singer, 1975; Pegg, 1977). These alkylated bases 
almost certainly undergo mispairing with thymine and guanine, 
respectively, to generate GO to AT and TA to GO substitutions (Drake 
eind Baltz, 1976). Alkylation at the N7 position of guanine generally 
correlates with the lethality of these agents (Lawley, 1974; Auerbach, 
1976). The internucleotide phosphates of DNA are also potential sites 
of alkylation (Lawley, 1974; Singer, 1975). However, the significance 
of this type of DNA lesion to either the mutagenic or the lethal 
effects of these particular alkylatingagents remains uncertain 
(Gichner and Veleminsky, 1982; Sega, 1984).
Alkylating agents may also induce mutation indirectly by a
49
misrepair mechanism (Drake and Baltz, 1976). This occurs when a 
premutational lesion interrupts daughter strand elongation during DNA 
replication. The gap produced in the daughter strand becomes a 
substrate for an enzymatic error-prone post-replication DNA mechanism 
(Heidelberger, 1975; Hart et al., 1978). When these gaps are filled 
either base-pair substitutions or frameshift mutations can be 
generated. The ratio of directly to indirectly induced mutations 
depends upon both the alkylating agent and the particular organism. 
For example, in Escherichia coli only about 30% of EMS mutagenesis 
occurs indirectly, while in yeasts EMS mutagenesis occurs almost 
exclusively by this mechanism (Drake and Baltz, 1976).
1.7.3 Dialkylaminoalkyl Chlorides
Dimethylaminoethyl (DMAE) l(2-Chloroethyl)piperidine (CEP)
CH.
CH3
N- -CH2CH2CI \ N-y •CH2CH2C1









These are monofunctional alkylating agents extensively employed in the 
pharmaceutical industry for the addition of side chains. At neutral pH 
the dialkylaminoethyl-like members of the series probably exist in 
equilibrium with a cyclic aziridinium ion form. The aziridinium ion is 
a potent alkylator of functional nucleophilic groups (Auerbach, 1976).
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No chronic toxicity studies have been performed on these compounds. 
However, they have been detected as base-pair substitution mutagens in 
bacteria (Soper et al., 1979) and mammalian cells (Thompson et al., 
1981). In both studies, the mutagenic activity of a series of these 
compounds was correlated with .their ability to form the aziridinium 
ion. Two of the compounds used in these investigations, DMAE and CEP, 
can form this ionic species, while DMAP cannot.
1.7.4 7,12-Dime thyIbenz [&]anthracene (DMBA)
CH3
Mol Wt. 256.8
DMBA is a known carcinogen frequently used as an initiating agent in 
the mouse skin model of two-stage tumour induction. In common with 
other polycyclic hydrocarbons, it requires metabolic activation to 
produce the active species which interacts with DNA (Miller and 
Miller,■1976). Different activating systems may produce different 
mutagenic species (Arcos and Argus, 1974; Sims, 1980; Singer and 
Kusmierek, 1980). However, these all appear to induce mutations by a 
similar mechanism. Following its reaction with DNA it is proposed that 
the bound mutagenic species may intercalate between the base pairs 
causing distortion and localised unwinding of the helical DNA 
structure (Arcos and Argus, 1974). Mutations then arise by an 
indirect mechanism, as the distorted DNA becomes the substrate for 
error-prone repair systems.
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CHAPTER 2. MATERIALS AND METHODS 
2-1 Equipment
Laminar flow hood. During the course of this work two different 
laminar flow hoods were used for all aseptic preparations and cell 
culture work.
(i) 2 m, horizontal displacement type (Fell Clean Air (1971) Ltd., 
Newhaven, Sussex).
(ii) 1.3 m, vertical displacement type. Class I biological safety 
cabinet. Microflow model No. 20229 (MDH Ltd., Andover,
Hampshire).
All the surfaces of the hoods were swabbed with 70% alcohol 
before and after use.
Incubator. LEEC PF2 anhydric incubator with forced air circulation 
(Laboratory and Electrical Engineering Company, Nottingham). The 
thermostatic controls were adjusted to maintain a temperature of 
37.5°C.
Bench centrifuge. MSE Minor, model No. S-61 (MSE Scientific 
Instruments, Crawley, Sussex).
Pipette fillers. For use with graduated glass pipettes, Pi-pump 
suction pumps (Glasfrin Giessen via Jencons Ltd.) were used for all 
pipette filling. Pipetting by mouth was never undertaken.
Adjustable replicating pipettes.
Pipetman P20 2-20 yl
Pipetman P200 20-200 yl
Pipetman PIOOO 200-1000 \xl
Pipetman P5000 1000-5000 \il
Pipetman pipettes with tips were obtained from Anachem Ltd., Luton, 
Bedfordshire. All pipettes were checked at regular intervals to ensure
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they were delivering accurately and reproducibly. A gravimetric method^ 
was used in which 10 replicates of a set volume of water at 20°C were 
each weighed on an analytical balance.
Liquid nitrogen freezers. Stock cultures of cells were stored in 2 ml 
ampoules in one of two types.
i) Union Carbide model no. LR-33-10 (Union Carbide UK Ltd., 
Cleveland), in which the ampoules are held on canes in the 
liquid Ng refrigerant or its overlying vapour.
ii) Union Carbide model no. LR40, in which the ampoules are shelved 
in the vapour phase of the liquid N̂ .
Freezing unit. Union Carbide BF- 6  biological freezer, a plug-type 
device, designed for use with the LR-33-10 freezer. This unit is 
capable of cooling up to eight 2 ml ampoules at between 0.5°C and 7°C 
min to below -70°C.
Haemocytometer. Standard double grid improved Neubauer-type blood cell 
haemocytometer, with coverslips (Fisons Ltd., Loughborough). 
Microscopes
(i) For the examination of growing cell cultures under phase 
contrast and for haemocytometer counting an inverted biological 
microscope Wild M40 (Wild Heerburgg Ltd., Heerburgg,
Switzerland) was employed. This instrument fitted with 
appropriate condensers and XIO and X20 objectives gives 
magnifications of X187 and X375, respectively.
(ii) Binocular dissecting microscope. Standard microscope model (C.
Baker Ltd., London), which allows subject examination at X20.
2Disposable cell culture plasticware. 25 cm tissue culture (T/C) 
flasks, 100 mm x 16 mm T/C tubes with screw caps, 50 mm x 13 mm and 90 
mm X 16 mm T/C petri dishes with triple vented lids, were all of 
tissue culture grade polystyrene and obtained ready sterilised, from
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Sterilin Ltd., Feltham. Ampoules for the storage of cells in liquid 
Ng, 2 ml volume, polypropylene, with silicone rubber-lined screw tops, 
were obtained, ready sterilised from Sterilin.
30 ml polystyrene universal containers with screw caps were 
obtained ready sterilised from Sterilin.
Glassware. 125 ml and 500 ml bottles for the storage of solutions and 
media were obtained with caps, from Flow Laboratories Ltd., Irvine, 
Scotland.
The 150 ml soda glass 'medical' flat bottles in which cells were 
routinely grown, all other bottles and caps, and general laboratory 
glassware were obtained from Fisons Ltd.
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2.2 General Methods '*
2.2.1 Sterilisation by membrane filtration. All heat labile liquids,
solutions and media were sterilised by membrane filtration.
(i) Small volumes were filtered through autoclave sterilised 25 mm 
Swinnex units (Millipore UK Ltd., London), fitted with 0.2 ym or 
0.45 ym pore size Sartorius membrane filter discs (V.A. Howe and 
Co. Ltd., London).
(ii) Small volumes of hazardous solutions were filtered from luer- 
locked syringes through disposable Millex-GS units (Millipore), 
fitted with membrane filters of 0 . 2  pm pore size.
(iii) Non-aqueous solvents, incompatible with cellulose nitrate 
filters, were filtered through disposable Millex-FG units 
(Millipore), fitted with Fluorophore hydrophobic membrane 
filters of 0 . 2  ym pore size.
(iv) Large volumes of solutions and media, greater than 250 ml, were
filtered from a positive pressure apparatus (AB Stalmanufaktur, 
Stockholm, Sweden) through an autoclave sterilised 47 mm Swinnex 
unit fitted with an AP25 prefilter (Millipore), a Dacron filter 
separator (Millipore) and a 0.2 pm pore size membrane filter 
disc (Sartorius). Filtration under positive pressure was used in 
preference to filtration under negative pressure as it prevents 
frothing and minimises the loss of CO^ from bicarbonate 
containing media.
2.2.2 Recycling of glassware. Immediately after use all glassware was
rinsed with tap water, and, except for pipettes, processed as follows.
(i) All articles were soaked in a hand-hot 2% v/v solution of RBS25
detergent (Fisons Ltd.) for 30 min.
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(ii) Thoroughly cleaned, using a China brush on all surfaces under
running water.
(iii) Rinsed in three changes of tap water, being left for 30 min in 
the last rinse.
(iv) Rinsed in three changes of distilled water, again leaving for 30
min in the last rinse.
(v) Finally, all articles were rinsed and left for at least 30 min
in a large volume of freshly collected glass distilled water.
After drying in a hot air oven, all items were foil capped and 
sterilised at 160°C for a minimum of one hour. Graduated glass 
pipettes were rinsed in a pipette washer with tap water, for at least 
30 min, and then rinsed as above, from (iii). After drying in a hot 
air oven, pipettes were put into metal canisters and sterilised at 
1G0°C for a minimum of one hour.
2.2:3 Recycling of non-glass items. Specifically the tips for the 
replicating pipettes, bottle caps and membrane filter holders. 
Immediately after use these were rinsed with tap water and cleaned by 
boiling in three changes of single distilled water. After this they 
were rinsed as for glassware (from 2.2.2(iii)). After drying in a 
warm air oven, all items were sealed in autoclave bags (DRG Hospital 
Supplies, Bristol) and sterilised by autoclaving at 121°C for 15 mins.
2.2.4 Gases and gassing procedures.
(i) Cylinders of N̂ , CO^ and 5% CO^ in air mixture (5% CO^ and 20%
0 in N^) were all obtained from British Oxygen Company, ̂ d.
Bristol. COg and 5% CO^ in air mixture were piped to each work 
station from a central holding reservoir.
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(ii) Gas flowmeter, floating-needle type, 0.1-1.0 Imin  ̂ (Rotameter 
Manufacturing Co. Ltd., Croydon), calibrated for use with CO^.
(iii) Incubation boxes, rigid clear plastic boxes, 3.25 litre volume 
(A. Gallenkamp and Co. Ltd., London).
(iv) Gas-tight tape, British standard vinyl tape, 2.5 cm wide (Intech 
Tapes Ltd., Manchester).
All the cell culture media used contain a bicarbonate pH buffer 
system designed to equilibrate with 5% CO^ in air. To achieve this all 
gas-tight culture bottles and flasks were charged with such a mixture, 
introduced at a low flow rate through a sterilised Pasteur pipette 
plugged with non-absorbent cotton wool. Cell culture dishes were 
placed in incubation boxes which were flushed with 150 ml of CO^ from 
a metered supply, through a plugged Pasteur pipette. The boxes were 
then sealed with gas-tight tape. When only a few plates were put into 
a particular box an open 50 ml beaker of sterile water was included to 
prevent excessive evaporation of the culture medium.
2.2.5 Siliconising of Pasteur pipettes. Pasteur pipettes were coated 
by twice drawing up dimethylsilane solution (BDH Chemicals, Poole, 
Dorset) into them. They were allowed to air dry, and then immersed in 
a large volume of freshly collected distilled water for a minimum of 
30 min. The siliconised pipettes were dried in a warm air oven, sealed 
in autoclave bags and sterilised by autoclaving at 121°C for 15 min.
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2.3 Cell Culture Materials
2.3.1 Water. Double glass distilled water (DDH^O) was used in the 
preparation of all solutions and media. This was obtained from a 4 
litre hr  ̂bi-distillation Fistream still, model 2903 (Fisons Ltd.) 
fitted with a Fistream pre-deionizer (Fisons Ltd.) which was changed 
at regular intervals. DDH^O was sterilised by autoclaving at 121°C in 
100 ml, 500 ml and 1 litre quantities in glass bottles, for 
appropriate times. Sterile DDH^O produced in this way has a pH of 4.5.
2.3.2 Balanced salt solution. Dulbecco's phosphate buffered saline was 
routinely used, either with or without added calcium and magnesium 
ions, solutions designated PBS and PBS(A), respectively.
Composition: (Dulbecco and Vogt, 1954).
'2'
_1Component gl DDH 0
NaCl 8
KCl 0.2 PBS (A) p^g




Sterile PBS(A) was prepared by dissolving one Dulbecco A tablet (Oxoid 
Ltd., London) in 100 ml of freshly collected DDH^O and autoclaving for 
15 min at 121°C. PBS was prepared by the aseptic addition of 0.5 ml 
Dulbecco B solution (Oxoid Ltd.) to 100 ml of sterile PBS(A). Both PBS 
and PBS(A) were stored at room temperature, for a maximum of one 
month.
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2.3.3 Additives for Cell Culture Media ^
(i) Antibiotic solution, penicillin (5,000 lU ml ^) and streptomycin 
(5,000 yg ml ^) sterile solution was obtained from Flow Labs 
Ltd. in 100 ml unit quantities. This was subdivided into 15 ml 
volumes and stored frozen in plastic universals at -20°C, for a 
maximum of one year.
(ii) L-Glutamine solution was obtained as a sterile 200 mM solution 
in 100 ml unit quantities from Flow Labs. Ltd. This was 
subdivided into 15 ml volumes and stored frozen in plastic 
universals at -20°C, for a maximum of one year.
(iii) L-Proline solution was prepared at a concentration of 100 mM 
from chromatographically homogeneous L-proline (cell culture 
tested. Sigma Chemicals Ltd., Poole, Dorset) in DDH^O, and 
sterilised by membrane filtration. 5 ml volumes of this solution 
were stored in glass bijou bottles at -20°C, for a maximum of 
one year.
(iv) L-Cysteine solution was prepared as a 40 mM solution of 
L-cysteine hydrochloride (cell culture tested. Sigma) in DDH^O 
and sterilised by membrane filtration. 1 0 ml volumes of this 
solution were stored in plastic universals at -20°C, for a 
maximum of one year.
(v) Glutathione (GSH) solution was prepared as a 20 mM solution of 
GSH, reduced form (cell culture tested. Sigma) in DDH^O and 
sterilised by membrane filtration. 1 0 ml volumes of this 
solution were stored in plastic universals at -20°C for a 
maximum of one year.
(vi) Sodium bicarbonate was obtained as a sterile 7.5% w/v NaHCO^ 
solution in 100 ml unit quantities from Flow Labs Ltd. This
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solution was stored at room temperature for a maximum of one 
year.
(vii) Thymidine solution was prepared as a 3 mM solution of
chromatographically homogeneous thymidine (BDH Chemicals) in 
DDHgO and sterilised by membrane filtration. 5 ml volumes were 
stored in glass bijou bottles at -20°C for a maximum of one 
year.
2.3.4 Media
(i) Ham's FIO medium, Eagle's minimal essential medium with Earle's 
salts, and 199 medium with Earle's salts were all obtained as 
sterile 10 x liquid concentrates with phenol red but without 
L-glutamine and NaHCG^ from Flow Labs Ltd. in 100 ml units. 
These were stored at 4°C for a maximum of one year.
500 ml volumes of single strength media were aseptically 
prepared from these concentrates, with other media components 
added in the order given (Table 2.1). Once prepared the single 
strength media were stored in 100 ml volumes at 4°C and used 
within 4 weeks.
(ii) Ham's FIO medium without hypoxanthine, thymidine and NaHCO^ was 
obtained in powder form from Flow Labs Ltd. and stored at 4°C 
for a maximum of one year. Powder to prepare 1 litre of Ham's 
FIO medium without hypoxanthine (FIO(-HX)) was added to 
approximately 800 ml of freshly collected DDH 0. The powder was 
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Antibiotic solution 10 ml
L-proline solution 2 ml
L-glutamine solution 10 ml
Thymidine solution 1 ml
NaHCOg solution 16 ml
The medium was made up to 1000 ml with DDH^O, rendered slightly acidic 
by bubbling with CO^ and sterilised under positive pressure membrane 
filtration (2 .2 .1 ).The sterilised medium was stored in 1 0 0 ml volumes 
at 4°C and used within 4 weeks.
2.3.5 Trypsin solutions.
Trypsin (1:250) was obtained as a sterile 2.5% w/v solution in 
Hank's balanced salt solution without calcium, magnesium and phenol 
red, in 100 ml unit quantities from Flow Labs Ltd. This was 
aseptically diluted to working strengths of 0.05% w/v, 0.025% w/v or
0.025% w/v with 0.02% w/v EDTA with PBS(A). These solutions were 
stored at -20°C in approximately 16 ml volumes in plastic universals, 
and used within 4 weeks. Prior to use the solutions were thawed in a 
37°C water bath.
2.3.6 Sera
For all the cell lines used the culture medium was supplemented 
with 5% foetal calf serum (FCS). To achieve this level 5.3 ml of FCS
was added to 1 0 0 ml of medium immediately before use.
During the course of these studies FCS from four different 
batches was used. These were selected after the evaluation of FCS 
samples from a number of different commercial sources for the ability, 
as a media supplement, to support clonal growth.
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Batch 1: Sera Labs Ltd., Crawley Batch No 001090
Batch 2: Gibco Ltd., Paisley, Scotland Batch No. U523901D
Batch 3: Sera Labs Ltd. Batch No. 301110
Batch 4: Gibco Ltd. Batch No. 40G4136S
Serum from both sources was obtained filter sterilised in 500 ml unit 
quantities. These were allowed to thaw at 4°C and were then subdivided 
into 100 ml volumes. These were stored frozen at -20°C, for a maximum 
of 18 months. As required, 100 ml volumes were withdrawn from stock 
and allowed to thaw at 4°C. Once thawed the serum was used within 2 
weeks.
2.3.7 Cryoprotectants and Solvents
(i) Glycerol, AnalaR grade (Fisons Ltd.) was stored at room 
temperature, protected from moisture. Prior to use as a 
cryoprotectant, 2-3 ml volumes were sealed in glass powder 
ampoules and sterilised by dry heat at 160°C for one hour.
(ii) Dimethylsulphoxide (DMSO), grade 1 (Sigma) was obtained in 100 
ml quantities sind stored in tightly capped bottles at room 
temperature. For use as a cryoprotectant DMSO was filter 
sterilised through 0.2 ym Millex-FG units. As a solvent it was 
used without sterilisation.
(iii) Acetone, HPLC grade (Fisons Ltd.) was stored at room 
temperature, protected from moisture. It was used as a solvent 
without sterilisation.
2.3.8 Stain
For staining colonies attached to plates a 0.5% w/v solution of 
methylene blue (BDH Chemicals) in 50% methanol was used.
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2.4 Mutagens
2.4.1 N-Methyl-N*-nitro-N-nitrosoguanidine (MNNG) was obtained in 
crystalline form (Sigma) and stored in a desiccator at -20°C. Stock 
solutions of 1 mg ml were prepared in DDH^O. 6 ml aliquots of this 
were sterilised through 0.2 ym Millex-GS filter units and stored in 
glass bijou bottles at -20°C, protected from light for a maximum of 4 
weeks. Immediately before use stock solutions were thawed in a 37°C 
water bath and diluted with sterile DDH^O before addition to cell 
cultures. The purity of the MNNG used in these studies was assessed by 
the spectrophotometric method of La Polla et al. (1972) - see 
Appendix.
2.4.2 N-Methyl-N-nitrosourea (MNU) was obtained in crystalline form, 
with approximately 25% of its weight made up from a 5% solution of 
acetic acid as a stabiliser (Sigma). This was stored at 4°C. Solutions 
were prepared at the appropriate concentrations in culture medium 
immediately prior to use.
2.4.3 Methylmethane sulfonate (MMS) and ethylmethane sulfonate 
(EMS) were both obtained as pure liquids (Sigma) and stored at
4°C. Solutions at appropriate concentrations were prepared in culture 
medium immediately prior to use.
2.4.4 7,12-Dimethylbenz [g anthracene (DMBA) was obtained in 
crystalline form (Sigma) and stored at 4°C. Solutions were prepared at 
appropriate concentrations in DMSO immediately prior to use.
2.4.5 Dialkylaminoalkyl chlorides. Dimethylamino prOpylchloride (DMAP) 
was obtained in crystalline form (Aldrich Chemical Co. Ltd).
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Dimethylaminoethyl chloride (DMAE) and 1 (2-chloroethyl)piperidine 
(CEP) were synthesised and chemically characterised in the School of 
Pharmacy, University of Bath. Solutions of these were prepared, 
immediately prior to use, at a concentration of 50 mg ml in DDH^O 
and sterilised through 0.2 ym Millex-GS filter units. Before addition 
to cell cultures these solutions were diluted in sterile DDH^O.
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2.5 Promoters
2.5.1 12-0-Tetradecanoylphorbol-13-acetate (TPA) was obtained in 
nitrogen purged glass ampoules and stored at -20°C, protected from 
light. It has been reported that the activity of this compound may be 
dependent upon its source (Nagasawa and Little, 1981). The TPA used 
throughout these studies was therefore obtained from one single 
supplier from 3 different lots (Sigma).
Batch 1 10 mg Lot no. 13F-0219
Batch 2 1 mg Lot no. 52F-0205
Batch 3 15 mg Lot no. 34F-0682.
Stock solutions were prepared in DMSO at 1 mg ml , and subdivided 
into approximate 0.5 ml aliquots in small glass bijou bottles with 
foil-lined caps. Each bottle was purged with before sealing, and 
stored at -20°C protected from light. Under such storage conditions 
phorbol esters are reported to be stable for many months (Schmidt and 
Hecker, 1975).
2.5.2 Benzoyl peroxide (BZP) was obtained from Stieful Research 
Institute, New York, as a 70% active granular powder moistened with 
30% water. To prevent the interference of oxidation products in 
experimental results, solutions were prepared in acetone at a 
concentration of 1.5 mg ml immediately prior to use.
2.5.3 Formaldehyde (HCHO) was obtained as a 38% w/v solution 
containing 10-14% methanol as a stabiliser to prevent polymerisation 
(Fisons Ltd.) and stored at room temperature. Immediately before use 
this was diluted in sterile DDH^O before addition to cell cultures.
2.5.4 Linear alkanes. n-Decane, n-dodecane and n-tetradecane were all
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obtained as 99%+ pure liquids (Sigma) and stored at room temperature. 
Immediately before use they were diluted in acetone to a concentration 
of 0.12M before addition to cell cultures.
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2.6 Mutagenesis Assay Selecting Agents
2.6.1 Ouabain (Qua) was obtained as ouabain octahydrate crystals 
(Sigma) and stored at room temperature. Stock solutions were made at 
30 mM or 10 mM in culture medium by dissolving at 50°C, protected from 
light. Solutions were sterilised by membrane filtration, stored in the 
incubator at 37.5°C and used within 48 hours. 1 ml of the appropriate 
stock solution was added to each selection plate with 9 ml of medium 
to give 3 mM or 1 mM Oua as required.
2.6.2 Thioguanine (TG) was obtained in crystalline form, assay 
approximately 98% (Sigma) and stored at room temperature. A 10 mM 
stock solution was prepared in 0.5% w/v aqueous sodium carbonate and 
sterilised through a 0.2 ym Millex-GS filter unit. 5 ml volumes were 
stored at -20°C protected from light for a maximum of 4 weeks.
2.6.3 Emetine (Emt) was obtained as emetine dihydrochloride (Sigma) 
and stored at 4°C. A 10  ̂M stock solution was made in DDH^O and 
sterilised through a 0.2 ym Millex-GS filter unit. 5 ml volumes were 
stored at -20°C protected from light, for a maximum of 4 weeks. 
Immediately before use the stock solution was thawed at 37°C and 
diluted in culture medium before addition to selection plates.
2.6.4 Methylglyoxal bis(guanylhydrazone) (MGBG) was obtained in 
crystalline form (Sigma) and stored at -20°C. A 10 M stock solution 
was made in DDH^O and sterilised through a 0.2 ym Millex-GS filter 
unit. 5 ml volumes were stored at —20°C protected from light, for a 
maximum of 4 weeks. Immediately before use the stock solution was 
thawed at 37°C and diluted in culture medium before addition to 
selection plates.
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2.6.5 Aminopterin was a gift from Lederle Laboratories and stored at
_4-20°C. A 10 M stock solution was prepared in a 0.5% w/v aqueous 
sodium carbonate and sterilised through a 0.2 ym Millex-GS filter 
unit. 5 ml volumes were stored at -20°C protected from light, for a 
maximum of 4 weeks.
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2.7 Cell Lines
(i) CHO-KIA cells, a subclone of CHO-Kl, a L-proline requiring 
Chinese hamster cell line (Kao and Puck, 1968), were isolated 
and characterised by Dr. R.S. Dewdney (1982). These cells were 
used in experiments between passages 30 and 40.
(ii) V79-379A cells, a subclone of V79-1 mature male Chinese hamster 
lung fibroblasts (Ford and Yerganian, 1958), were obtained from 
Flow Labs Ltd. These were obtained at an unknown passage number 
and used in experiments for up to 1 0 passages after receipt, as 
recommended by the suppliers.
(iii) Chinese hamster ovary cells, designated CHO(S), originating from 
the University of Swansea, were kindly provided by Dr. J.
Asquith (Toxicol Laboratories Limited, Ledbury). Cells were 
received at an unknown passage number and used in experiments 
for up to 1 0 passages after receipt.
The maintenance of more than one cell line in the same 
laboratory presents a problem of cross contamination (Paul, 1975). 
Great care was therefore taken to maintain the purity of cultures 
throughout these studies. Simultaneous handling of different cell 
lines was never undertaken and bottles of medium were designated for 
use with only one particular cell line.
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2.8 Cell Culture Methods
2.8.1 Maintenance of Cell Lines
The cell lines employed in these studies are all capable of
monolayer growth attached to glass surfaces. Stock cultures were
routinely maintained in culture medium in 150 ml clear, soda-glass
'medical' flat bottles at 37.5°C. For some experiments monolayer
2cultures were maintained in 25 cm growth area plastic T/C flasks.
Cultures were never allowed to reach a point where cells were 
released from a confluent monolayer, since this can lead to an 
increased heterogeneity within the cell population (Ham and Puck, 
1962). Routine subculture protocols were designed to keep cells in a 
state of active growth, whilst never allowing them to reach complete 
confluence (2.8.4).
2.8.2 Preparation of cell suspensions from monolayer cultures
The essential procedure in the maintenance of cells in culture 
is subculture, involving the transfer of cells from one culture vessel 
to another. To effect this for monolayer cultures a suspension of 
cells must first be obtained. Once in suspension cells can also be 
greatly diluted and plated so that colonies arise from single cells, a 
procedure important in many experiments.
The same method was used for the preparation of cell suspensions 
of all the three cell lines employed, although the trypsin solutions, 
incubation and centrifugation conditions were varied (Table 2.2).
Prior to manipulation cultures of cells in glass bottles were 
examined by naked eye. For routine subculture the culture medium had 
to be clear, with no floating cellular debris, and not unduly acidic 
or basic, as indicated by the phenol red component. Cell growth was 
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in plastic T/C flasks closer examination of cell growth, under phase 
contrast microscopy, was possible. For these cultures cells had to 
have a normal appear since, dependent on cell type, with no retractile 
granules in their cytoplasm. If a particular culture failed to fulfil 
these requirements it was discarded.
The medium was removed from the culture and the monolayer rinsed
with 5 ml of trypsin solution (Table 2.2). This was discarded and
replaced by another 2 ml of trypsin solution. The culture was
incubated, as indicated (Table 2.2) and then shaken vigorously to
release the cells. The suspension of cells was aspirated with a
sterile Pasteur pipette, added to 5 ml of serum containing medium in a
T/C tube, and sedimented by centrifugation, as indicated (Table 2.2).
The supernatant was discarded and the cells resuspended in 5-10 ml of
6 -1medium, at an approximate cell density of 10 cells ml . Although the 
Ca^^ and Mg^^ present in culture medium and serum provide some 
protection against the deleterious effects of the enzyme, resuspending 
the cells in trypsin-free medium limits its carry over into fresh 
cultures. This was found to be of particular importance in the 
maintenance of V79-379A cells, and CHO-KIA cells grown in 199 medium.
2.8.3 Determination of cell density
This was achieved by haemocytometer count, a method which also 
allows visual examination of the cells prior to experiments. Cells 
were thoroughly mixed before a small volume was withdrawn from just 
below the surface of the suspension, and introduced into the 
haemocytometer chamber. A total cell count was performed on eight 
large squares of the haemocytometer grid under phase contrast 
microscopy. If cell clumping was observed the count was discarded, and 
the suspension aspirated to break up the clumps and new sample taken.
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If the cell density was greater than 150 per large squsire, at which 
point counting becomes impeded by crowding, the suspension was further 
diluted and sampling repeated.
Cell count per ml  ̂is given by:
-1 4cell ml =10 n, where n is the average no. of cells per
large square.
2.8.4 Subculture Routine
To maintain cultures in a state of active growth the cells were 
subcultured at low inoculation density at least three times a week, in 
the following protocol.
MONDAY----------------- ► WEDNESDAY------------ ► FRIDAY
Inoculate Inoculate Inoculate
5 5 55 X 10 cells/culture 5 x 10 cells/culture 2x10 cells/ culture
t___________:____________ I
Aliquots of counted cell suspensions were added to 14.5 ml 
volumes of culture medium, pre-warmed to 37.5°C, in standsird culture 
bottles and the cells evenly distributed by gentle agitation. Culture 
bottles were then purged with 5% CO^ in air mixture for 10-15 sec 
(2.2.4), capped tightly and returned to the incubator. As photo­
products toxic to mammalian cells are known to be formed from certain 
media components (Wang et al., 1974), cultures were incubated in the 
dark. For the.maximum surface area to be available for growth, bottles 
were incubated horizontally.
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For use in experiments, cultures were put up at the subculture
preceding the experiment. When a culture was required for use 3 days
5 5later 2 x 10 cells were inoculated, and for use 2 days later 5 x 10
cells were inoculated.
2.8.5 Cell Storage
Stocks of cells were routinely stored frozen in liquid N^, or 
its overlying vapour, in the presence of a cryoprotectant. Either 5% 
DMSO or 8% glycerol were employed as cryoprotectants. No noticeable 
differences in subsequent recovery of growing cells was observed with 
either of these compounds.
A culture in a state of active growth and ready for routine 
subculture was selected. A cell suspension was prepared (2.8.2) and 
the cell density determined (2.8.3). A number of cells was then 
withdrawn and adjusted to 5 x 10^ cells ml ^, first with medium and 
finally the required volume of cryoprotectant. This cell suspension 
was thoroughly mixed and 1 ml volumes immediately distributed into 2 
ml screw-capped polypropylene ampoules. Once distributed into 
ampoules the cells could be kept at 4°C for many hours without any 
noticeable effects on recovery. Batches of 8 ampoules were cooled at 
1°C min in the freezing unit on top of a LR-33-10 liquid N^ freezer, 
to below -70°C, and then rapidly transferred to a liquid N^ freezer 
for long-term storage. A few days after every freezing operation one 
ampoule was removed from storage. If the cells could be recovered to 
normal growth the freezing procedure was considered successful.
2.8.6 Recovery of Cells from Storage
After removal of the ampoule from storage, the contents were 
thawed rapidly at 37°C and the ampoule swabbed with 70% alcohol. The
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cells were transferred by sterile Pasteur pipette to 14 ml of 
prewarmed culture medium in a culture bottle and evenly distributed by 
gentle agitation. The culture bottle was purged with 5% CO^ in air 
mixture and incubated at 37.5°C. Within 2-3 hours the cells had 
usually attached to the glass surface, and after 2-3 days were grown 
sufficiently to be passaged. The culture was then subjected to the 
normal subculture routine.
2.8.7 Dilution Plating
For the majority of experiments the plating of a small number of 
single cells into petri dishes, and their subsequent growth into 
macroscopic colonies is a key operation. This single-cell plating 
technique allows the determination of the plating (cloning) 
efficiency, the proportion of cells in a given population which are 
viable, measured as their ability for clonal growth.
Although the dilution plating procedure varies with the nature 
of the particular experiment the following is the basis for all the 
procedures. 4.9 ml aliquots of culture medium in 50 mm T/C petri 
dishes were equilibrated at 37.5°C in a humidified 5%C0^ atmosphere, in 
plastic incubation boxes. To prevent cell loss through attachment to 
glass surfaces, which occurs rapidly at 37.5°C (Ham and Puck, 1962), 
all other medium and solutions were used at room temperature. A cell 
suspension was prepared (2.8.2) and the cell density determined 
(2.8.3). The counted cell suspension was serially diluted to a final 
cell density of 10^ to 2 x lo"̂  viable cells ml For each step of the 
dilution 0.5 ml of the cell suspension was diluted with 4.5 ml of 
medium without FCS in a T/C tube, and whirlimixed for 3-4 sec. 
Mammalian cells tend to settle rapidly from suspension because of 
their large size. To maintain the uniformity of the cell suspensions
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the dilution procedure was performed as quickly as possible with 
frequent mixing. Replicate 0.1 ml volumes of the final dilution were 
added to the equilibrated T/C dishes and the cells evenly distributed 
by gentle agitation. Inoculated dishes were replaced in the incubation 
boxes and provided with a 5% CO^ atmosphere (2.2.4). The sealed boxes 
were incubated in the dark at 37.5°C for 7-8 days, a time sufficient 
for the clonal growth of all three cell lines employed. During 
incubation the dishes were left undisturbed to prevent the formation 
of satellite colonies.
2.8.8 Staining
To determine the plating efficiency of the cells, the medium was 
poured from the culture and the dishes flooded with 0.5% methylene blue 
in 50% methanol. After 30 min the dishes were carefully rinsed under 
running tap water and allowed to dry. Colonies were scored by naked 
eye against a white background, with aggregates containing 50 or more 
cells qualifying as survivors. Colonies of marginal size were examined 
under a binocular dissecting microscope to confirm that they fulfilled 
this criterion. For the majority of experiments, and all those 
comprising control aind test treatments, plates were coded and. 
randomised prior to counting.
2.8.9 Determination of growth parameters
One of the characteristics of Chinese hamster cell lines that 
made them useful to these studies is their ability to grow under 
various culture conditions. To ensure that differences in culture 
conditions would not significantly affect the interpretation of later 
results growth parameters were determined for the three cell lines, as 
follows.
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5Inocula of 2 X 10 cells were subcultured with 5 ml of the 
appropriate culture medium in a number of 25 cm̂  T/C flasks and 
incubated at 37.5°C. At intervals a culture was removed and its total 
cell number determined. The medium in the culture flask was withdrawn 
and placed on a 16 mm graduated round bottomed test tube (MSE 
Scientific Instruments). The cell monolayer was rinsed with 2 ml of 
the appropriate trypsin solution (Table 2.2) and dispersed by 
incubation with 1 ml of trypsin solution. Both the rinse solution and 
the suspended cells were added to the medium in the tube. The flask 
was then rinsed with two 1 ml portions of PBS to remove the residual 
cells. Complete removal of the cells was confirmed by microscopic 
examination. Cell losses due to adherence was minimised by the use of 
a single siliconised Pasteur pipette (2.2.5) for all the above 
transferences. Cells were sedimented by centrifugation (1500 rpm; 5 
min) £ind resuspended in approximately 0.5 ml of the supernatant. The
5suspension was adjusted to an expected cell density of 2.5 x 10 - 1.5
6 -1X 10 cells ml with PBS and the final volume of suspension noted.
The cell density was determined by haemocytometer count and the total 
cell number calculated.
Under all the conditions of growth examined all three cells 
lines exhibited "classical” growth kinetics, with three distinct 
phases of growth: i) a lag phase, ii) an exponential growth phase, and 
iii) a stationary phase. Fig. 2.1 shows a typical growth curve for 
CHO-KIA cells grown in FIO medium. From such curves two parameters can 
be determined, the lag time (a), the time taken for growth to 
commence, and the population doubling time (T). The exponential phase 
of growth can be represented by the following equation
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Fig. 2.1 Growth curve for CHO-KIA cells grown in Flo.
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or in its logeirithmic form
log = log + kt log 2
where N is the cell number at time 0 o
is the cell number at time t 
and k is the exponential growth rate constant.
The population doubling time (T) is the inverse of k, i.e. T = 1/k.
The growth parameters calculated for the three cell lines grown under 
different culture conditions are given in Table 2.3.
With the exception of CHO-KIA cells grown in the 199 based 
media, these values are in good agreement with the literature values 
for various OHO and V79 cell lines (T = 10-16 hr, Bradley et al.,
1981; Hsie et al., 1981). The growth parameters for CHO-KIA cells 
grown in FIO medium, calculated from Fig. 2.1, are in close agreement 
with those obtained during their initial characterisation (T = 11-12 
hr, lag time 6-7 hr, Dewdney, 1982). The slightly longer doubling 
times for cells grown in the 199-based media might be due to the 
presence of growth inhibitory factors in the medium. This medium was 
designed for the short term culture of chick embryo cells, rather than 
established cell lines, and contains a number of components not 
present in either FIO or EMEM, most particularly the surface active 
agent Tween 80 (Morgan et al., 1950).
2.8.10 Effects of TPA on growth parameters of CHO-KIA cells
During these proposed investigations CHO-KIA cells would be 
exposed to TPA for prolonged periods. Because of its profound effects 
on cellular growth in cells in culture (see 1.5) the effects of TPA 
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2 X 10 CHO-KIA cells were inoculated into 25 cm̂  T/C flasks 
with 5 ml FIO containing either TPA (1 yg/ml) or TPA vehicle (DMSO 
1 yl/ml), and incubated. At intervals a culture was removed and its 
total cell number determined (see 2.8.9). The total cell number at 
various times following inoculation for DMSO- and TPA-exposed cultures 
of CHO-KIA cells are given in Table 2.4, together with the calculated 
growth parameters.
Table 2.4 Growth parameters for CHO-KIA cells grown in FIO medium 












11.6 hr 11.1 hr
lag time 3 hr 4 hr
When compared with values obtained previously for growth 
parameters (Table 2.3) these results show that neither TPA nor DMSO 
affects the growth of CHO-KIA cells in FIO.
When examined under inverted phase microscope, the morphology of 
the cultures was noticeably different. The cells in DMSO-treated 
cultures retained their normal epitheloid appeeirance. The cells in
82
TPA-treated cultures, however, were irregular in shape with an 
increased number of cytoplasmic processes. Similar effects of TPA on 




Statistical tests of difference between any apparently elevated 
frequencies of mutation in TPA-treated cell populations and mutation 
frequencies in corresponding TPA-untreated populations were done by 
the method of Stevens (1942). This method was previously used to test 
the statistical significance of any effect of TPA on mutagen-elevated 
mutation frequency in CHO-KIA (Dewdney, 1982), and V79 cells (Trosko 
and Chang, 1976). It involves the calculation of an upper probability 
limit for the control mutation frequency. Any mutation frequency 
higher than this limit, induced in the presence of TPA, was assumed to 
be significantly elevated above control level. All tests were 
one-tailed and carried out at the 5% significance level.
84
CHAPTER 3. THE EFFECTS OF TPA ON GENE MUTATION IN CHO-Kl CELLS
3.1 Introduction
In previous studies in this Department a mutagenic enhancing
activity has been detected for TPA (Dewdney and Soper, 1984). It
enhanced chemical-induced Oua mutation of CHO-Kl cells, while having
no effect on spontaneous mutation to Oua^ or mutagen-induced
lethality. This effect, however, was mutagen dependent, being observed
with MNNG-induced mutation but not with mutations induced by EMS or UV
(Dewdney and Soper, 1984). In these studies, the findings of Trosko et
al. (1977) and Lankas et al. (1980), that the extent of enhancement of
mutagenesis by TPA was dependent upon the duration of promoter
treatment, were also confirmed. This chapter reports experiments
conducted to extend these previous studies on CHO-Kl cells and
examines in more detail the mutagen specific activity of TPA.A description of
the mutagens used in these studies is given in Chapter 1 (see 1.7).
The results of preliminary experiments by Dewdney (1982) also
suggested that there were differences in mutation enhancement at
R Rdifferent genetic loci (Oua and TG ) Experiments were therefore
conducted where TPA enhancement of mutation at four independent
R R R Rgenetic loci - Oua , TG , Emt and MGBG was assessed. The biochemical
basis of mutagen testing at these loci is described below.
85
3.2 Drug resistance markers
p
3.2.1 Mutation to ouabain resistance (Oua )
In mammalian cells the active transport of sodium and potassium
ions is associated with the Na^ - - Mg^^ -activated ATPase (E.G.
3.6.1.3, hereafter referred to as Na^K^ATPase) of the plasma membrane
(Baker et al., 1974). The steroid compound ouabain (Oua) which
specifically inhibits this enzyme, also inhibits the growth of
mammalian cells and is ultimately cytotoxic (Baker et al., 1974;
Davies and Parry, 1974). Clones of both established and primary cell
lines have been obtained, by selection in Oua containing medium,
which have greatly increased resistance to Oua cytotoxicity when
compared with wild-type cells (Baker et al., 1974; Davies and Parry,
1974; Cole and Arlett, 1976; Arlett, 1977a).
A number of observations have been confirmed that the occurrence
of ouabain resistance (Oua ) reflects a mutant genotype (Baker et al.,
1974; Davies and Parry, 1974; Cole and Arlett, 1976; Arlett, 1977a;
Gupta and Siminovitch, 1980).
ROua is considered to arise by virtue of gene mutations which
alter Na^K^ATPase, or an adjacent membrane component, such that the
enzyme has a reduced affinity for Oua or gives an altered response to
the bound drug. EMS and UV, agents capable of inducing base-pair
substitution mutations, are efficient inducers of Oua mutants (Baker
et al., 1974; Arlett, 1977a). Agents which cause chromosomal-deletion
type mutations, such as X-rays, and those inducing frameshift
mutations, such as B-methoxypsoralen, are incapable of enhancing 
Rmutations to Oua (Arlett, 1977b; Gupta and Siminovitch, 1980). This 
can be readily explained on the basis that Na^K^ATPase activity is an 
essential function for the survival of the cell and mutations which 
result in its deletion or inactivation will be lethal. Mutations to
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Oua are likely, therefore, to be base-pair substitutions resulting iq 
a single amino acid or stable conformational alteration of either 
Na^K^ATPase itself or some adjacent membrane components.
p
3.2.2 Mutation to 6-thioguanine resistance (TG )
The biochemical basis of the resistance to the cytotoxic actions
of the purine analogue 6-thioguanine (TG) is well established and has
been extensively reviewed by Caskey and Kruh (1979). Briefly, TG is
converted into the nucleoside 5'monophosphate, thioguanosine
monophosphate, by the enzyme hypoxanthine-guanine-phosphoribosyl-
transferase (E.C. 2.4.2.8, hereafter abbreviated to HGPRT), present in
the purine salvage pathway. After further phosphorylation this can
then be incorporated into nucleic acids in place of guanine. Although
sufficiently similar to guanine to be metabolised in an identical
manner, TG is sufficiently dissimilar to functionally alter the DNA
and RNA into which it is incorporated and thus causes cell death.
Clones of rodent and human cells have been isolated, from
primary and established cell lines, which are markedly more resistant
to the toxic actions of TG than their parental cell strains
(Abbondandolo, 1977). This is almost certainly a consequence of HGPRT
deficiency and is confirmed by the observations of greatly reduced or
Raltered HGPRT enzyme activity in cell-free extracts from TG clones of 
both CHO-Kl (Hsie et al., 1975) and human lymphoblastoid cells 
(Epstein et al., 1977). Additionally, 98% of TG^ CHO-Kl clones will
3not incorporate H-hypoxanthine into their nucleic acids, presumably 
because they have lost the ability, through loss of HGPRT, to 
metabolise this exogenous purine (Hsie et al., 1975).
A 'back selection' system has also been utilized to prove that 
TG^ cells are HGPRT-negative (HGPRT”). Normal (HGPRT'*’) cells can
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survive when grown in the presence of the de novo purine synthesis 
inhibitor aminopterin, as long as they are provided with exogenous 
hypoxanthine (HX) and thymidine. Under these conditions, HGPRT^ cells 
are still able to obtain sufficient amounts of purine nucleosides to 
maintain normal nucleic acid synthesis, through the purine salvage 
pathway. HGPRT cells, however, are unable to utilize HX because this 
pathway is missing. When plated into hypoxanthine, aminopterin and 
thymidine containing medium (HAT medium) HGPRT cells are growth 
inhibited and eventually die. Using this, O'Neill et al. (1977) have 
shown that 98% of TG CHO-Kl mutants, are incapable of growth in HAT 
medium and are presumed to be HGPRT .
The gene coding for HGPRT is located on the X-chromosome in man 
(De Mars, 1968) and in the hamster (Caskey and Kruh, 1979). Thus, only 
one HGPRT locus is present in male cells and only one is expressed in 
female cells (Albertini and De Mars, 1970). As HGPRT function is coded 
by a hemizygous gene, TG has been shown to behave like a recessive 
genetic trait in appropriate cell hybrids (Paul, 1975).
There is considerable evidence that a phenotypic change to TG 
represents a true gene mutation (O'Neill et al., 1977, 1979; Hsie, 
1980).
All classes of physical and chemical mutagens have been reported
p
to induce mutations to TG in CHO-Kl (O'Neill et al., 1977; Hsie, 
1980), V79 (Arlett, 1977a, 1977b) and L5178Y mouse lymphoma cells 
(Cole and Arlett, 1976; Arlett, 1977b). De Mars and Jackson (1977) 
suggest that TG variants can result from all conventional classes of 
mutations, except leirge scale or whole chromosome deletions.
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3.2.3 Mutation to emetine resistance (Emt )
The ipecac alkaloid emetine is a rapidly acting reversible 
inhibitor of protein synthesis (Grollman, 1966). Its mechanism of 
action is similar to that of cycloheximide in that it inhibits 
polypeptide chain elongation. The molecular lesion associated with 
Emt has yet to be identified although it appears to be localized in 
the 40S ribosomal subunit (Gupta and Siminovitch, 1977).
Clones of HeLa and CHO cells have been isolated, by single-step 
selection, which are markedly more resistant to the cytotoxic actions 
of emetine than their parental cell strains (Grollman, 1966; Gupta and 
Siminovitch, 1976). Protein synthesis in cell-free extracts of Emt 
CHO mutants is resistant to the inhibitory action of emetine, con- 
firming that the molecular lesion in these Emt cells lies in the 
protein synthesis pathway (Gupta and Siminovitch, 1976, 1977).
For CHO cells Emt has been shown to be a true gene mutation 
(Gupta and Siminovitch, 1976). Somatic cell hybridization studies show 
that Emt^ is phenotypically recessive to Emt^ (Gupta and Siminovitch, 
1977).
As the Emt locus codes for an essential gene function only
Rlimited classes of mutagens are capable of inducing Emt in CHO cells. 
Base-pair substitution mutagens, such as alkylating agents and UV, are 
efficient inducers of Emt (Gupta and Singh, 1982; Singh and Gupta,
31982). Tritium decay of H-thymidine incorporated into DNA and 
frameshift mutagens, such as ICR 191, are incapable of enhancing 
mutation to Emt (Gupta and Siminovitch, 1980).
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3.2.4 Mutation to methylglyoxal bis(guanylhydrazone) resistance
MGBG^)
Polyamines are ubiquitous molecules which influence many 
biochemical reactions, particularly those involved with cell 
proliferation and synthesis of macromolecules. Methylglyoxal 
bis(guanylhydrazone) (MGBG) is a powerful inhibitor of S-adenosyl- 
L-methionine decarboxylase (E.G. 4.1.1.50, SAMD), a key-enzyme in 
polyamine synthesis (Williams-Ashman and Schenone, 1972). MGBG has 
been used clinically in the treatment of leukaemia because of these 
antiproliferative properties.
MGBG is extremely toxic to cells both 'in vivo and in vitroi 
although clones of established CHO cells and rat myoblasts have been 
isolated which sire resistant to the actions of MGBG (Mandel and 
Flintoff, 1978). None of these isolated mutants, however, show any 
alterations in SAMD activity, and MGBG was found to result from a 
dramatic reduction in polyamine and MGBG transport across the cell 
membranes (Mandel and Flintoff, 1978).
The stability of the MGBG phenotype sind its increased frequency 
after mutagenesis suggests that resistance to MGBG represents a true 
genetic mutation, although definite proof is still lacking (Mandel and 
Flintoff, 1978). However, in somatic cell hybrids the MGBG phenotype 
behaves recessively (Mandel and Flintoff, 1978).
As polyamine synthesis is essential for cell viability only
limited classes of mutagens induce MGBG in CHO cells (Gupta and
Singh, 1982). Base-pair substitution mutagens are effective inducers 
Rof MGBG , while frameshift mutagens do not enhance the frequency of 
MGBG^ (Gupta and Siminovitch, 1980).
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3.3 The effects of TPA on chemically-induced mutation of CHO—K1
Rcells to Qua
In CHO-KIA cells, TPA has been shown to enhance the recovery of 
Qua mutants induced by MNNG, but not those induced by EMS (Dewdney 
and Soper, 1984). The first part of this investigation was to examine 
the effect of TPA on Qua mutations induced by mutagens producing a 
wide variety of DNA lesions, using a standard experimental procedure. 
The test mutagens used were MNNG, MNU, MMS, EMS, DMAE, DMAP, CEP and 
DMBA (see 1.7).
Quantification of the frequency of mutation of CHO-KIA cells to
RQua was assessed by an in situ protocol previously validated for this 
cell line (Dewdney, 1982). In this type of assay the cells are plated, 
treated with a mutagen and then left undisturbed except for the 
addition of the selecting agent. The optimum conditions for the 
recovery of CHO-KIA Oua mutants, as characterised by Dewdney (1982) 
are as follows: the initial density of the cells on selection plates,
52 X 10 cells/90 mm dish/10 ml medium; the mutation expression time,
49 hr; the mutant selection time, was 8 days; and the concentration of 
Oua in the selection medium, 3 mM.
3.3.1 Toxic response tests: single plated CHO-KIA cells.
As mutation assays are expensive and time consuming, it is 
desirable to have an indication of the mutagen doses likely to yield 
meaningful results. For a given mammalian cell line the dose range 
over which the mutagenic agent produces lethality is usually similar 
to that over which it produces significant mutations (Kao and Puck, 
1969; Carver et al., 1979). Dose-response curves were therefore 
constructed for each mutagen prior to its use in mutation assays. 
Since sin in situ protocol would be used for the assessment of Oua^^
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the toxicity of the mutagens towards single-plated cells was 
determined.
55 X 10 CHO-KIA cells were inoculated into a 150 ml culture 
bottle with 15 ml FIO, gassed with 5% CO^ and incubated (2.8.4). After 
two days growth, a cell suspension was prepared (2.8.2) and cell 
density determined (2.8.4). Aliquots of this cell suspension were 
serially diluted to final cell densities of 10^ - 2x10^ cells ml  ̂
(2.8.7). Depending upon the expected lethality, replicate 0.1 ml 
volumes of these suspensions, containing 100-2000 cells, were 
inoculated into 50 mm T/C dishes containing 4.9 ml FIO. If there was 
uncertainty about the cytotoxicity cells were treated at more than one 
density. The inoculated plates were incubated for 4 hr, to allow the 
cells to recover from trypsinisation and to attach. The test concen­
trations of mutagen or vehicle (2.4) were then added to the culture 
medium. After a 2 hr mutagen exposure the medium was aspirated and 
replaced with 5 ml fresh FIO. When assessing the cytotoxicity of DMBA
the plates were rinsed with two 5 ml aliquots of PBS prior to the
addition of fresh medium to remove residual insoluble DMBA. The plates 
were reincubated undisturbed for 7 days, then stained and the colonies 
scored 'blind' (2.8.8).
The data obtained are presented as dose-response plots in Figs.
3.1 - 3.3. Relative cell survival (R.) was calculated as R. = Y./Y ,
1 1 1 o
where Y^ is the plating efficiency after treatment i and Y^ the 
plating efficiency after treatment o. Plating efficiency is defined as 
the fraction of cells plated that produce macroscopic colonies.
The dose-response curves for both N-nitroso agents tested, MNNG 
and MNU, show an immediate simple exponential reduction in cell 
survival, with an apparent hit number of 1 (Drake, 1970). Below 0.15 
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The value, defined as the dose required to kill 63% of a cell 
population and considered to be a valid measure of cytotoxic potency 
(Carver et al., 1979), can be interpolated for both agents. The 
value for MNNG, from Fig. 3.1a is 0.021 jjg/ml. This is comparable 
with the value of 0.035 ug/ml obtained for CHO-KIA cells during their 
initial characterisation (Dewdney, 1982). The value for MNU, from 
Fig. 3.1b, is 6.25 yg/ml.
The shouldered-type dose-response curves for CHO-KIA cells 
treated with MMS (Fig. 3.2a) and EMS (Fig. 3.2b) are of a similar type 
to those obtained by other workers for CHO-Kl cells (O'Neill et al., 
1979; Dewdney, 1982). However, in those studies longer mutagen 
exposure times (16 hr) and consequently, lower mutagen concentrations 
were used. No valid comparison of D^y values can, therefore, be made. 
CHO-KIA cells are, however, considerably more resistant to the 
cytotoxic effects of these agents than to those of the N-nitroso 
agents.
Only limited data is available on the cytotoxicity of the 
dialkylaminoalkyl chlorides in mammalian cells. Consistent with their 
low toxicity in other mammalian cells (Thompson et al., 1981) they are 
relatively non-toxic to CHO-KIA cells during this short exposure (Fig. 
3.3a). A similar rank order of toxicity CEP > DMAE > DMAP, has also 
been reported in these studies (Thompson et al., 1981).
The toxicity of DMBA was assessed in CHO-KIA cells without the 
inclusion of an exogenous activating system. However, the dose- 
response curve (Fig. 3.3b) shows an exponential reduction to a DMBA 
concentration of 47 W-g/ml which suggests that CHO-Kl cells retain some 
endogenous metabolic activity for this agent. CHO cells have also been 
reported to retain their metabolic activating capacity (Gupta and 
Singh, 1982).
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3.3.2 Initial investigation of the effects of TPA on chemically-
p
induced Oua mutations in CHO-KIA cells.
In these initial experiments, where possible, the concentrations 
of each mutagen tested was chosen to yield a plating efficiency of 
approximately 25%. This was the survival level Used in TPA muta­
genesis enhancing studies in V79 cells where different mutagens were 
employed (Lankas et al., 1977, 1980).
TPA enhancement of MNNG-induced mutation of CHO-KIA to Oua^ 
required the promoter to be added immediately at the end of mutagen 
treatment (2-3 hr), and to be present throughout the remaining 
mutation expression and the mutant selection periods (Dewdney and 
Soper, 1984). For this reason, a short mutagen treatment of 2 hr was 
used during these investigations. The cells were then exposed to TPA, 
which was maintained in the culture medium for the remainder of the 
experiment.
TPA was tested at a single concentration of 1 yg/ml, which was 
maximally effective in previously reported investigations of its 
possible mutagenesis enhancing activity. The effects of TPA on the 
recovery of spontaneous Oua CHO-KIA mutants was also examined. Thus, 
for each mutagen four treatment groups were included - control, TPA 
alone, mutagen alone and mutagen + TPA.
55 X 10 CHO-KIA cells were inoculated into 150 ml culture
bottles with 15 ml FIO, gassed with 5% CO^ and incubated (2.8.4).
After 48 hr growth a cell suspension was prepared (2.8.2) pooling
cells from duplicate cultures where necessary and the cell density
determined (2.8.3). This cell suspension was used to seed FIO with
4 -1approximately 2 x 10 cells ml . 10 ml volumes of this seeded medium 
were inoculated into 90 mm T/C dishes (selection plates). A further 
portion of the original cell suspension was diluted and used to
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inoculate replicate 50 mm T/C dishes, containing 4.9 ml FIO, with 200 
- 1000 cells, depending on the expected cytotoxicity of the mutagen 
(survival plates). The inoculated plates were incubated for 4 hr to 
allow for recovery from trypsinisation and for cell attachment, then 
the mutagen or vehicle was added to the culture medium. After a 2 hr 
mutagen exposure, the medium in all plates was replaced with fresh 
FIO. As in the toxicity studies, when DMBA was tested as the 
initiating mutagen the plates were rinsed with two washes of PBS 
before the addition of fresh FIO. TPA or TPA vehicle (DMSO 1 yl/ml 
medium) was then added to all plates. Following a further 47 hr 
incubation, the medium in selection plates was replaced with 10 ml FIO 
containing 3 mM Oua (3 mM Oua FIO) and that in survival plates with 
fresh Flo. TPA or TPA vehicle was added as before. The plates were 
incubated then stained and scored 'blind' after 6 days (survival 
plates) or 8 days (selection plates). A diagram summarising this 
experimental protocol is given in Fig. 3.4.
Using data obtained from such experiments the mutation frequency 
for a particular treatment can be calculated as the number of mutants 
per 10^ survivors using the formula 
Observed mutation frequency =
_______________total number of mutants xlO^______________________
total number of cells plated x plating efficiency of cells
in selection plates in parallel survival plates
For each mutagen, the number of cells plated and the mutant 
colonies recovered, the plating efficiencies and the mutation 
frequencies are given in Tables 3.1 - 3.6.
In all the experiments TPA was not toxic to control cells and
p
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Table 3.1 The effect of TPA(lpg/ml) on the incidence of spontaneous^
and 0.02|ig/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in FIO.







Control 72.0 0 0
TPA 69.3 0 0
MNNG 30.3 26 85




Control 74.5 1 1.7
TPA 60.0 1 2.1
MNNG 21.3 12 70
MNNG + TPA 25.5 17 83*
Cells/plate - 2.02x10^ 
Plates/treatment - 4
Not significantly higher than MNNG alone (see 2.9). p>0.1
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Table 3.2 The effect of TPA(l|ig/ml) on the incidence of spontaneous.
and 4.4pg/ml MNU-induced Oua^ mutation of CHO-KIA cells 
grown in FIO.







Control 83.2 1 1.2
TPA 84.0 2 2.4
MNU 24.8 29 72
MNU + TPA(b) 27.0 33 76*
Cells/plate - 2.02x10^
Plates/treatment - (a) 5 (b) 8
Expt 2
Control 95.0 1 1
TPA (a) 91.8 1 1
MNu(b) 36.4 26 44
MNU + TPA(b) 35.7 25 50*
Cells/plate - 2.02x10^
Plates/treatment - (a) 5 (b) 8
Not significantly higher than MNU alone. p>0.1
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Table 3.3 The effect of TPA(lpg/ml) on the incidence of spontaneous-*
and 77pg/ml MMS-induced OuaB mutation of CHO-KlA cells
grown in FIO.







Control 74.3 1 1.3
TPA 71.8 0 0
MMS 27.9 9 32




Control 69.0 0 O
TPA 69.2 0 0
MMS 23.3 7 30
MMS + TPA 26.4 8 30
Cells/plate - 2.01xlo5 
Plates/treatment - 5
-10,2
Table 3.4 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 1.24mg/ml EMS-induced Oua^ mutation of CHO-KIA cells
grown in FIO.







Control 71.4 1 1.4
TPA 69.8 2 2.8
EMS 28.4 46 159




Control 70.0 0 0
TPA 76.1 1 1.3
EMS 20.1 44 218
EMS + TPA 22.0 41 185
Cells/plate - 2.01x10^
Plates/treatment - 5
* Not significantly higher than EMS alone. p>0.1
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Table 3.5 The effect of TPA(Ipg/ml) on the incidence of spontaneous ̂
and dialkylaminoalkyl chloride-induced Oua^ mutation of
CHO-KIA cells grown in FIO.






Control 74.0 0 0
TPA 70.3 0 0
DMAE (lOOpg/ml) 59.4 32 54
DMAE + TPA 54.2 31 57*
DMAP(lOOpg/ml) 82.5 0 0
DMAP + TPA 75.3 0 0
CEP(lOOpg/ml) 67.8 19 28
CEP +TPA
Cells/plate - 2.01x10^ 
Plates/treatment - 5
63.3 17 27
* Not significantly higher than DMAE alone. p>0.1
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Table 3.6 The effect of TPA(Ipg/ml) on the incidence of spontaneous,^
and 40pg/ml DMBA-induced Oua^ mutation of CHO-KIA cells
grown in FIO without exogenous activation.






Control 57.8 - -
2%DMS0 40.5 1 2.5
2%DMS0 + TPA 41.4 1 2.4
DMBA 17.6 3 17
DMBA + TPA 15.8 3 19*
Cells/plate - 2x10^ 
Plates/treatment - 5 -
Not significantly higher than DMBA alone. p>0.1
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cells. This is consistent with the observations of other workers that 
TPA is non-mutagenic in the Oua^ system. Additionally, TPA did not 
enhance the cytotoxic effects of the mutagens.
As has been noted previously EMS (Table 3.4) is a more effective 
inducer of viable Qua mutants than either MNNG (Table 3.1) or MNU 
(Table 3.2) in CHO-KIA cells (Dewdney, 1982). MMS (Table 3.3), 
however, is a poor inducer of Oua CHO-KIA mutants. A weak mutagenic 
activity is observed for both CEP and DMAE, while DMAP does not affect 
the spontaneous levels of Oua^ mutants in CHO-KIA cells (Table 3.5). 
Although no exogenous activation system was included in this experi­
ment DMBA was still detected as a mutagen, albeit a weak one, at this 
locus (Table 3.6). This confirms the observations from toxicity 
studies (Fig. 3.3b) that CHO-KIA cells retain some endogenous meta­
bolic activating capacity for polycyclic hydrocarbons.
The effect of TPA on induced Oua^ mutations in CHO-KIA cells are 
inconclusive. It may enhance both MNNG- and MNU-induced Oua^ 
mutations although the mutation frequencies are not significantly 
higher than following the mutagen alone (Tables 3.1 and 3.2). TPA does
p
not enhance Oua mutations induced in CHO-KIA cells by EMS, MMS, the 
dialkylaminoalkyl chlorides or DMBA (Tables 3.3 - 3.6).
p
3.3.3 Further investigation of the effects of TPA on Oua mutations 
induced in CHO-KIA cells by alkylating agents.
In V79 cells, the enhancing activity of TPA on both MNNG- and 
MAM-induced Oua^ mutations increases with increasing mutagen 
concentration (Lankas et al., 1977). In CHO-KIA cells, TPA has been 
shown to enhance the frequency of Oua^ mutants induced by 0.05 pg/ml 
MNNG, but not that induced by 0.04 yg/ml MNNG (Dewdney, 1982). The 
concentration of a mutagen used as the initiating dose therefore
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appears to be important to the effect of TPA on chemical induced gene
mutations. The concentrations of the mutagens used in the initial
investigation may not have been sufficiently high to elicit a TPA
R —response. The effect of TPA on the Oua mutations induced by the 
simple alkylating agents was therefore re-examined using a higher 
concentration of each mutagen. In these experiments -^e concentration 
of each agent was selected to yield a plating efficiency of 
approximately 10%.
As in the initial investigation the experimental protocol 
followed was that indicated by Fig. 3.4.
The results from duplicate experiments for MNNG and MNU are 
given in Tables 3.7 and 3.8, respectively, and for single experiments 
for MMS and EMS in Tables 3.9 and 3.10, respectively. Consistent with 
the results obtained above TPA alone was both non-toxic and non- 
mutagenic in CHO-KIA cells. Furthermore, it did not enhance the lethal 
effects of the higher doses of alkylating agents.
Consistent with the results obtained by Dewdney (1982) for this 
cell line, TPA significantly enhanced the frequency of Oua^ mutants 
induced by MNNG (Table 3.7), but not that induced by a similarly toxic 
dose of EMS (Table 3.10). In this extended study of alkylating agents 
the frequency of Oua^ CHO-KIA mutants induced by a second N-nitroso 
compound, MNU, is also significantly increased by TPA (Table 3.8). For 
MMS (Table 3.9), TPA has no effect on the frequency of induced Oua^ 
mutants.
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Table 3.7 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 0.08pg/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in FIO.







Control 77.8 0 0
TPA 67.8 0 0
MNNG 8.9 12 135




Control 72.3 1 1.4
TPA 74.0 2 2.7
MNNG 11.2 21 186
MNNG + TPA 11.5 38 328*
Cells/plate - 2.01x10^
Plates/treatment - 5
* Significantly higher than MNNG alone. p<.0.005
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Table 3.8 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 30pg/ml MNU-induced Oua^ mutation of CHO-KIA cells
grown in FIO.







Control 72.5 0 0
TPA 73.0 0 0
MNU 8.8 14 159
MNU + TPA 10.4 41 393*
Cells/plate - 2.01x10$ 
Plates/treatment - 5
Expt 2
Control 84.1 1 1.2
TPA 81.7 1 1.2
MNU 8.8 32 364
MNU + TPA 9.5 67 705*
Cells/plate - 2x10^ 
Plates/treatment - 5
* Significantly higher than MNU alone. p<0.005
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Table 3.9 The effect of TPA(lpg/ml) on the incidence of lOOpg/ml
MMS-induced OuaR mutation of CHO-KIA cells grown in FIO.






Control 74.3 - -
MMS 11.3 6 53
MMS + TPA 10.9 5 46
Cells/plate - 2.01x10^
Plates/treatment - 5
Table 3.10 The effect of TPA(lug/ml) on the incidence of 2mg/ml
EMS-induced OuaR mutation of CHO-KIA cells grown in FIO.






Control 74.1 - -
EMS 12.9 29 225




3.3.4 The effects of adding TPA at different times during mutation
nexpression on the expression of MNNG-induced Oua mutations in
CHO-KIA cells.
Previous studies have reported that the extent of the 
enhancement of mutagenesis by TPA in CHO-KIA cells was dependent on 
the duration of promoter treatment (Dewdney and Soper, 1984). TPA 
enhanced MNNG mutagenesis when added 2 hr following mutagen treatment. 
However, when added 43 hr or later after MNNG a mutagenesis enhancing 
activity for TPA was not evident. This time-dependent activity was 
further investigated by adding TPA to culture medium at different 
times during mutation expression.
The procedure followed the Oua^ mutagenesis protocol given in 
Fig. 3.4. CHO-KIA cells were plated and incubated for 4 hr. MNNG 
(0.08 Mg/ml) or MNNG vehicle was then added to the culture medium. At 
various times following MNNG treatment TPA was added to a set of 
selection plates and parallel survival plates. 49 hr following the 
addition of MNNG, medium in selection plates was replaced with 10 ml 3 
mM Oua FIO and that in survival plates with 5 ml FIO. TPA was added as 
before. Plates were incubated, stained and scored in the usual way.
The data obtained in two separate experiments for different TPA 
exposure times are given in Tables 3.11a and b. The mutagenesis 
enhancing activity of TPA expressed as the enhancement of MNNG-induced 
mutation frequency is given in Table 3.12. These results show that the 
mutagenesis enhancing activity of TPA in CHO-KIA cells does vary with 
the duration of exposure. Mutagenesis enhancing activity reaches a 
peak when CHO-KIA cells are first exposed 12 hr after MNNG treatment. 
From 15 hr after MNNG treatment this activity rapidly falls, and when 
present for mutant selection time only TPA had no effect on the 
frequency of MNNG-induced OuaR mutations. This loss of mutagenesis
Ill
Table 3.11 The influence of the time of addition of TPA(Ipg/ml) on 
0.08pg/ml MNNG-induced Oua^ mutation of CHO-KIA cells 
grown in FIO.









Control 64.1 0 0
MNNG (t=0) 15.3 10 81
*5 18.0 24 165*
1 16.1 21 161*
2 16.8 22 162*
6 16.2 22 168*




Control 79.8 0 0
MNNG (t=0) 9.0 12 163
12.5 34 335*
10 10.5 35 410*
12 11.1 43 477*
15 11.2 40 440*
18 13.4 25 230
49 10.7 13 150
Cells/plate - 2.03x10^
Plates/treatment - 4 (a) 3
Significantly higher than MNNG alone.
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Table 3.12 The enhancement of 0.08|ig/ml MNNG-induced Oua^ mutation 
of CHO-KIA cells grown in FIO by TPA (Ipg/ml) added at 
different times during mutation expression time.















(a) From table 3.11 a)
(b) From table 3.11 b)
* Significant enhancement of MNNG mutagenesis. 
** Enhancement factor = (Mutation frequency)MNNG + TPA
(Mutation frequency)
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enhancing activity when added late in the expression is in agreement 
with the results of Dewdney and Soper (1984).
R S3.3.5 The effect of TPA on metabolic cooperation between Qua and Qua 
CHO-KIA cells.
The density of cells on plates at the time of mutant selection 
is an important parameter forin situ mutagenesis assays (1.7.1). Cell 
crowding at this time can lead to an impaired recovery of mutant 
colonies by metabolic cooperation between normal and mutant cells. TPA 
is a membrane active compound, and has been shown to enhance the 
recovery of mutants in TG assay systems by an inhibitory effect on 
metabolic cooperation (Yotti et al., 1979). A similar effect in the 
Qua system could explain the observed mutagenesis enhancing activity 
of TPA in CHO-KIA cells. For this reason the effects of TPA on the 
recovery of a known number of Oua^ cells cocultured with wild-type
S(Qua ) cells was examined in a reconstruction experiment,
a) Isolation of Oua^ CHO-KIA strains:
For the proposed reconstruction study it was first necessary to 
isolate and propagate strains of Oua^ CHO-KIA cells.
52 x 10 CHO-KIA cells at passage 33 were inoculated into two 90 
mm T/C dishes with 10 ml FIO and incubated for 4 hr for cell 
attachment. MNU (4.4 %g/ml) was then added to the culture medium and 
the plates reincubated. Mutagen exposure was assumed to be 
self-limiting as MNU has a reported half-life of approximately 8 min 
in cell culture medium at 37°C (Jensen et al., 1977). 49 hr after the 
addition of MNU the medium was aspirated from both plates and replaced 
with 10 ml 3 mM Oua FIO. Plates were incubated for a further 8 days, 
then one discrete Oua^ colony was located by eye on each. Medium was
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aspirated and a sterile glass cylinder (5 mm internal diameter x 10 mm
high) whose bottom edge had been coated with sterile silicone grease
was placed over each colony. The cylinder was rinsed with a few drops
of 0.05% trypsin solution and then a few more drops of trypsin
solution were added. After 5 min incubation the cells were suspended
by gentle aspiration with a Pasteur pipette and transferred into 5 ml
3 mM Oua FIO in a 25 cm̂  T/C flask. After 7 days growth, each of the 
ROua cultures was trypsinised and transferred with 15 ml 3 mM Oua FIO 
to a 150 ml culture bottle. After two days incubation, the cultures 
were trypsinised, suspended at 5 x 10^ cells ml  ̂in 3 mM Oua FIO plus 
5% DMSO and frozen down in 1 ml volumes (2.8.5). These two independent 
Oua^ cell strains were designated CHO-KIA Oua 1 and CHO-KIA Oua 2.
b) Reconstruction experiment:
The experimental procedure was analogous to the Oua^ mutagenesis
protocol (3.3.2).
Sets of 90 mm T/C dishes were inoculated with 10 ml volumes of
either FIO or FIO containing 2 x 10^ wild-type CHO-KIA cells, at
passage 37 from a 48 hr culture, and incubated for 4 hr. 100 Oua^
cells in 0.1 ml FIO were then added to each plate and distributed by
gentle agitation. The Oua cells were provided by a 48 hr culture of
CHO-KIA Oua 2 cells in 3 mM Oua FIO at passage 37, which was
trypsinised and diluted in FIO. Plates were incubated for a further 2 
♦hr before TPA or DMSO was added. Following a 47 hr incubation time, 
the medium in the plates was replaced with 10 ml 3 mM Oua FIO. TPA or 
DMSO was added as before. The plates were then incubated for a further 
8 days, stained and the Oua^ colonies scored 'blind'. Parallel 
survival plates (unselected controls) of 100 cells in 5 ml FIO in 50
115
mm T/C dishes were also included for both Oua^ and wild-type CHO-KIA 
cells.
pThe numbers of cells plated, the percentage of Oua colonies 
recovered and the plating efficiency of unselected controls Eire given 
in Table 3.13, together with a diagram summarising the experimental 
procedure. These results (Table 3.13) show that in the absence of
p
wild-type cells TPA is not toxic to Oua cells. In the presence of 
wild-type CHO-KIA cells both TPA sind DMSO increase the recovery of 
Oua colonies, but to a simileur extent. Thus, in this system the 
mutagenesis enhancing activity of TPA cannot be explained by an 
inhibition of metabolic cooperation.
in previous experiments, TPA was dissolved in DMSO before addition 
to the culture medium.
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3.4 The effects of TPA on MNNG—induced mutation of CHO—K1 cells to 
TG^
An investigation was undertaken to determine the effect of TPA 
on the frequency of spontaneous and MNNG-induced mutation to TG in
RCHO-KIA cells, to compare with findings in the Oua selection system. 
Although both MNNG- and MNU-induced mutation to Oua^ was enhanced by 
TPA, MNNG was chosen as the model mutagen for the TG experiments. 
O'Neill et al. (1977) have reported MNNG to be an efficient inducer of 
stable TG mutants in CHO-Kl cells.
3.4.1 Toxic response test: MNNG toxicity to CHO-KIA cells in monolayer
culture.
In the protocol for determining TG^ the cells are seeded 24 hr 
prior to the addition of the mutagen. Thus, it was necessary to 
determine the toxicity of MNNG towards monolayer CHO-KIA cultures 
which are then subcultured and plated for survival 24 hr after mutagen 
treatment.
The dose range of MNNG investigated, 0.02 yg/ml - 0.2 yg/ml, was 
suggested by the results of O'Neill et al. (1977) and Dewdney (1982).
5 X 10^ CHO-KIA cells were inoculated into a number of 25 cm̂
T/C flasks with 5 ml FIO medium without hypoxanthine (FIO(-HX)) 
(2.3.4). After 24 hr growth the test concentration of MNNG or vehicle 
was added to the culture medium. Following a 24 hr mutagen exposure 
the cells were suspended in 1 ml of trypsin solution and transferred 
with 5 ml FIO(-HX) to a 16 mm T/C tube. Cells were sedimented by 
centrifugation, resuspended in 3 ml F10(-HX) and the cell density 
determined. Each treated cell population was serially diluted and 
plated for the determination of survival. Depending on the expected 
lethality 100 - 2000 cells were inoculated into four replicate 50 mm
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T/C dishes with 5 ml FIO(-HX). If the likely cytotoxicity was ^̂
uncertain cells were plated at more than one density. Plates were 
incubated for 7 days, then stained and scored in the usual way.
The data obtained, from two separate determinations are shown in 
the dose-response curve given in Fig. 3.5. The value is 
0.023 yg/ml, which is similar to the value of 0.025 yg/ml estimated 
from the dose-response curve reported by O'Neill et al. (1977) for
CHO-Kl-BH^ cells.4
3.4.2 Determination of the expression time for TG CHO-KIA mutants
HGPRT is a constitutive enzyme in wild-type cells (see 3.2.2).
To allow for the dilution and decay of pre-existing HGPRT in the 
mutant cells, there will be a delay in the expression of the TG 
phenotype (phenotypic delay). For CHO-Kl-BH^ cells the induced 
frequency of TG mutants is reported to reach a stable maximum at 7-9 
days of expression and to be independent of the mutagen concentration 
(O'Neill et al., 1977; O'Neill and Hsie, 1979). Before the TG^ 
protocol could be used to investigate the mutagenesis enhancing 
effects of TPA it was necessary to assess the phenotypic expression 
time of MNNG-induced TG^ CHO-KIA mutants. This was examined for three 
concentrations of MNNG.
Quantification of the frequency of mutation to TG employed
5essentially the respreading method of O'Neill et al. (1977). 5 x 10 
CHO-KIA cells were inoculated into 25 cm̂  T/C flasks with 5 ml FIO 
(-HX). After a 24 hr growth period, MNNG or vehicle was added to each 
culture. 24 hr later the medium was removed and the cells dispersed in 
1 ml trypsin solution and transferred with 5 ml FIO(-HX) to a 16 mm 
T/C tube. The cells were sedimented by centrifugation and resuspended 
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Fig. 3.5 Dose-response curve for CHO-KIA cells grown in FlO(-HX) 
treated with MNNG in monolayer culture.
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For determination of initial cell survival, a portion of the cell 
suspension was diluted and 200 - 1000 cells/5 ml FIO(-HX) plated into 
four 50 mm T/C dishes. For the assessment of mutant induction five
590 mm T/C dishes were each seeded with 1.5 x 10 cells in 10 ml of 
FTO(-HX) containing 30 yM TG (2.6.2). From the remaining suspension 
10^ cells were inoculated into a 150 ml culture bottle with 20 ml FIO 
(-HX). This culture was then subcultured every 48 hr. At each
5subculture five x 1.5 x 10 cells were plated for mutant selection and 
parallel survival plates inoculated for the determination of plating 
efficiency. Mutant selection and survival plates were incubated and 
stained, in the usual way, after 7 days. The time of mutagen addition 
was designated day 0. Cells were plated for mutant selection, as 
(described, on day 1 (24 hr after initiation of mutagen treatment) and 
subsequently on days 3, 5, 7, 9, 11 and 15.
The initial cell survivals and the spontaneous and MNNG-induced 
frequencies of TG mutants at each subculture are given in Table 3.14. 
The induced mutation frequencies are plotted as a function of 
expression time in Fig. 3.6. The mutation frequency/expression time 
profile (Fig. 3.6) shows that for all MNNG concentrations TG colonies 
aire observed at day 5 of expression. The mutation frequency reaches a 
peak between 7 and 11 days of expression and is dependent on the MNNG 
concentration. The maximum frequency of TG mutants recovered also 
increases in a dose-dependent manner.
p3.4.3 Initial investigation of the effects of TPA on MNNG-induced TG 
mutations in CHO-KIA cells.
The MNNG concentration used in these studies was 0.08 yg/ml. 
This yields approximately 10% relative survival, a level similar to
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Fig. 3,6 Expression times for TG^ CHO-KIA mutants selected in 30pM 
TG FlO (-HX) induced by different concentration of MNNG.
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p
that used in the Oua studies. The effects of TPA on the spontaneous 
level of TG^ CHO-KIA was also examined. Four treatment groups were 
thus included - control, TPA, MNNG and MNNG + TPA.
CHO-KIA cells were inoculated into four 25 cm̂  T/C flasks with 
Flo(-HX). After 24 hr growth the cultures were treated with MNNG 
(0.08 pg/ml) or vehicle and processed as described above (3.4.2). TPA 
or TPA vehicle was added to the culture medium at the first subculture 
of the cell population and renewed at each subculture. The tumour 
promoter or vehicle was added to all mutant selection and survival 
plates. Thus, TPA was present throughout the mutation expression and 
mutant selection periods.
As the maximal mutation induction for this concentration of MNNG 
is not reached until day 9 of expression the cells were first plated 
into TG containing medium 7 days after mutagen treatment and 
subsequently on days 9 and 11.
Initial cell survivals and mutation frequencies at the different
expression times for each treatment are given in Table 3.15. The
spontaneous levels of TG mutants recovered in this experiment are
considerably higher than those previously observed. TPA does not
affect this elevated level of spontaneous mutation to TG . For MNNG
alone, a peaked profile of mutant recovery, similar to that shown in
Fig. 3.6, was observed. TPA has no effect on the frequency of TG
mutants induced by MNNG. However, in this limited study TPA does
appear to affect the shape of the mutation frequency/expression time
profile. The previously observed 'peaked' profile, with maximal TG
Rrecovery at day 9, is replaced by a plateau of induced TG mutants
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3.4.4 Further investigation of the effects of TPA on MNNG-induced TG 
mutations in CHO-KIA cells.
In cell culture medium at 37°C MNNG has a reported half-life of 
14 mins (Jensen et al., 1977). O'Neill et al. (1977) have found that 
MNNG is only effective as a mutagen for 2 hr after its addition to the 
culture medium. In the previous experiment TPA was added to cells 24 
hr after the addition of MNNG and thus the period of growth during 
which the cells are susceptible to the mutagenesis enhancing actions 
of TPA may have already passed. The effects of continuous TPA exposure 
from the end of effective mutagen treatment,ie 2 hr,were therefore 
investigated.
In an attempt to reduce the numbers of spontaneous TG^ mutants 
present, CHO-KIA cells were grown in HAT medium (FIO containing 10  ̂M 
aminopterin) for the passage interval immediately prior to their use 
in this experiment (see 3.3.2). These cells were inoculated into four 
25 cm̂  T/C flasks with 5 ml FIO(-HX). Cultures were incubated for 24 
hr, then treated with MNNG (0.08 Pg/ml) or vehicle, and processed as 
described in 3.4.2. TPA or vehicle was added to the cultures 2 hr 
after the initiation of MNNG treatment and renewed at each subculture 
of the cell population. The tumour promoter or vehicle was added to 
survival and mutant selection plates. For a complete examination of 
the effect of TPA on the mutation frequency/expression time profile, 
cells were plated into selection medium at each subculture from day 1.
Initial cell survivals and mutation frequencies on days 1, 3, 5, 
7, 9 and 11 for each treatment are given in Table 3.16. The mutation 
frequencies plotted as a function of expression time are given in Fig. 
3.7. A comparison of the results in Tables 3.15 and 3.16, shows that 
the growth of CHO-KIA cells in HAT medium reduces the incidence of
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Fig. 3.7 The effect of TPA (l|ig/ml) on the recovery of 0.08pg/ml MNNG- 
induced TG^ CHO-KIA mutants selected in 30|iM TG FIO(-HX). 
Tumour promoter present from 2hr following MNNG treatment 
until the end of mutant selection.
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p
TPA has no effect on either the frequency of spontaneous TG 
mutants or on the maximum frequency of MNNG-induced TG mutants. It 
does, however, alter the expression profile for MNNG-induced TG^ 
mutants. As shown in Fig. 3.7 continuous exposure to TPA from the end 
of mutagen treatment decreases the phenotypic delay for TG^ mutants. A 
significant enhancement of MNNG-induced TG mutations is observed on 
days 5 and 7 of expression. Although not signficantly higher than for 
MNNG alone on days 9 and 11, the recovery of TG^ mutants is then 
maintained until day 11 of expression, with no loss of mutants during 
subsequent subcultures.
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3.5 The effects of TPA on MNNG-induced mutation of CHO-Kl cells at 
other drug resistance markers
Gupta and Singh (1982) have reported a multiple drug-resistance
marker mutation assay for CHO cells, in which mutagenic responses can
be assessed simultaneously at five independent genetic loci. Qua and
TG^ studies with TPA have shown that the action of tumour promoters
may be loci specific. A multiple marker system may thus provide a more
extensive screening system for compounds with tumour promoting
R Ractivity. The inclusion of other markers, together with TG and Oua
may also provide information as to the identity of the specific
genetic lesions enhanced by TPA in these mutagenesis systems. The
effect of TPA on MNNG-induced mutation of CHO-KIA cells to resistance
R Rat two of these markers, Emt and MGBG was investigated.
R R3.5.1 Mutagenic effects of MNNG at the Emt and MGBG loci in CHO-KIA 
cells
R RThe mutagenic response of MNNG at the Emt and MGBG markers has 
not previously been reported, although other alkylating agents are 
effective inducers of mutations at these loci. The effects of a single 
MNNG concentration (0.08yg/ml) were investigated using the replating 
method of Gupta and Singh (1982). Resistance to Oua was included in 
this experiment as a control marker. The concentration of Oua 
suggested by Gupta and Singh (1982) for use in this system (1.6 mM) 
was, however, increased to 3 mM, the concentration used in Oua 
studies (3.3).
5Four 90 mm T/C dishes were seeded with 4 x 10 CHO-KIA cells in 
15 ml FIO and incubated for 48 hr. The medium was then replaced with 
15 ml fresh FIO and MNNG (0.08 pg/ml) or vehicle was added to the 
culture medium of duplicate plates. Following a 16 hr mutagen exposure
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the cells were dispersed and pooled separately. Cell density was 
determined by haemocytometer count. For the determination of initial 
cell survival, a portion of each suspension was diluted and 1 0 0 - 1 0 0 0  
cells/5 ml FIO plated into four 50 mm T/C dishes. The remaining cells
5were plated into 90 mm T/C dishes at a cell density of 4 x 10 
cells/15 ml FIO. After a further 56 hr incubation the cells from these 
plates were dispersed and pooled separately. The cell density was 
determined and adjusted to 1 0  ̂cells/ml. 1 ml volumes of this 
suspension were then inoculated into 90 mm T/C dishes with 9 ml FIO
containing the desired final concentration of selecting agent - Emt
-7 - 61.5 X 10 M, MGBG 5 x 10 M, or Oua 3 mM. Parallel survival plates
were also inoculated with 200 cells/5 ml FIO in 50 mm T/C dishes.
Mutant selection and survival plates were incubated in the usual way
for 7 days (survival plates) or 10 days (selection plates), then
stained and scored 'blind'. A diagram summarising this experimental
protocol is given in Fig. 3.8.
The initial cell survivals, the number of mutants recovered and
the mutation frequencies at the three loci are given in Table 3.17.
R RThe incidence of spontaneous Emt and MGBG CHO-KIA mutants are 
comparable with those reported for CHO cells (Gupta and Singh, 1982). 
MNNG does induce resistant CHO-KIA mutants at the three genetic loci 
assessed in this experiment. The frequency of MNNG-induced MGBG^ 
CHO-KIA mutants is similar to that induced by other alkylating agents 
in CHO cells (Gupta and Singh, 1982). The incidence of MNNG-induced 
Oua CHO-KIA mutants is, however, lower than that previously obtained 
in this cell line using an in situ protocol. Possible reasons for this 
are discussed in Chapter 7. The incidence of MNNG-induced Emt^ CHO-KIA 
mutants is higher than that reported for other alkylating agents in 
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concentration of Emt (1.5 x 10 ^ M) was not sufficient to completely 
kill wild-type cells within the period of mutant selection. 
Consequently, it was very difficult to distinguish Emt^ colonies 
against a background of wild-type cell growth.
3.5.2 Determination of Emt concentration for the selection of Emt 
CHO-KIA mutants.
Preliminary studies showed that the optimum Emt concentration
for the selection of CHO-KIA cells was between 1.5 x 10 M and 3.0 x
-7 610 M. These experiments were performed by seeding 10 CHO-KIA cells
into 10 ml FIO containing Emt at concentrations between 1.5 x 10 ^ M
and 12 X 10 M in 90 mm T/C dishes. Growth was assessed after 10 days
by staining plates in the usual way. 1.5 x 10  ̂M Emt allowed wild
_7type cell growth, while at 3 x 10 M Emt no growth was visible.
The effects of three concentrations of Emt, 1.5 x 10  ̂M, 2.0 x
-7 -7 R10 M and 2.5 x 10 M, on the recovery of MNNG-induced Emt CHO-KIA
mutants was investigated. 4 x 10^ CHO-KIA cells were seeded into 90 mm
T/C dishes with 15 ml FIO and then processed as described in 3.5.1. At
the end of the mutation expression time 10^ cells were plated into 90
mm T/C dishes with FIO containing the desired final concentration of
Emt. Parallel survival plates were also inoculated. The plates were
incubated, stained and scored in the usual way. The data obtained are
given in Table 3.18.
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pTable 3.18 The effect of Emt concentration on the recovery of Emt







* considerable wild-type cell growth
**evidence of some wild-type cell growth
-7It was concluded from this data that a concentration of 2.5 x 10 M 
Emt is sufficient to reduce background wild-type cell growth, without 
significantly affecting the growth of Emt mutants.
3.5.3 The effects of TPA on spontaneous and MNNG-induced mutation of 
CHO-KIA cells at three genetic loci.
Evidence from other mutation studies has suggested that for a 
maximal effect the presence of TPA is required from 2 hr after the 
initiation of MNNG treatment until the end of mutant selection. The 
effects of this TPA exposure on spontaneous and MNNG-induced mutation 
of CHO-KIA at the Emt^, MGBG^ and Oua^ loci was assessed using the 
protocol described in 3.5.1. TPA or vehicle was added 2 hr after the 
initiation of MNNG treatment. TPA or vehicle was renewed at each 
subculture and added to all selection and survival plates. The Emt
_7concentration in selection medium was increased to 2.5 x 10 M. As 
for other mutation studies where the effects of TPA on spontaneous 
gene mutations were also assessed 4 treatment groups were included - 
control, TPA alone, MNNG alone and MNNG + TPA.
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The initial survivals, the numbers of mutants recovered and the 
mutation frequencies for each treatment at each resistance marker are 
given in Table 3.19. Consistent with the observations from other 
resistance marker systems, these results show that TPA has no effect 
on the frequency of spontaneous mutants recovered for any of the three 
genetic loci examined. TPA, also, does not effect the recovery of 
MGBG^ CHO-KIA mutants induced by MNNG.
The results for the recovery of Oua CHO-KIA mutants suggest 
that TPA may exert a cytotoxic effect on newly arisen Oua cells. This 
may be the result of additional stresses placed on the membranes of 
cells aready known to be sensitive to trypsinisation (Arlett, 1977a).
A significant increase in the recovery of MNNG-induced Emt^ 
CHO-KIA mutants is observed following continuous exposure to TPA. 
However, the level of Emt mutants induced by MNNG alone in this 
experiment was considerably lower than that observed previously for 
the same MNNG concentration (see Table 3.18).
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From the results reported in this chapter the following can be 
concluded.
1. TPA alone was neither toxic to CHO-KIA cells nor mutagenic at 
the loci studied.
2. TPA did not enhance the lethal effects of the mutagens tested.
3. The enhancing activity of TPA in CHO-KIA cells is mutagen
specific. TPA enhanced the expression of MNNG- and MNU-induced 
Qua mutations, but not mutations induced by EMS, MMS, 
dialkylaminoalkyl chlorides or DMBA (3.3.2 and 3.3.3).
4. The enhancement of MNNG and MNU Qua mutagenesis by TPA was
dependent on the dose of initiating mutagen (3.3.3).
5. The effect of TPA on the recovery of induced Oua^ mutants is not
due to an inhibition of metabolic cooperation (3.3.4).
6. At the TG locus TPA does not increase the frequency of
MNNG-induced TG^ mutants. It does however, reduce the phenotypic
Rdelay for CHO-KIA TG mutants.
7. In contrast to the results obtained in an in situ Oua^ 
mutagenesis protocol (3.3), TPA does not enhance the expression 
of MNNG-induced Qua CHO-KIA mutants assessed using a replating 
protocol (3.5). This may be accounted for by a cytotoxic effect 
of TPA on newly arisen Oua^ mutants.
8. TPA may enhance the expression of MNNG-induced Emt^ mutations,
but does not enhance the expression of MNNG-induced MGBG^ 
mutations in CHO-KIA cells.
9. The enhancement of MNNG mutagenesis by TPA was dependent upon
the duration of the promoter treatment. CHO-KIA cells were only 
susceptible to the mutagenesis enhancing effects of TPA when 
exposed to the promoter during the first 15 hr after MNNG
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treatment for the remaining expression and selection periods 
(3.3.4).
These conclusions will be discussed, together with those from 
other experimental chapters, in Chapter 7.
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CHAPTER 4. THE INFLUENCE OF CULTURE CONDITIONS ON 
MUTAGENESIS ENHANCING ACTIVITY IN CHO-Kl CELLS
4.1 Introduction
With the growing evidence for the involvement of free radicals in 
the mechanism of action of TPA (see 1.3 and 1.5), the free radical 
scavenging potential of culture media has been implicated to explain 
the discordant results observed for TPA -in vitro (Emerit and Cerutti, 
1981; Nagasawa and Little, 1981). As part of an investigation into its 
mechanism of action the influence of culture media components on the 
mutagenesis enhancing activity of TPA in CHO-Kl cells was examined.
It has been suggested that TPA itself is not directly involved in either 
radical release or the subsequent DNA damage. In cultured human lympho­
cytes DNA damage induced following TPA treatment is mediated by a 
clastogenic factor, comprised of free arachidonic acid together with 
low molecular weight peroxides and aldehydes (Emerit and Cerutti, 1981, 
1982). Thus, peroxides and aldehydes may be important to the mutagenesis 
enhancing activity of TPA. For this reason, the influence of culture 
media components on the activity of benzoyl peroxide (BZP) and formalde­
hyde (HCHO) as in vitro mutagenesis enhancing agents was also 
investigated.
In contrast to TPA, both BZP and HCHO are highly reactive and may 
chemically interact with culture media components to produce toxic and 
mutagenic products. The investigations into the influence of culture 
conditions on mutagenesis enhancing activity were thus extended to 
other chemically inert tumour promoters, the linear alkanes.
The biological properties of BZP, HCHO and the linear alkanes are 
described in the following sections.
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4.2 Biological properties of other promoters
4.2.1 Benzoyl peroxide (BZP)
O
Mol. wt. 242.2
Benzoyl peroxide (BZP) is a free radical generating compound widely 
used as an additive in cosmetics and pharmaceuticals, particularly those 
used in the treat ment of acne. It can, however, cause irritation when, 
applied to human skin and has come under scrutiny as a human carcinogen.
In skin painting studies BZP has been reported to be neither a complete 
carcinogen (Van Duuren et al., 1963) nor a tumour initiating compound 
(Slaga et al., 1981). Although when applied to mouse skin BZP does induce 
hyperplastic and morphological changes similar to those of TPA (Klein- 
Szanto and Slaga, 1982). A single application of BZP (20 or 40 mg) 
elicited a marked epidermal hyperplasia noticeable after 48 hr. Epidermal 
thickness reached a maximum 4 days after BZP application and then decreased 
to normal values after 10 days (Klein-Szanto and Slaga, 1982).
Furthermore, BZP induced a large number of dark kératinocytes, which 
constituted approximately 10% of the basal cell population 2 to 4 days 
after treatment. These had also returned to control values 10 days 
after BZP treatment (Klein-Szanto and Slaga, 1982). When repeatedly applied 
to mouse skin, following initiation with DMBA, BZP has now been shown 
to be an effective tumour promoting agent. As little as 1 mg applied 
twice weekly produced a significant number of papillomas and carcinomas 
(Slaga et al., 1981).
In vitroj BZP has yet to be tested for a mutagenesis enhancing 
activity. However, it has been reported to inhibit metabolic cooperation 
in Chinese hamster V79 cells (Slaga et al., 1981) and human kératinocytes
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(Lawrence et al., 1984), in a dose-dependent manner. Following these 
observations, it has been suggested that the mechanism by which BZP 
promotes skin tumours may result from membrane changes caused by the 
free radicals generated by BZP (Slaga et al., 1981).
4.2.2 Formaldehyde (HCHO)
H^
C = = 0
H
Mol. wt. 30.0
Formaldehyde is a common environmental pollutant found in many 
occupational settings and in tobacco smoke. It is also a normal biological 
intermediate, present in all tissues, which participates in many 
biosynthetic reactions requiring one-carbon units. Endogenous HCHO 
is, however, reversibly bound to intracellular nucleophiles such as gluta­
thione and tetrahydrofolate.
The reactivity of HCHO towards biological macromolecules has been 
well documented (Feldman, 1973), and it has been recognised as weakly 
mutagenic in many mutation assay systems (Auerbach et al., 1977). Single 
strand breaks induced in DNA by HCHO may be the lesion responsible 
for its mutagenicity (Fornace et al., 1982). Other investigations, however, 
have suggested that some of the mutagenic properties of HCHO are 
caused by reaction with cellular constituents producing altered 
nucleotides, organic peroxides or free radicals (Auerbach et al., 1977).
HCHO is a respiratory carcinogen in rats, and there is evidence 
that multiple stages may be involved in HCHO carcinogenesis in this 
system (Swenberg et al., 1980). This suggests that HCHO might also 
possess tumour promoting potential. When tested in the two-stage mouse 
skin model, HCHO is neither a skin tumour initiator nor a complete
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skin carcinogen, although it may possess very weak skin tumour promoting 
activity (Spangler and Ward, 1983).
In vitro HCHO is reported to be a weak promoter of transformation 
of cells in culture. For MNNG-initiated C3H/10T Vz cells transformed 
foci were observed following continuous exposure to HCHO (0.5 yg/ml or 
1.0 yg/ml) (Frazelle et al., 1983). Neither MNNG nor HCHO treatment 
alone induced transformed foci.
HCHO can inhibit DNA repair in cells in culture (Grafstrom et al., 
1983, 1984) and this might explain its promoting action. In support of 
this HCHO has been reported to have a mutagenesis enhancing activity in 
vitro. Grafstrom et al. (1985) have shown that HCHO potentiates the 
mutagenicity of MNU in human fibroblasts.
4.2.3 Linear alkanes
General structure C H^n 2n+2
In comparison to BZP and HCHO the linear alkanes are chemically 
inert compounds. However, they are present in cigarette smoke and human 
sebum and have been implicated in the enhancement of human carcinogenesis 
(Bingham and Horton, 1966; Van Duuren and Goldschmidt, 1976).
Members of the series from n-decane to n-hexadecane have been 
shown to have weak promoting activity, approximately 400-fold less potent 
than TPA, in mouse skin (Sice, 1966). In this system their promoting 
activity was related to their carbon chain length.
When assessed in vitro for mutagenesis enhancing activity the
results obtained are in agreement with in vivo studies. At a
concentration of 0.12 mM n-decane, n-dodecane and n-tetradecane
all enhanced the frequency of MAM-induced mutation of V79 cells to 
ROua , while n-hexane and n-hexadecane were inactive (Lankas et al.,1978).
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Similar to their potency in mouse skin, these compounds were about 
400-fold less potent than TPA as in vitro mutagenesis enhancing agents 
(Lankas et al., 1978).
The mechanism by which the linear alkanes exert their promoting 
actions is, as yet, unclear. However, their lipophilic nature is 
such that they would be expected to partition into cell membranes and 
they have been reported to affect membrane functions (Horton and McClure, 
1971; Horton et al., 1976). Thus, the promoting activity of these 
compounds may be derived from disturbances of membrane functions.
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4.3 The influence of culture conditions on the mutagenesis enhancing 
activity of TPA in CHO-Kl cells
4.3.1 The influence of L-cysteine on the enhancement of MNNG-induced 
Oua^ mutations of CHO-KIA cells by TPA.
The sulphydryl compound L-cysteine is reported to react with free
radicals and can thus protect cells in culture against the lethal and
DNA damaging effects of physical and chemical free radical generating
agents (Sasaki and Matsubara, 1977; Raj and Heddle, 1980). The influence
-4of L-cysteine,present in culture media at a concentration of 2 x 10 M 
was therefore investigated on the mutagenesis enhancing activity of ,
TPA in a previously established Oua mutation assay (see 3.3). CHO-Kl 
cells were grown and treated in four culture media EMEM, EMEM + LC, 199 and 
199 4- LC (see 2.3.4). The cells were grown for at least two passage 
intervals in the appropriate culture medium prior to each experiment.
The concentration of MNNG used throughout was 0.08 yg/ml. In 
toxicity studies this was found to yield between 15% and 40% plating 
efficiency of CHO-KIA cells grown in the different culture media.
For each experiment, the procedure followed the Oua^ mutagenesis 
protocol described in 3.3.2 and illustrated in Fig. 3.4. CHO-KIA cells 
were plated into mutant selection and survival plates and incubated 
for 4 hr. MNNG (0.08 yg/ml) or MNNG vehicle was then added to culture 
medium. In these, and all subsequent experiments in which MNNG was 
employed, the mutagen treatment was assumed to be self-limiting (see 
3.4.3) and a terminating medium change was unnecessary. 2 hr after 
the addition of MNNG, TPA or TPA vehicle was added to each plate.
47 hr later the medium in selection plates was replaced with 10 ml 
medium containing 3 mM Oua and that in survival plates with 5 ml ■ 
fresh medium. TPA or vehicle was added as before. Plates were reincubated,
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stained and scored in the usual way.
The data obtained from duplicate experiments for cells in EMEM 
and EMEM + LC are given in Tables 4.1 and 4.2, respectively, and for 
single experiments for cells in 199 and 199 + LC in Table 4.3.
In agreement with the results obtained previously in the Oua^ 
system (3.3),TPA alone was neither toxic nor mutagenic to CHO-KIA cells 
grown in any of the culture media employed. Also, TPA did not affect 
the survival of CHO-KIA cells following MNNG treatment.
As observed previously (Table 3.7), TPA does enhance MNNG-induced 
mutation of CHO-KIA cells to Oua^. However, the mutagenesis enhancing 
activty of TPA is only apparent when L-cysteine is present in the 
culture medium (Tables 4.2 and 4.3b). FIO medium used in previous 
experiments (3.3) is also a L-cysteine containing medium. In the absence 
of L-cysteine TPA does not significantly enhance MNNG mutagenesis (Tables
4.1 and 4.3a).
4.3.2 The influence of glutathione (GSH) on the enhancement of
P
MNNG-induced Oua mutation of CHO-KIA cells by TPA.
The series of experiments reported in 4.3.1 indicated that L-
cysteine can affect the mutagenesis enhancing activity of TPA. The
influence of another sulphydryl free radical scavenging compound,
glutathione (GSH), on this enhancing activity was examined. GSH was
—4added to EMEM at a concentration of 2 x 10 M (see 2.3.4).
As in other MNNG experiments, the procedure followed that
illustrated in Fig. 3.4. CHO-KIA cells were grown for at least two
-4passages in EMEM containing 2 x 10 M GSH prior to use in experiments.
The data obtained for duplicate experiments are given in Table 
4.4. TPA alone was neither toxic nor mutagenic to CHO-KIA cells, and
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Table 4.1 The effect of TPA (Ipg/ml) on the incidence of spontaneous
and 0.08|ig/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in EMEM.







Control 92.5 1 1
TPA 84.5 3 3.4
MNNG 25.6 37 139
MNNG + TPA 37.3 57 148*
Cells/plate - 2.07x10^ 
Plates/treatment - 5
Expt 2
Control 77.8 1 2
TPA 74.3 ■ 1 2
MNNG 32.3 54 256
MNNG + TPA 32.5 70 330*
Cells/plate - 1.3x10$ 
Plates/treatment - 5
* Not significantly higher than MNNG alone. Expt 1 p>0.1
Expt 2 0.1?p>0.05
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Table 4.2 The effect of TPA (l|ig/ml) on the incidence of spontaneous
and 0.08jig/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in EMEM+LC.







Control 73.3 0 0
TPA 68.5 1 1.8
MNNG 30.5 38 153
MNNG + TPA 28.3 60 260*
Cells/plate - 2.04x10^ 
Plates/treatment - 4
Expt 2
Control 68.5 1 1.8
TPA 65.8 1 1.9
MNNG 31.8 19 74
MNNG + TPA 32.3 38 146*
Cells/plate - 2.01x10^ 
Plates/treatment - 4
* Significantly higher than MNNG alone. p<0.005
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Table 4.3 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 0.08|ig/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in a) 199 or b) 199+LC.
a) 199






Control 61.4 1 1.6
TPA 66.3 0 0
MNNG 24.0 6 25
MNNG + TPA




TREATMENT % PLATING TOTAL MUTANTS/10^
EFFICIENCY MUTANTS SURVIVORS
Control 54.1 2 4.4
TPA 50.2 0 0
MNNG 23.3 7 36
MNNG + TPA
Cells/plate - 1.7x10^ 
Plates/treatment - 5
21.3 13 72*
* Significantly higher than MNNG alone. p<0.005
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Table 4.4 The effect of TPA (l|ig/ml) on the incidence of spontaneous
and 0.08|ig/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in EMEM with 2xlO"^M GSH.







Control 89.5 0 O
TPA 84.8 2 2.4
MNNG 44.9 103 229
MNNG + TPA 52.3 117 224
Cells/plate - 2x10$ 
Plates/treatment - 5
Expt 2
Control 86.4 - -
MNNG 43.1 105 244
MNNG + TPA 40.8 117 287*
Cells/plate - 2x10^ 
Plates/treatment - 5
Not significantly higher than MNNG alone. 0.1>p>o.05
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it did not enhance the lethal effects of MNNG. In the presence of GSH, 
however, the mutagenesis enhancing activity, previously noted for TPA 
in the presence of L-cysteine, is absent.
4.3.3 The influence of L-cysteine on the enhancement of EMS-induced
Oua^ mutation of CHO-KIA cells by TPA.
As culture conditions can affect the enhancing activity of TPA 
on MNNG-induced mutation of CHO-KIA cells, they may also affect the en­
hancing activity of TPA towards mutations induced by other mutagens.
Thus, the effects of TPA on EMS-induced mutation to Oua^ was investigated 
in CHO-KIA cells grown in EMEM and EMEM + LC.
The Oua^ mutagenesis protocol given in Fig. 3.4 was used. However, 
in these experiments a terminating medium change was necessary following 
a 2 hr exposure to 1.24 mg/ml EMS.
The data obtained for single experiments for CHO-KIA cells grown 
in either EMEM or EMEM + LC are given in Table 4.5. These show that 
TPA did not affect the survival of CHO-KIA cells following EMS treatment. 
In agreement with the results obtained previously (Tables 3.4 and 3. 10 
TPA did not enhance EMS-induced mutation of CHO-KIA cells to Oua^, 
irrespective of culture conditions.
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Table 4.5 The effect of TPA(lpg/ml) on the incidence of 1.24mg/ml 
EMS-induced OuaR mutation of CHO-KIA cells grown in 
a) EMEM or b) EMEM+LC.
a) EMEM






Control 93.2 - -
EMS 18.3 67 358
EMS + TPA




TREATMENT % PLATING TOTAL MUTANTS/10^
EFFICIENCY MUTANTS SURVIVORS
Control 67.5 - -
EMS 15.5 121 776
EMS + TPA
Cells/plate - 2.01x10$ 
Plates/treatment -5
15.5 136 872*
Not significantly higher than EMS alone. pfO.l
152
4.4 The influence of culture conditions on the mutagenesis enhancing 
activity of benzoyl peroxide (BZP) in CHO—K1 cells
4.4.1 Toxicity of BZP to CHO-KIA cells.
As BZP has not been previously tested for mutagenesis enhancing 
activity, it was necessary to find a suitable non-toxic concentration 
for use in such studies. The cytotoxicity of BZP was assessed in CHO-KIA 
cells grown in three culture media - FIO, EMEM and EMEM + LC, The 
experimental protocol employed a double exposure to BZP, similar to 
that to be used in mutation experiments.
Suspensions of cells were prepared from 48 hr cultures of CHO-KIA 
cells grown for at least two passage intervals in the appropriate 
medium. 200 cells were then plated into 50 mm T/C dishes with 5 ml 
medium. The seeded plates were incubated for 4 hr before BZP or vehicle 
(acetone 1 yl/ml) was added. Following a further 47 hr incubation, the 
medium in all plates was replaced and BZP or vehicle added as before.
The plates were incubated for a further 5 days, then stained and scored 
in the usual way.
The relative survival of CHO-KIA cells treated with different 
concentrations of BZP in each media are shown in Table 4.6.
Following these studies it was decided to use a BZP concentration 
of 1.5 yg/ml in mutagenesis enhancing investigations.
4.4.2 The effect of BZP on spontaneous and MNNG-induced Oua^ mutation 
of CHO-KIA cells under different culture conditions.
The effects of BZP (1.5 yg/ml) on spontaneous and MNNG-induced
Oua^ mutations was examined in CHO-KIA cells grown in three culture 
media - FIO, EMEM and EMEM + LC. As for previous MNNG experiments a
mutagen concentration of 0.08 yg/ml was used. For each experiment the
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Table 4.6 The toxicity of BZP to single-plated CHO-KIA cells grown 







O 1.00 1.00 1.00
0.5 0.92 0.96 1.06
1.0 0.99 0.94 0.93
1.5 1.10 1.03 1.01
2.0 0.92 - 1.01
3.0 0.14 0.01 0.23
Control plating 
efficiency 87.2% 87.1% 76.8%
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Oua^ mutagenesis protocol, given in Fig. 3.4, was followed. BZP 
(1.5 yg/ml) or vehicle was added 2 hr after MNNG treatment, and 
maintained in the culture medium for the remaining mutation expression 
time and the whole of the mutant selection time.
The data obtained for duplicate experiments for CHO-KIA cells in 
each culture media are given in Tables 4.7 - 4.9. In no instance was 
BZP alone toxic or mutagenic to CHO-KIA cells. Furthermore, it did not 
enhance the cytotoxic effect of MNNG. BZP did, however, enhance MNNG- 
induced Oua mutations in CHO-KIA cells, but only in the absence of 
L-cysteine, i.e. when cells are grown in EMEM (Table 4.8). For cells 
grown in the cysteine containing media FIO (Table 4.7) and EMEM + LC 
(Table 4.9), BZP did not significantly increase the recovery of MNNG- 
induced Oua^ CHO-KIA mutants.
4.4.3 The effect of BZP on EMS-induced Oua^ mutations in CHO-KIA 
cells under different culture conditions.
As the mutagenic enhancing activity of TPA in the CHO-Kl/Oua^ 
system is mutagen specific, the effects of BZP on the Oua mutations 
induced by EMS was investigated. This was assessed in CHO-KIA cells 
grown in two culture media - EMEM and EMEM + LC.
The Oua mutagenesis protocol (Fig. 3.4) used previously was 
employed. The EMS concentration used was 1.24mg/ml and as for other EMS 
studies a terminating medium change was necessary following a 2 hr 
mutagen exposure.
The data obtained for cells grown in the two culture media are
given in Table 4.10. These results show that BZP had a similar effect
R Ron EMS-induced Oua mutation to that observed for MNNG-induced Oua
mutations. BZP did enhance the recovery of EMS-induced Oua^ mutations
155
Table 4.7 The effect of BZP (1.5pg/ml) on the incidence of spontaneous
and 0.08pg/ml MNNG-induced OuaR mutation of CHO-KIA cells
grown in FIO.







Control 87.2 0 0
BZP 88.3 0 0
MNNG 9.7 8 104
MNNG + BZP 10.6 8 94
Cells/plate - 2.02x10$ 
Plates/treatment - 4
Expt 2
Control 75.2 0 0
BZP 76.0 1 1.5
MNNG 6.4 8 147
MNNG + BZP 7.3 8 129
Cells/plate - 2.13x10^ 
Plates/treatment - 4
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Table 4.8 The effect of BZP(1.5pg/ml) on the incidence of spontaneous
and 0.08pg/ml MNNG-induced Oua^ mutation of CHO-KIA cells
grown in EMEM,
TREATMENT % PLATING TOTAL MUTANTS/10$
EFFICIENCY MUTANTS SURVIVORS
Expt 1
Control 89.0 3 5
BZP 84.4 3 5.2
MNNG 28.1 24 126




Control 87.1 0 0
BZP 68.8 1 1.4
MNNG 39.7 29 91
MNNG + BZP 29.0 42 181*
Cells/plate - 2x10$
Plates/treatment - 4
* Significantly higher than MNNG alone. p<0.005
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Table 4.9 The effect of BZP(1.5pg/ml) on the incidence of spontaneous
and 0.08pg/ml MNNG-induced Oua* mutation of CHO-KIA cells
grown in EMEM+LC.







Control 80.0 1 1.6
BZP 90.0 1 1.4
MNNG 31.4 37 146
MNNG + BZP 27.6 40 179*
Cells/plate - 2.02x10$ 
Plates/treatment - 4
Expt 2
Control 77.5 0 o'
BZP - - -
MNNG 31.7 53 202
MNNG + BZP 28.9 62 259*
Cells/plate - 2.07x10^ 
Plates/treatment - 4
* Not significantly higher than MNNG alone. Expt 1 p>0.1
Expt 2 0.1>p>0.05
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Table 4.10 The effect of BZP(1.5pg/ml) on the incidence of 1.24mg/ml
EMS-induced Oua^ mutation of CHO-KIA cells grown in
a) EMEM or b) EMEM+LC.
a) EMEM






Control 93.2 - -
EMS 18.3 67 358
EMS + BZP




TREATMENT % PLATING TOTAL MUTANTS/10^
EFFICIENCY MUTANTS SURVIVORS
Control 67.5 - -
EMS 15.5 121 776
EMS + BZP
Cells/plate - 2.01x10$ 
Plates/treatment - 5
10.1 95 934**
* Significantly higher than EMS alone. pcO.005
** Not significantly higher than EMS alone. 0.1>p>0.05
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in CHO-KIA cells grown in EMEM (Table 4.10a), but did not significantly 
increase the EMS-induced Oua mutations of cells grown in EMEM + LC 
(Table 4.10b). This is discussed in Chapter 7.
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4.5 The influence of culture conditions on the mutagenesis
enhancing activity of formaldehyde (HCHO) in CHO—K1 cells
4.5.1 Toxicity of HCHO to CHO-KIA cells.
To find a suitable non-toxic concentration for use in mutagenesis 
enhancing studies the toxicity of HCHO was assessed in CHO-KIA cells.
The range of HCHO tested, 0.6 - 12 yg/ml, was suggested by the data of 
Grafstrom et al. (1985). The cytotoxicity of HCHO was assessed using 
the double exposure procedure, previously used for BZP (see 4.4.1), 
in CHO-KIA cells grown in two culture media - EMEM and EMEM + LC.
The relative survival of CHO-KIA cells treated with different 
HCHO concentrations in either EMEM or EMEM + LC are given in Table 4.11.
These results indicate that the cytotoxic effects of HCHO are 
independent of culture conditions. At concentrations greater than
0.6 y g/ml continuous exposure to HCHO significantly decreased 
the survival of CHO-KIA cells. It was thus decided to use a HCHO 
concentration of 0.6 yg/ml in mutagenesis enhancing studies.
4.5.2 The effect of EÔEO on spontaneous and MNNG-induced Oua^ mutations 
of CHO-KIA cells under different culture conditions.
The Oua^ mutagenesis protocol given in Fig. 3.4 was employed 
with 0.08 yg/ml MNNG as the mutagen. HCHO (0.6 yg/ml) or vehicle was 
added 2 hr after the MNNG treatment and was maintained in the 
culture medium for the remaining mutation expression time and the whole 
of the mutant selection period.
The data obtained in single experiments for CHO-KIA cells grown 
in either EMEM or EMEM + LC are given in Table 4.12. These results 
show that at the concentration selected HCHO was not toxic to either 
control or MNNG-treated CHO-KIA cells. Furthermore, HCHO alone was
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Table 4.11 The toxicity of HCHO to single-plated CHO-KIA cells grown 
















Table 4.12 The effect of HCHO(0.6pg/ml) on the incidence of
spontaneous and O.OSpg/ml MNNG-induced Oua^ mutation
of CHO-
EMEM
-KIA cells grown in a) EMEM or b) EMEM+LC.
TREATMENT % PLATING TOTAL MUTANTS/10$
EFFICIENCY MUTANTS SURVIVORS
Control 87.6 1 1.1
HCHO 87.3 2 2.3
MNNG 41.3 165 397




TREATMENT % PLATING TOTAL MUTANTS/10$
EFFICIENCY MUTANTS SURVIVORS
Control 85.4 0 0
HCHO 76.3 0 0
MNNG 36.1 86 238
MNNG + HCHO 31.0 115 375**
Cells/plate - 2.00x10$
Plates/treatment - 5
* Not significantly higher than MNNG alone. p>0.1
** Significantly higher than MNNG alone. p<0.005
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non-mutagenic to CHO-KIA cells at the Oua locus.
With regard to the mutagenesis enhancing activity of HCHO, 
culture conditions are important. Similar to the effects observed for 
TPA (4.3), HCHO only enhance MNNG-induced Oua^ mutation of CHO-KIA 
cells when cysteine was present in the culture medium.
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4.6 The influence of culture conditions on the mutagenesis enhancing
activity of the lineeir alkanes in CHO-Kl cells
The effects of culture conditions on the mutagenesis enhancing 
activities of the linear alkanes was investigated in CHO-KIA cells grown 
in FIO, EMEM and EMEM + LC. In this series of experiments the concen­
tration of the three alkanes, n-decane^ n-dodecane and n^tetradecane, 
was 17 yg/ml, 20 pg/ml and 24 yg/ml, respectively. These non-toxic 
concentrations have been found to enhance MAM-induced mutation of V79 
cells to Oua (Lankas et al., 1978).
The mutagenesis enhancing activity of these compounds was assessed 
using the Oua^ mutagenesis protocol given in Fig. 3.4. The alkanes were 
added 2 hr after MNNG treatment and maintained in the culture medium 
for the remaining expression time and the whole of the mutant selection 
period.
The data obtained for single experiments for each alkane tested 
in CHO-KIA cells grown in each culture medium are given in Tables 4.13 
- 4.15. These results show that at the concentrations tested none of 
the linear alkanes alone was toxic or mutagenic to CHO-KIA cells. None 
of the alkanes affected the survival of CHO-KIA cells following MNNG 
treatment. In contrast to the results obtained in V79 cells, none of 
the linear alkanes tested enhanced MNNG-induced mutation of CHO-KIA 
cells to Oua .
Culture conditions had little effect on the activity of these 
compounds. Increased levels of MNNG-induced Oua mutants were recovered 
when CHO-KIA cells were grown in EMEM + LC following treatment with 
all the alkanes (Tables 4.13c, 4.14c and 4.15c), but in no instance was 
this level of mutation significantly higher than for MNNG alone.
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Table 4.13 The effect of n-decane(17pg/ml) on the incidence of
spontaneous and 0.08pg/ml MNNG-induced Oua^ mutation
of CHO-KIA cells grown in a) Flo b) EMEM or c) EMEM+LC.







Control 78.1 3 3.8
n-decane 74.3 1 1.3
MNNG 7.5 22 293




Control 84.5 1 1.2
n-decane 81.0 1 1.2
MNNG 49.5 61 122
MNNG + n-decane 45.6 33 71
Cells/plate - 2.03x10$
Plates/treatment - 5
C )  EMEM+LC
Control 77.7 0 0
n-decane 77.2 1 1.3
MNNG 30.9 33 105
MNNG + n-decane 28.0 37 130*
Cells/plate - 2.03x10$
Plates/treatment - 5
Not significantly higher than MNNG alone. p>0.1
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Table 4.14 The effect of n-dodecane(20pg/ml) on the incidence of 
spontaneous and 0.08|ig/ml MNNG-induced Oua^ mutation
of CHO-KIA cells grown in a) Flo b) EMEM or c) EMEM+LC.
TREATMENT % PLATING TOTAL MUTANTS/10^
EFFICIENCY MUTANTS SURVIVORS
a) Flo
Control 87.3 0 0
n-dodecane. 86.8 0 0
MNNG 10.1 17 167




Control 77.2 2 2,6
n-dodecane 76.0 2 2.6
MNNG 45.9 45 98




Control 71.5 4 5.6
n-dodecane 70.5 1 1.4
MNNG 18.8 36 191
MNNG + n-dodecane 27.8 66 236*
Cells/plate - 2.01x10^
Plates/treatment - 5
Not significantly higher than MNNG alone. p>0.1
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Table 4.15 The effect of n-tetradecane (24|ig/ml) on the incidence of
spontaneous and 0.08pg/ml MNNG-induced Oua^ mutation of
CHO-KIA cells grown in a) Flo b) EMEM or c) EMEM+LC







Control 101.2 0 0
n-tetradecane 104.5 0 0
MNNG 7.4 11 146
MNNG + n-tetradecane 7.4 11 146
Cells/plate - 2.04x10$ 
Plates/treatment - 5
b) EMEM
Control 66.8 0 O
n-tetrade cane 62.5 0 0
MNNG 27.1 57 209
MNNG + n-tetradecane 24.8 55 220*
Cells/plate - 2.02x10^ 
Plates/treatment - 5
c) EMEM+LC
Control 71.8 1 1.4
n-tetradecane 68.6 0 0
MNNG 32.7 50 153
MNNG + n-tetradecane 31.6 55 174*
Cells/plate - 2x10^ 
Plates/treatment - 5
Not significantly higher than MNNG alone. p>0.1
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4.7 Conclusions
The results reported in this chapter can be summarised as follows.
1. At the concentrations tested none of the tumour promoters, TPA,
BZP, HCHO or linear alkanes, was cytotoxic or mutagenic in 
CHO-KIA cells at the Oua^ locus.
2. The mutagenesis enhancing activity of TPA in CHO-KIA cells was 
mutagen specific. TPA enhanced the expression of MNNG-induced 
Oua^ mutations (4.3.1) but not those induced by EMS (4.3.3).
3. The enhancement of MNNG mutagenesis by TPA was only observed when 
L-cysteine was present in the culture medium (4.3.1). This was 
not a general effect of sulphydryl compounds, in the presence of 
GSH the mutagenesis enhancing activity of TPA was abolished 
(4.3.2).
4. The free radical generating compound BZP enhanced the expression
TD
of both MNNG-induced (4.4.2) and EMS-induced (4.4.3) Oua mutations, 
but only in the cysteine free medium EMEM.
5. For HCHO, a similar profile of mutagenesis enhancing activity 
was obtained as for TPA. Enhancement of MNNG mutagenesis by HCHO 
was only observed when L-cysteine was present in the culture 
medium (4.5). (Preliminary results.)
6. In contrast to the results reported for V79 cells (Lankas et al., 
1978), a mutagenesis enhancing activity could not be detected for 
the linear alkanes tested in CHO-KIA cells, irrespective of culture 
conditions
These conclusions will be discussed, together with those from 
the other experimental chapters, in Chapter 7.
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CHAPTER 5. THE EFFECTS OF TPA ON GENE MUTATION IN OTHER 
CHINESE HAMSTER CELL LINES
5.1 Introduction
In vivo it is becoming increasingly apparent that tumour promoting 
agents are both species and organ specific (Tablel.l). Similar cell 
line specificity has also been noted for their mutagenesis enhancing 
activity in vitro. TPA enhanced induced mutation in Chinese hamster 
V79 cells (Lankas et al., 1977, 1980; Trosko et al., 1977) but not 
mutations induced in either CHO (Thompson et al., 1980) or mouse lymphoma 
L5178Y cells (Lasne et al., 1980). Furthermore, in CHO-Kl cells the 
action of TPA appears to be dependent on themutaqenic dose and the culture 
conditions. Different mechanisms may be involved in the mutagenesis 
enhancing activity of TPA in different cell lines. The effects of TPA 
on chemical-induced Oua^ mutations was therefore examined in V79 and 
CHO cells to compare with the results obtained in CHO-Kl cells.
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5-2 The effects of TPA on chemical-induced mutation of V79 cells to
Oua®
5.2.1 Toxic response tests: single-plated V79 cells.
Dose-response curves for V79 cells treated with MNNG and EMS
were constructed prior to their use in mutation assays. Since an in situ 
protocol would again be used for the assessment of Oua®, the toxicity 
of these mutagens towards single-plated cells was determined. MNNG 
toxicity was assessed in V79 cells grown in three culture media - FIO,
EMEM and EMEM + LC. EMS toxicity was assessed in cells grown in 
EMEM + LC.
Initially MNNG concentrations were selected from the survival data 
for V79 cells presented by other workers (Roberts et al., 1971; Lankas 
et al., 1977; Peterson et al., 1979). However, in preliminary studies 
these doses were found to be far too toxic towards V79-379A cells and 
the doses were reduced by a factor of 10. The MNNG concentrations selected 
for this study were in the range 0.02 - 0.16 yg/ml.
The EMS concentration used, 0.3 - 1.25 mg/ml, were suggested 
by Arlett et al. ( 1975 ).
The experimental protocol followed that used previously for 
toxicity studies in CHO-KIA cells (see 3.3.1). A series of 50 mm T/C 
dishes were inoculated with 100-2000 V79 cells, depending upon the 
expected leth ality. Cells were provided by 48 hr cultures of V79-379A 
cells, grown in the appropriate culture medium for at least two 
passage intervals. Seeded plates were incubated for 4 hr to allow cells 
to recover from trypsinisation, then dosed with mutagen or vehicle. After 
a 2 hr mutagen exposure, the medium was replaced in all plates. Plates 
were incubated, then stained and scored in the usual way after 7 days.
The data obtained are presented as dose-response plots in Fig.











































for V79 cells in FIO (Fig. 5.1a), 0.011 ng/ml for cells in EMEM + LC 
and 0.03 ng/ml for cells in EMEM (Fig. 5.1b). The value for EMS was 
0.49 mg/ml (Fig. 5.1c).
5.2.2 The effect of TPA on spontaneous and MNNG-induced Oua^ mutation 
of V79-379A cells under different culture conditions.
Oua^ mutations in V79 cells can be assessed under exactly the 
same conditions as used previously for CHO-Kl cells. Thus, the density
5of cells seeded onto selection plates was 2 x 10 cells/90 mm dish/10 ml
medium, the mutation expression time was 49 hr and the mutant
selection time was 8 days. In these studies, however, the concentration 
of Oua in selection medium was 1 mM. Similar selection conditions have 
been used previously in Oua mutation assay? with other V79 cells 
(Bradley et al., 1981).
The effects of TPA were examined at a single concentration of 
1 yg/ml. This was added to plates 2 hr after MNNG treatment and maintained 
in culture medium for the remainder of the mutation expression and the 
whole of the mutant selection. The MNNG concentration used throughout 
was 0.04 yg/ml.
The effects of TPA were examined in V79-379A cells grown in three
culture media - FIO, EMEM and EMEM + LC. Prior to their use in
experiments the cells were grown for at least two passage intervals in 
the appropriate culture medium. The effects of TPA on spontaneous Oua^ 
mutations was also assessed, thus four treatment groups were included 
in each experiment - control, TPA, MNNG and MNNG + TPA. The experimental 
procedure followed that described in 3.3.2 and illustrated in Fig. 3.4.
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The data obtained for duplicate experiments for V79-379A cells 
grown in different culture media are given in Tables 5.1 - 5.3. In contrast 
to the reports of other workers, these results indicate that V79-379A 
cells may be sensitive to the cytotoxic effects of TPA. In all 
experiments TPA reduced the survival of both control and MNNG-treated 
cells. However, in agreement with previous studies in V79 TPA alone was 
not mutagenic in V79-379A cells. TPA did increase the frequency of 
Oua^ V79-379A mutants following MNNG treatment and this mutagenesis 
enhancing activity for TPA was independent of culture conditions.
5.2.3 The effect of TPA on spontaneous and EMS-induced Oua^ mutation 
of V79-379A cel Is.
The effects of TPA on EMS-induced Oua^ mutations was investigated 
in V79-379A cells grown in EMEM + LC. The concentration of EMS used was 
0.8 mg/ml. The experimental procedure was that employed for MNNG 
studies (5.2.2), except that a terminating medium change was necessary 
following a 2 hr mutagen exposure.
The data obtained for this experiment are given in Table 5.4.
These results show that TPA is not toxic to either control or EMS- 
treated V79-379A cells. TPA per se was not mutagenic but it did 
enhance the frequency of EMS-induced Oua^ mutations.
R S5.2.4 The effect of TPA on metabolic cooperation between Oua and Oua 
V79-379A cells
V79 cells have been reported to metabolically cooperate (Yotti 
et al., 1979), and an inhibition of this process may explain the muta­
genesis enhancing activity of TPA in the V79-379A cell line. Thus,
Rthe effects of TPA on the recovery of a known number of Oua V79-379A
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Table 5.1 The effect of TPA(l|ig/ml) on the incidence of spontaneous
and 0.04pg/ml MNNG-induced Ouaî  mutation of V79-379A cells
grown in FIO.







Control 62.3 1 1.6
TPA 45.8 1 2.2
MNNG 5.3 6 111
MNNG + TPA 5.6 11 195*
Cells/plate - 2.03x10^ 
Plates/treatment - 5
Expt 2
Control 60.6 1 1.6
TPA 53.5 0 0
MNNG 7.6 6 78
MNNG + TPA 4.8 12 248*
Cells/plate - 2.02x10^ 
Plates/treatment - 5
* Significantly higher than MNNG alone. p<0.05
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Table 5.2 The effect of TPA(l|ig/ml) on the incidence of spontaneous
and 0.04pg/ml MNNG-induced Oua^ mutation of V79-379A cells
grown in EMEM.







Control 80.8 0 0
TPA 49.3 2 4
MNNG 17.5 128 719
MNNG + TPA 5.6 89 1577*
Cells/plate - 2.03x10^ 
Plates/treatment - 5
Expt 2
Control 64.1 1 1.5
TPA 45.3 3 6.6
MNNG 24.5 76 307
MNNG + TPA 17.0 130 757*
Cells/plate - 2.02x10^ 
Plates/treatment - 5
* Significantly higher than MNNG alone. p<0.005
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Table 5.3 The effect of TPA(l|ig/ml) on the incidence of spontaneous
and 0.04pg/ml MNNG-induced OuaR mutation of V79-379A cells
grown in EMEM+LC.







Control 63.0 1 1.6
TPA 55.1 1 1.8
MNNG 9.4 50 532
MNNG + TPA 4.9 97 1980*
Cells/plate - 2x10^ 
Plates/treatment - 5
Expt 2
Control 73.0 0 0
TPA 54.4 3 5.5
MNNG 22.5 80 355
MNNG + TPA 15,3 114 744*
Cells/plate - 2x10^ 
Plates/treatment - 5
* Significantly higher than MNNG alone. p40.005
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Table 5.4 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 0.8mg/ml EMS-induced Oua^ mutation of V79-379A cells
grown in EMEM+LC.






Control 62.5 2 3.1
TPA 63.3 2 3.1
EMS 12.9 96 726
EMS + TPA 13.3 181 1337*
Cells/plate - 2.05x10^
Plates/treatment - 5
* Significantly higher than EMS alone. p<0.005
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Qcells cocultured with wild-type (Oua ) cells was examined in a 
reconstruction experiment.
(a) Isolation of Oua^ V79-379A strains:
For the proposed reconstruction experiment it was necessary to 
isolate and propagate strains of Oua^ V79-379A cells.
52 X 10 V79-379A cells at passage 5 were inoculated into two
90 mm T /C dishes with 10 ml EMEM + LC and incubated for 4 hr. MNNG 
(0.04 yg/ml) was then added to the culture medium. 49 hr after the addition 
of MNNG the medium in both plates was replaced with 10 ml 1 mM Oua 
EMEM + LC. Plates were incubated for a further 8 days, then one discrete 
Oua colony was isolated from each plate following the method given in 
3.3.4a.
These two independent cell strains were designated V79-379A Oua 
3 and V79-379A Oua 4.
(b) Reconstruction experiment:
The experimental protocol followed that described in 3.3.4b, except 
that V79-379A cells were grown in EMEM + LC and the concentration of
3Oua in selection medium was 1 mM. The Oua cells were provided by a 
48 hr culture of V79-379A cells at passage 8. The Oua^ cells were 
provided by a 48 hr culture of V79-379A Oua 3 cells also at passage 8.
The numbers of cells plated, the percentage of Oua^ colonies 
recovered and the plating efficiencies of unselected controls are given 
in Table 5.5. This data indicates that in the absence of wild-type cells 
TPA was not toxic to Oua^ V79-379A cells.
5 pIn the presence of 2 x 10 wild-type cells the recovery of Oua 
colonies was decreased from 63.2% to 34.3%. However, when TPA was also
p
present the percentage of Oua colonies recovered was similar to that
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Table 5.5 The effect of TPA(l]ig/ml) on the recovery of Oua^ V79-379A 










- + - 63.2
- + + 63.0
+ + - 34.3
+ + + 56.2
(a) Plating efficiency Oua^ cells - 62.4%
(b) Plating efficiency Oua^ cells - 64.1%
(c) Plates/treatment - 5
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in the absence of wild-type cells. An inhibition of metabolic cooperation 
may thus provide an explanation for the enhancement of Oua mutations 
by TPA in V79-379A cells.
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p5.3 The effect of TPA on MNNG-induced mutation of CHO cells to Oua
5.3.1 Toxic response test: toxicity of MNNG to single-plated CHO(S) cells.
As an in situ protocol would again be employed for the assessment 
of Oua^ mutation, the toxicity of MNNG was determined in single-plated 
CHO(S) cells grown in FIO. Initially MNNG concentrations were selected 
from the survival data reported by Kao and Puck (1968) and Bempong (1979) 
for other CHO cells. In preliminary studies, however, these doses 
were found to be too toxic towards CHO(S) cells and the doses were reduced 
by a factor of 10. The MNNG concentrations selected for this study were 
in the range 0.01 - 0.08 yg/ml.
The experimental procedure followed that used previously for 
toxicity studies in CHO-KIA cells (see 3.3.1), except that MNNG 
treatment was assumed to be self-limiting and a terminating medium change 
unnecessary.
The data obtained are represented in a dose-response curve in 
Fig. 5.2. In contrast to the curves obtained for CHO-KIA (Fig. 3.1a) 
and V79-379A (Fig. 5.1a), the dose-response curve for CHO(S) cells 
treated with MNNG shows an exponential reduction with no change in 
gradient at low survival levels. By interpolation, the value for 
MNNG is 0.011 yg/ml.
5.3.2 The effect of TPA on spontaneous and MNNG-induced Oua^ 
mutation of CHO(S) cells.
As for studies with CHO-KIA and V79-379A cells, Oua^ mutations 
in CHO(S) cells were assessed using the in situ protocol described in 
3.3.2, except that the concentration of Oua in selection medium was 
1 mM. Similar selection conditions have been used in Oua mutation 
assays with other CHO cells (Hsie et al., 1981). The concentration
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1.0
0.01 0.02 0.03 0.04O
MNNG CONCENTRATION (pg/ml)
Fig. 5.2 Dose-response curve for single-plated CHO (S) cells grown in 
Flo treated with MNNG.
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of MNNG used was 0.02 yg/ml. TPA at a concentration of 1 yg/ml was added 
2 hr after MNNG treatment, and maintained in the culture medium for 
the remainder of mutation expression and the whole of mutant selection.
The effects of TPA on spontaneous Oua mutations was also 
assessed in CHO(S) cells, therefore, four treatment groups were included 
- control, TPA, MNNG and MNNG + TPA.
The data obtained for duplicate experiments, for CHO(S) cells 
grown in FIO, are given in Table 5.6. In CHO(S) cells TPA alone was 
neither toxic nor mutagenic. Furthermore, it did not affect the lethal 
effects of MNNG. In contrast to its action in other cell lines, TPA 
did not enhance the expression of MNNG-induced Oua mutations in the 
CHO(S) cell line. This is in agreement with the results presented by 
Thompson et al. (1980) that TPA does not enhance mutagenesis in CHO cells.
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Table 5.6 The effect of TPA(Ipg/ml) on the incidence of spontaneous
and 0.02|ig/ml MNNG-induced Oua^ mutation of CHO(S) cells
grown in FIO.
TREATMENT % PLATING TOTAL MUTANTS/10^
EFFICIENCY MUTANTS SURVIVORS
Expt 1
Control 102.3 3 2.9
TPA 91.0 1 1.1
MNNG 13.9 10 72




Control 93.8 2 2.1
TPA 85.1 3 3.5
MNNG 17.2 19 110
MNNG + TPA 24.8 21 84




From the results presented in this chapter the following can be 
concluded.
1. Both V79-379A and CHO(S) cells were considerably more sensitive 
to the lethal effects of MNNG than other V79 and CHO cells.
2. In agreement with previous reports, TPA was neither toxic nor 
mutagenic in V79-379A or CHO(S) cells.
3. The mutagenesis enhancing effect of TPA is cell line specific.
TPA enhanced MNNG-induced mutation of V79-379A cells to Oua^
R ♦
(5.2) but not MNNG-induced Oua mutations in CHO(S) cells (5.3).
4. The mutagenesis enhancing activity of TPA in V79-379A cells
was neither mutagen specific nor dependent on culture conditions.
R S5. An inhibition of metabolic cooperation between Oua and Oua cells 
may explain the mutagenesis enhancing activity of TPA in 
V79-379A cells.
These conclusions will be discussed, together with those from 
the other experimental chapters, in Chapter 7.
* These conclusions are based on the assumption that the treatment 
conditions employed are optimal for both V79-379A and CHO(S) cells.
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CHAPTER 6. THE EFFECTS OF TPA ON THE INACTIVATION OF 
UV IRRADIATED CHO-Kl CELLS
6.1 Introduction
The ultraviolet (UV) spectrum is conventionally divided into three 
regions which have distinct physical and biological properties,
Near-UV (UVA) 400 nm - 320 nm
Mid-UV (UVB) 320 nm - 290 nm
Far-UV (UVC) less than 290 nm.
These regions are usually represented by 'typical' wavelengths 
of UV radiation based on the emission lines of mercury vapour lamps;
UVA 365 nm, UVB 313 nm and UVC 254 nm. Studies in bacterial and mammalian 
cells in culture indicate that the spectrum of lesions induced by UV 
changes as wavelength increases (Jagger,1985). Thus, the biological 
effects of near-UV radiation are now recognised to be distinct from those 
of far-UV radiation.
In the far-UV region, there is good evidence that the radiation 
is directly absorbed by DNA and this causes the formation of photo­
products such as the pyrimidine dimer (Varghese and Wang, 1967; Brash 
and Heseltine, 1982). The action spectra for a number of biological end 
points in rodent, frog and human cells have been correlated with the 
induction of these dimers (reviewed by Jagger, 1985). Thus, pyrimidine 
dimers are now accepted as the lesions responsible for the lethal and 
mutagenic effects of far-UV.
With increasing wavelength it is apparent that other forms of 
damage to both DNA and other cellular components may become important. 
Although evidence indicates that DNA is still the primary site of lethal 
damage (Webb, 1977; Jagger, 1981; 1985), there are suggestions that membrane 
damage may be important for near-UV-induced cell inactivation (Moss and
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Smith, 1981; Ito and Ito, 1983; Kelland et al., 1983a, 1983b,1984).
Mid-UV is regarded as a transition region sind its action seems 
to be a mixture of far- and near-UV effects (dagger, 1985).
On the basis of a possible membrane action for UV radiation it 
was proposed to investigate the membrane activity of TPA in CHO-Kl 
cells. The rationale for these investigations was that cells with 
damaged membranes are likely to be more susceptible to other forms of 
membrane-mediated toxicity. This has previously been used as the basis 
for studies into the membrane effects of UV radiation in bacteria 
(Moss and Smith, 1981; Kelland et al., 1983a, 1983b). The effects of 
TPA on the inactivation of CHO-KIA cells following irradiation with UV 
light of 3 different wavelengths, representing the distinct spectral 
regions, was examined.
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6.2 Equipment for UV irradiation experiments
6.2.1 Dark room
All experiments employing UV light were carried out in a 'dark 
room' under illumination from red fluorescent tubes (Atlas Ltd., BOW) 
emitting only light of wavelengths greater than 500 nm.
6.2.2 Radiation sources
i) Penray lamp (Ultraviolet Products Inc.) - a 5 cm low pressure 
mercury lamp fitted with an integral filter (G-275). This is designed
to isolate the 253.7 nm line of the mercury spectrum and about
92-97% of lamp output is at this wavelength. This lamp provides a
-2 -1254 nm dose rate of 0.073 J m s
ii) Bausch and Lamb SP 200 lamp (Bausch and Lamb, Rochester,
New York) - a 200 W high pressure mercury vapour lamp with a fused 
silica envelope and an appropriate fused silica condensing lens 
system. Lamps were replaced after 100 hr use and a 2 hr burn off was 
allowed for newly fitted lamps prior to their use for irradiation. This 
light source was used in conjunction with a Bausch and Lamb high intensity 
grating monochromator, and can be operated at a wavelength range
from 200 nm - 800 nm.
6.2.3 Arrangement of optical bench
The general arrangement of the apparatus for irradiation of cell 
suspensions is given in Fig. 6.1(a). This refers specifically to the 
Bausch and Lamb SP 200 source, although only minor differences in 
detail occurred when the penray source was employed. All optical 
components were arranged in a horizontal plane on an Ealing Beck optical 




Fig. 6.1a Diagram of the optical bench for UV irradiation of cells in
suspension.
1 Mercury UV source (SP200)




6 Stray light filter




Fig. 6.1b Diagram of the irradiation 
cuvette.
1 Irradiation cuvette
a. Entry and exit ports for cooling 
solution




i) The shutter was an iris camera shutter (G.B. Kershaw 630) 
with a 2 cm aperture and was fitted with a cable release.
ii) The focusing lens used only in conjunction with the Bausch 
Lamb SP 200 source. This was a 40 mm diameter Spectrosil biconvex lens 
having a focal length of 55 cm. This produced an inverted magnified 
image of the exit slit of the monochromator 3 cm long and 1 cm wide 
allowing full illumination of the irradiation cuvette.
iii) Stray light filters. During irradiation at wavelengths longer 
than 254 nm using a monochromator it is essential that any stray light 
of shorter wavelengths is removed from the irradiation beam. This 
prevents errors in the biological sensitivity measured at a particular 
wavelength due to inactivation by shorter wavelength irradiations. An 
appropriate UV absorbing filter was thus positioned between the mon- 
chromator and the irradiation cuvette. Details of the stray light 
filters used for each wavelength are given in Table 6.1.




ON LOW SIDE (nm)
STRAY LIGHT FILTER
254 - G-275
313 301 Mylar C (2.5ym)
365 332 Corning 0-52
(iv) Irradiation cuvette - a jacketed 10 mm internal width,
10 mm path length quartz cuvette was used (Thermal Syndicate Ltd.), 
illustrated in Fig. 6.1(b). The temperature of the cell suspension 
was controlled by the circulation of 25% ethylene glycol solution 
through the cuvette jacket. For irradiations at 0°C an insulated 20 litre
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bath of glycol solution was cooled by a U-cool refrigeration unit (Neslab 
Instruments Ltd.). This solution was circulated at a high flow rate 
through lagged rubber tubing by a peristaltic pump (Watson Manlow Ltd.). 
The cuvette temperature was monitored by a probe thermometer (Comark 
Ltd.) and a temperature of 0°C ± 0.5°C was always maintained.
Condensation which formed on the cuvette faces during irradiation 
was removed at the sampling interval with a clean tissue.
(v) The stirrer. Cell suspensions were stirred during irradiation 
by means of a quartz paddle in a laboratory stirrer (Stanhope Seta Ltd.) 
at approximately 600 rpm.
(vi) Fluence rate determinations. The fluence rates of UV 
radiation received by cell suspensions were measured using a calibrated 
Oriel 7102 thermophile.
For use on the optical bench the thermopile was mounted on a 
sliding bench saddle beside the cuvette such that the detector was 
coincident with the inside front face of the cuvette when moved across 
into the radiation beam. Output voltages were measured on a micro­
voltameter (Kiethley Instruments Ltd.).
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6.3 The inactivation of CHO—K1 cells by far-, mid- and near-UV
radiations
Although the UV inactivation of CHO and CHO-Kl cells to monolayer 
has been reported (Zelle et al., 1980; Dewdney, 1982) no data are 
avai1 able for the response of CHO-Kl cells irradiated in suspension.
The inactivation of CHO-KIA cells by the three wavelengths to be used 
(254 nm, 313 nm and 365 nm) was investigated prior to an examination 
of the effects of TPA on cell survival. The dose ranges for each 
wavelength were suggested by studies for V79 cells irradiated under 
similar conditions (Rothman and Setlow, 1979; Wells and Han, 1985).
6.3.1 Preparation of cell suspensions for irradiation experiments.
As irradiation of culture medium in the near-UV region leads to 
the formation of toxic photoproducts (Wang et al., 1974), cell suspensions 
were prepared in PBS.
55 X 10 CHO-KIA cells were inoculated into a 150 ml culture 
bottle with 15 ml FIO and incubated. After 48 hr growth, the cell 
monolayer was dispersed with trypsin (2.8.2) and the cells transferred 
with 5 ml PBS to a 16 mm T/C tube. Cells were sedimented by 
centrifugation (1500 rpm; 5 min) and resuspended in 3 ml fresh PBS.
Cell density was determined by haemocytometer count and adjusted to 
2 X 10^ cells/ml with further PBS.
6.3.2 Procedure for UV irradiation of cells in suspension.
Before use time was always allowed for the radiation source to 
'warm up' and for the UV output to stabilise, in the case of the penray 
lamp 20 min and for the Bausch and Lamb lamp at least 30 min. The 
irradiation cuvette was then positioned on the optical bench at a height
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and distance from the source such that its front face was within the 
field of illumination. The thermopile was then moved into the radiation 
beam and a number of microvolt readings were taken by using the shutter. 
The mean of these readings was used to calculate the incident fluence 
rate from the formula:
Fluence rate = thermopile, calibration x mean microvolt
factor reading
-2 -1The calibration factor for the Oriel 7102 thermopile was 0.0267 Wm mV 
The irradiation cuvette was moved back into position and rinsed 
twice with sterile PBS. The stirring paddle was then moved into position 
and switched on. The cuvette was sterilised, with the stirrer in motion,
by a 15 min exposure to the 254 nm output of a penray lamp.
A 3 ml volume of cell suspension (see 6.3.1) was then transferred 
to the sterile cuvette and the circulation of the cooling liquid through 
the jacket started. 10 min was allowed for the cell suspension to reach 
the desired temperature (0°C). The cell suspension was then exposed to 
graded fluences of UV radiation.
For the assessment of viability a 0.2 ml sample of cell suspension
was removed from the cuvette both as a control and after each fluence.
Control and irradiated cell samples were diluted in complete medium,
FIO. The dilution employed depended upon the expected sensitivity of 
the cells to UV radiation. 0.1 ml of these dilutions were plated into 
triplicate 50 mm T/C dishes containing 4.9 ml FIO, so that 20 to 200 
macroscopic colonies were visible after incubation. Where the sensitivity 
of the cells was uncertain cells were plated at more than one density. 
Seeded dishes were placed into incubation boxes, gassed, sealed and 
incubated in the dark. After 7 days the colonies were stained and scored 
in the usual way (2.8.8).
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The inactivation curves for CHO-KIA cells following irradiation 
with 254 nm, 313 nm and 365 nm UV using the procedure outlined above 
are given in Fig. 6.2. The survival curves for CHO-KIA cells at the 
wavelengths examined are of the shouldered type. These are similar to 
those of other cell lines irradiated in suspension (Wells and Han, 
1985). The values can be interpolated from these curves. They are 
44 Jm  ̂at 254 nm (Fig. 6.2a), 20 kJm  ̂at 313 nm (Fig. 6.2b) and 
220 kJm  ̂at 365 nm (Fig. 6.2c).
Compared to CHO-KIA cells irradiated as monolayers (D^^ value 
_236.5 Jm , Dewdney, 1982), CHO-KlA cells in suspension show a similar 
response to the lethal effects of 254 nm UV. At both 254 nm and 313 nm 
CHO-KIA cells are more resistant to UV inactivation than V79 cells.
The D^^ values reported for V79 cells under similar conditions at 
these wavelengths are 15 Jm ^ and 12 kJm ^ , respectively (Wells and 
Han, 1985). At 365 nm, however, CHO-KIA cells are slightly more 














































6.4 The effects of TPA on the inactivation of CHO-Kl cells by
fctr— , mid— and near-UV radiations
To assess its effect on the survival of CHO-KIA cells following 
UV irradiation TPA was added to the plating medium at a concentration 
of 1 yg/ml. This concentration has been repeatedly shown as non-toxic 
to normal CHO-KIA cells (see Chapters 3 and 4).
The experimental procedure used was that given above (6.3.2), 
except following dilution 0.1 ml aliquots of the appropriate diluted 
suspension were inoculated into six 50 mm T/C dishes containing 4.9 ml 
FIO. TPA or TPA vehicle was then added to three dishes for each fluence 
sample. Seeded dishes were boxed, gassed, sealed and incubated in the 
dark for 7 days. Colonies were stained and scored in the usual way. The 
effects of TPA on the inactivation of CHO-KIA cells following radiation 
with 254 nm, 313 nm and 365 nm UV are given in Figs. 6.3, 6.4 and 6.5, 
respectively. The results in Figs. 6.3 and 6.5 represent a single experi­
ment for each wavelength, while those in Fig. 6.4 represent duplicate 
experiments at 313 nm. The control plating efficiencies for untreated 
and TPA treated cells, also included in these figures,show that TPA was 
not toxic to CHO-KIA cells in the control groups.
The cells irradiated with either 313 nm (Fig. 6.4) or 365 nm (Fig.
6.5) UV are clearly sensitized to the radiation treatment in the 
presence of TPA. However, the presence of TPA in the plating medium 
did not affect the response of CHO-KIA cells to 254 nm UV radiation 
(Fig. 6.3).
All of the inactivation curves are of the shouldered-type obtained 
in 6.3. Their exponential regions can be described by the equation
N = N e“^^D o
where is the surviving fraction after dose D, the surviving 
fraction after dose 0, and k the inactivation factor. Quantification
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Fig. 6.3 The effect of TPA(Ipg/ml) in the plating medium on the 
survival of CHO-KIA cells irradiated in suspension at 
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Fig. 6.4 The effect of TPA(l|ig/ml) in the plating medium on the 
survival of CHO-KIA cells irradiated in suspension at 









100 200 300O 400
UV DOSE ( k J m - 2 )
Fig. 6.5 The effect of TPA (Ipg/ml) in the plating medium on the 
survival of CHO-KIA cells irradiated in suspension at 
0°C with 365nm ultraviolet light.
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of the effects of TPA at the different wavelengths is thus possible by 
comparing the k values of the curves. The inactivation factors 
calculated from Figs. 6.3 - 6.5 are given in Table 6.2, together with 
the ratio of TPA treated to untreated inactivation factors for each 
wavelength. These results indicate that TPA has a greater effect on the 
inactivation of CHO-KIA cells following irradiation with 313 nm than 
with 365 nm UV.
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Table 6.2 Quantification of the effects of TPA(Ipg/ml) on the 
survival of CHO-KIA cells following irradiation in 
suspension at 0°C with UV.
UV WAVELENGTH 
(nm)

















6.5 The effect of TPA on the survival of CHO-Kl cells after prolonged
holding in PBS
For both 313 nm and 365 nm prolonged irradiation times of approx- 
mately 210 min are required for the induction of their lethal effects 
in CHO-KIA cells. It is possible that the effects of TPA observed above 
may be due to its action on cells weakened by prolonged holding in PBS. 
The effects of TPA in the plating medium on the survival of unirradiated 
CHO-KIA cells following a prolonged holding in PBS was examined.
5A suspension of 2 x 10 CHO-KIA cells/ml was prepared in PBS 
(6.3.1) and held in the sterile irradiation cuvette at 0°C for 210 min. 
The suspension was stirred throughout at 600 rpm. For the assessment 
of viability 0.2 ml samples were removed from the cuvette at 30 min inter­
vals. Cells were diluted and inoculated into FIO medium containing TPA 
or TPA vehicle as before. Plates were incubated in the dark, then 
stained and scored in the usual way after 7 days.
The results of this experiment are given in Table 6.3.
These results indicate that there is no reduction in the survival 
of CHO-KIA cells held in PBS, whether TPA is present in or absent from 
the plating medium. The results obtained in 6.4, therefore, represent 
a true interaction between UV irradiated cells and TPA, rather than 
experimental artefacts.
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Table 6.3 The effect of TPA(ljig/ml) on cell viability following the



















The following conclusions can be drawn from the work reported in 
this chapter.
1. The inactivation curves for CHO-KIA cells (Fig. 6.2) exhibit
similar kinetics to those of other mammalian cell lines irradiated 
in suspension.
2. TPA does enhance UV inactivation of CHO-KIA cells, but only that
caused by 313 nm (Fig. 6.4) and 365 nm (Fig. 6.5) UV radiation.
In contrast to previous reports (Dewdney and Soper, 1984), TPA 
did not sensitize CHO-KIA cells to the cytotoxic effects of
254 nm UV (Fig. 6.3).
3. TPA sensitizes CHO-KIA cells to the cytotoxic effects of 313 nm
UV to a greater extent than those of 365 nm UV (Table 6.2 ).
4. The effects of TPA cannot be attributed to an experimental
artefact caused by the prolonged holding of CHO-KIA cells in 
PBS during irradiation (6.5).
These conclusions will be discussed, together with those from 
preceding experimental chapters, in Chapter 7.
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CHAPTER 7. DISCUSSION
The initiation of two-stage carcinogenesis is generally accepted
to be a mutational event .Thus, tumour promoters may act in vivo by
enhancing the mutagenic consequences of carcinogen exposure. In support
of this as a possible mechanism for tumour promotion it has been reported
that the potent mouse skin tumour promoter TPA has such a mutagenesis
enhancing activity in mammalian cells in culture. In V79 cells TPA en-
Rhanced gene mutations induced by UV or chemical agents at the Qua and 
TG^ loci (Lankas et al., 1977, 1980; Trosko et al., 1977). Likewise, 
this agent enhanced chemical-induced mutation to Qua in CHO-Kl cells 
(Dewdney and Soper, 1984). However, in CHO-Kl cells the activity of TPA 
was mutagen dependent, being observed with MNNG-induced mutation but 
not with mutations induced by EMS or UV. In both V79 and CHO-Kl cell 
lines TPA had no effect on spontaneous mutation frequencies or on 
mutagen-induced lethality. The aims of this present study were to 
further investigate this mutagen specific activity of TPA and to 
determine the mechanism of action of TPA as a mutagenesis enhancing 
agent in CHO-Kl cells.
To investigate the mutagen specificity it was envisaged that by 
using mutagens with different modes of action the type of mutagenic 
event potentiated by TPA could be inferred. Prior to their use in 
mutagenesis experiments the selected mutagens (1.7) were assessed for 
cytotoxic effects towards single-plated CHO-KIA cells (3.3.1). MNNG 
toxicity towards monolayer cultures of CHO-KIA cells was also 
determined (3.4.1).
The dose-response data for MNNG treatment of CHO-KIA cells 
(Figs. 3.1a and 3.5) are closely comp sirable with that obtained previously
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for this cell line (Dewdney, 1982). When compared to parental CHO cells 
(Dgy 0.44 ng/ml, Kao and Puck, 1968), single-plated CHO-KIA cells, and 
presumably otherCHO-Kl cells, are more sensitive to the toxic effects 
of MNNG 0.021 yg/ml. Fig. 3.1a). This sensitivity may be a general
response of CHO-Kl cells to N-nitroso agents. Single-plated CHO-KIA 
cells were also more sensitive to MNU (D^^ 6.25 pg/ml. Fig. 3.1b) than 
CHO cells (D^y 48 yg/ml, Kao and Puck, 1968).
The dose-response curves for single-plated CHO-KIA cells treated 
with either N-nitroso agent (Figs. 3.1a and 3.1b) show an immediate 
simple exponential reduction in cell survival, followed by a marked decrease 
in gradient below 0.15 relative survival. Similar survival kinetics have 
been reported previously for CHO-KIA cells treated with MNNG (Dewdney,
1982). This may be due to the rapid decomposition of MNNG and MNU, as 
their reported half-lives in cell culture medium at 37°C are 14 and 8 
min, respectively (Jensen et al., 1977). Alternatively, it has been 
suggested that a subpopulation resides within CHO-Kl cells which retains 
the resistant characteristics of parental CHO cells to these agents 
(Dewdney, 1982).
The toxicity of MNNG towards monolayer cultures of CHO-KIA cells 
is similar to that observed for another CHO-Kl subclone. The dose- response 
curve presented in Fig. 3.5 is superimposable upon that for CHO-Kl-BH^ 
cells reported by O'Neill et al. (1977).
The dose-response curves for single-plated CHO-KIA cells treated 
with MMS (Fig. 3.2a) and EMS (Fig. 3.2b) are of a shouldered-type and 
show similar kinetics to those reported by otherworkers for CHO-Kl cells 
(O'Neill et al., 1979; Dewdney, 1982). No valid comparison of D^^ values 
can be made as the conditions employed in these present studies differ 
greatly, with respect to mutagen dose and exposure time, from those of 
other workers.
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The presence of shoulders on the dose-response curves for these 
agents may be explained by one or more of the following.
1) The need for a minimum concentration of the agent in culture medium 
in order to overcome processes such as active transport, which prevent 
the agent reaching critical targets within the cell;
2) multiple structures within the cells which must be individually
inactivated by the agent; or
3) cellular repair mechanisms whose capacity must first be saturated
before damage can be elicited.
The toxic effects of the dialkylaminoalkyl chlorides (Fig. 3.3a)
have not previously been reported in CHO-Kl cells. However, a similar 
rank order of toxicity, CEP > DMAE > DMA?, has been reported for 
these compounds in L5178Y mouse lymphoma cells (Thompson et al., 1981). 
When compared to the other mutagens assessed for toxicity during these 
present studies the dialkylaminoalkyl chlorides are relatively non-toxic 
to single-plated CHO-KIA cells.
The toxicity of DMBA was assessed in CHO-KIA cells without the 
inclusion of an exogenous activating system. The dose-response curve 
obtained (Fig. 3.3b), however, suggests that CHO-Kl cells may retain 
some endogenous metabolic activation activity for DMBA. A similar 
metabolic capability has been reported in parental CHO cells (Gupta 
and Singh, 1982). Using a 16 hr exposure these workers have shown 
DMBA concentrations of 25 yg/ml and 50 yg/ml to yield 84% and 76.4% 
relative survival, respectively, in CHO cells. Thus, CHO-KIA cells are 
markedly more sensitive to the toxic effects of this mutagen, as a 2 
hr exposure at these concentrations resulted in 58% and 37% relative 
survival, respectively. The sharp inflexion of the dose-response curve 
for DMBA treatment (Fig. 3.3b) can probably be explained by the low
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solubility of this compound in aqueous solvents. The limiting solubility 
of DMBA in FIG medium is, therefore, presumed to be 47 yg/ml.
p
The mutation of CHO-KIA cells to Oua was assessed using an in
situ protocol. In this type of assay cells are plated, treated with a
mutagen and then left undisturbed except for the addition of the
selecting agent. The alternative respreading protocol, though less
susceptible to interference from metabolic cooperation (1.7), should
Rnot be used to assess mutation to Oua . Trypsinisation, necessary for 
the dispersal of cells, has been reported to lead to the loss of newly
p
arisen Oua mutants in respreading assays (Arlett, 1977a). The optimum
p
conditions for the recovery of Oua CHO-KIA mutants, as validated by 
Dewdney (1982), are similar to those for other CHO-Kl cells (Hsie et 
al., 1981).
Consistent with the findings of Baker et al. (1974) and Dewdney 
(1982) EMS (Tables 3.4 and 3.10) was a far more effective inducer of 
viable Oua^ CHO-KIA mutants than MNNG (Tables 3.1 and 3.7). Conversely,
p
MMS was a poor inducer of Oua CHO-KIA mutants (Tables 3.3 and 3.9).
p
Similar observations have been reported for MMS in other Oua systems 
(Arlett et al., 1975; Bradley et al., 1981). In bacteria MMS muta­
genesis has similarities to that of ionizing radiations (Bridges et al., 
1973). Thus, an explanation for the low mutagenic efficiency of MMS at 
the Oua^ locus in mammalian cells can be derived from this radiomimetic 
property. Ionizing radiations, which cause deletions of whole genes and 
chromosomes, are also incapable of increasing spontaneous mutation to
p
Oua in mammalian cells (Arlett, 1977a; Gupta and Siminovitch, 1980).
A weak mutagenic activity was observed for CEP and DMAE, while 
DMA? did not enhance spontaneous levels of Oua^ mutations in CHO-KIA 
cells (Table 3.5). The mutagenic activity of these compounds in the
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CHO-Kl/Oua system , therefore, correlates with their ability to form 
the active aziildinium ion (1.7.3). This is consistent with results 
obtained for these compounds in both bacterial (Soper et al., 1979) and 
mammalian cells (Thompson et al., 1981).
p
For DMBA, a weak mutagenic activity was detected at the Qua locus, 
in the absence of an exogenous activating system (Table 3.6). This confirms 
the observations from toxicity studies that CHO-KIA cells retain some 
endogenous metabolic activity for polycyclic hydrocarbons. A similar
p
weak mutagenic response at the Oua locus has been reported for DMBA 
in CHO cells in the absence of exogenous activation (Gupta and Singh,
1982).
The effects of a single TPA concentration, 1 yg/ml, on spontaneous 
and chemical-induced mutation of CHO-KIA to Oua^ was examined using a 
standard protocol (Fig. 3.4). In these initial experiments cells were 
maintained in FIO medium. Cells were exposed to TPA from the end of mutagen 
treatment for the remainder of mutation expression and the whole of 
mutant selection. This protocol ensured that if the cells were 
susceptible in the mutagenesis enhancing activity of TPA for a particular 
period following treatment, as seemed probable from the observations 
of Dewdney (1982), the promoter would be present for that period.
p
TPA alone was neither toxic nor mutagenic at the Oua locus in 
CHO-KIA (3.3). Subsequent investigations showed a similar non-mutagenic 
response for TPA at other genetic loci in CHO-KIA cells (3.4 and 3.5). 
Furthermore, TPA did not enhance the lethal effects of mutagen treatment 
of CHO-KIA cells. These observations are in agreement with those 
obtained in CHO-KIA (Dewdney, 1982) and other mammalian cell systems 
(Lankas et al., 1977; Trosko et al., 1977; Thompson et al., 1980;
Lasne et al., 1980).
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In initial investigations (3.3.2) the effects of TPA on chemically- 
induced mutation to Oua^ were inconclusive. Each mutagen was tested 
at a single concentration yielding approximately 25% plating efficiency.
At a similar survival level, TPA has been reported to enhance both MNNG- 
and MAM-induced mutation of V79 cells to Oua^ (Lankas et al., 1977).
In CHO-KIA cells, however, this was not sufficient to elicit a TPA 
mutagenesis enhancing effect for any of the mutagens. Although TPA did 
increase the frequency of both MNNG- (Table 3.1) and MNU-induced (Table 
3.2) mutation to Oua^ at this survival level, the increase was not 
significant.
That the concentration of the initiating mutagen may be important 
to the effects observed for TPA has been noted previously (Lankas et 
al., 1977; Dewdney, 1982). The simple alkylating agents, MNNG, MNU, MMS 
and EMS were therefore re-examined at concentrations yielding lower plating 
efficiencies (10 - 15%) in the ssime protocol (3.3.3). In this series 
of experiments the findings of Dewdney (1982) were confirmed. TPA 
enhanced the expression of MNNG-induced lesions (Table 3.7) but not 
lesions induced by EMS (Table 3.10) as Oua^ mutations in CHO-KIA cells. 
Differences in protocol which may have explained the results of Dewdney 
(1982) cannot be the reason for these present observations. TPA also 
enhanced the expression of MNU-induced (Table 3.8) but not MMS-induced
p
(Table 3.9), mutation of CHO-KIA cells to Oua . The lesions enhanced 
by TPA in these cells therefore, appear to be those specific to the 
N-nitroso class of alkylating agents, rather than those common to all 
alkylating agents. As MNNG and MNU induce a similar pattern of DNA 
méthylation (Lawley, 1974), presumably TPA enhances the mutagenesis 
of both agents by a common mechanism.
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Preliminary experiments by Dewdney (1982), with CHO-KIA cells,
suggested that there were differences in mutation enhancement by TPA at
R Rdifferent genetic loci (Oua and TG ). This may be similar to the organ
specificity reported for tumour promoters in vivo (Table 1.1). If, as
seems possible, the action of tumour promoters in vitvo is locus specific,
the study of their effects at other genetic loci may provide information
as to the nature of the specific lesion(s) enhanced. The investigations
of the effects of TPA on mutation induced by a single agent, MNNG, were
therefore extended to other drug-resistance markers in CHO-KIA cells,
TG^ (3.4), and Emt^ and MGBG^ (3.5). The TG^ system has been well
characterised for CHO-Kl cells (O'Neill et al., 1977; O'Neill and Hsie,
1979). Conversely, the multiple drug-resistance mutation assay
described by Gupta and Singh (1982), for CHO cells, has not been
characterised for CHO-Kl cells. However, with the ability to assess
mutagenic effects simultaneously at independent genetic loci this may
provide a more extensive screening system for compounds with tumour
promoting activity.
Quantification of MNNG mutagenesis at the TG locus of CHO-KIA
cells employed a respreading protocol based on that developed by
O'Neill et al. (1977) for the CHO-Kl subclone BH^. In an initial
experiment (3.4.2) the observations of O'Neill et al. (1977), with
Rrespect to the phenotypic delay for induced TG mutants, were confirmed.
For three concentrations of MNNG (0.04, 0.08, and 0.16 yg/ml) the
Rmaximal expression of TG mutation occurred 7-11 days after mutagen 
treatment (Fig. 3.6). However, two differences were apparent between
T>CHO-KIA and CHO-KL-BH^ cells. The time of maximal TG expression for 
CHO-KIA cells was dependent upon the MNNG concentration, and a decline 
in this peak mutation frequency was evident at all MNNG concentrations.
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In contrast to the expression profiles for CHO-KIA cells (Fig. 3.6), 
O’Neill et al. (1977) reported that the expression time for TG 
CHO-Kl-BH^ mutants was independent of MNNG concentration. Also, 
there was no loss of mutants during subculture once maximal expression 
was attained in CHO-Kl-BH^ cells. The loss of TG^ CHO-KIA mutants 
during subculture suggests that these cells are at some selective 
disadvantage when compared to wild-type cells. A similar "peaked'
expression profile has been reported for EMS-induced mutation of
R RCHO-KIA cells to TG . The loss of TG mutants during subculture
may, therefore, be a characteristic peculiar to CHO-KIA cells.
The effects of TPA on MNNG-induced mutation of CHO-KIA cells 
to TG^ were examined using two different promoter exposure regimes 
(3.4.3 and 3.4.4). When MNNG-treated cells were continuously exposed 
to TPA from 24 hr after the initiation of mutagen treatment (3.4.3) 
no enhancement of induced mutation was observed at any time (Table
3.5). However, these results did suggest that TPA may affect the 
expression profile of MNNG-induced TG CHO-KIA mutants. The previously 
observed peaked profile, with maximal TG recovery at day 9, was 
replaced by a plateau of induced TG mutants recovered between 
days 7 and 11 for TPA-treated cells.
The effect of TPA on MNNG-induced TG mutation are in contrast 
to those obtained previously for EMS-induced TG^ mutations in CHO-KIA 
cells. Using a similar promoter exposure, a significant enhancement 
of EMS-induced TG^ mutation was observed on days 6, 8 and 11 of 
expression (Dewdney, 1982).
In a more complete study (3.4.4), cells were exposed to TPA 
from the end of the effective mutagen treatment time (2 hr, O’Neill 
et al., 1977) for the remainder of mutation expression and the whole 
of mutant selection. The results in Table 3.16 (illustrated in Fig. 3.7)
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show that TPA enhanced the early expression of MNNG-induced TG^
CHO-KIA mutants. A significant enhancement of the incidence of MNNG-
induced TG mutants was observed on days 5 and 7 following TPA
treatment. As TPA does not affect the growth parameters of CHO-KIA
cells (Table 2.4), the early expression of TG^ mutants is not simply
due to an increased rate of HGPRT loss from newly induced TG^ mutants.
RTPA also affected the expression profile of TG mutants. Although
not significantly higher than for MNNG alone on days 9 and 11, and
recovery of TG^ mutants was maintained in TPA exposed cells. That
is, there was no loss of TG^ mutants during subculture once maximal
expression: frequency was attained.
MNNG mutagenesis at the Emt^, MGBG^ and Oua^ loci in CHO-KIA
cells was assessed using the replating method of Gupta and Singh
R R(1982) (3.5.1). The incidence of spontaneous Emt and MGBG CHO-KlA 
mutants was comparable with that reported for CHO cells (Gupta and 
Singh, 1982). MNNG mutagenesis has yet to be assessed in CHO cells 
at these loci using this mutation assay, however, other alkylating 
agents have been found to induce Emt^, MGBG^ and Oua^ mutants (Gupta 
and Singh, 1982).
Although the numbers of viable mutants was small, compared 
with results obtained in other mutation assays, MNNG was mutagenic 
at these three genetic loci in CHO-KIA cells (Table 3.17). The incidence 
of MNNG-induced MGBG CHO-KIA mutants was comparable to that induced 
in CHO cells by other alkylating agents. However, the incidence
p
of MNNG-induced Emt CHO-KIA mutants was higher than those observed 
in CHO cells (Gupta and Singh, 1982). This was probably explained 
by an insufficient concentration of Emt in the selection medium 
in this experiment (3.5.2).
When compared to the results obtained using the in situ protocol
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p
(Table 3.7), the incidence of MNNG-induced Qua CHO-KIA mutants 
is considerably reduced in this replating assay (Table 3.17). This
p
is probably because the newly arisen Oua mutants, known to be sensitive
to trypsinisation, are lost during subculture. Additionally, in
Rthis mutation assay Oua mutants are selected following an expression
p
time of 72 hr, while the optimum expression time for Oua CHO-KIA 
mutants is 48 - 52 hr (Dewdney, 1982). Once this optimum expression 
period is exceeded the recovery of Oua^ mutants has been reported 
to decline in CHO-KIA cells (Dewdney, 1982).
The mutagenesis enhancing activity of TPA, examined at these 
three genetic loci (3.5.3), confirmed the locus specific action
of this tumour promoter in vitro. The expression of MNNG-induced
R Rmutation of CHO-KIA cells to Emt , but not to MGBG was enhanced
by TPA (Table 3.19). These results also suggested that TPA may exert
a cytotoxic effect on newly arisen Oua cells.
The results obtained in the multiple drug-resistance marker
system should, however, be considered in the light of other observations.
1) The multiple drug-resistance marker mutation assay has yet
to be validated for CHO-KIA cells. The selection conditions for
CHO resistance mutants in this assay system (Gupta and Singh, 1982)
p
are not optimal for Oua CHO-KIA mutants (Dewdney, 1982), and by
R Ranalogy, may not be optimal for the recovery of either Emt or MGBG
_7CHO-KIA mutants. Indeed, an Emt concentration of 1.5 x 10 M,
p
sufficient for the selection of Emt CHO mutants, was insufficient 
to kill wild-type CHO-KIA cells within the period of mutant selection 
(3.5.1).
p
For Emt CHO-KIA mutants to be accurately scored the concentration 
of Emt was increased to 2.5 x 10 M (Table 3.18). Modifications
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of other selection parameters might also be required.
2) The experimental protocol for this assay (Fig. 3.8) is very 
cumbersome, requiring a great number of individual manipulations 
of the cultures. Thus, the system may be susceptible to interferences 
from external factors. For example, trypsinisation of the cultures 
immediately prior to mutant selection may affect the recovery of 
mutants at some loci on subsequent exposure to tumour promoting 
agents. This may provide an explanation for the cytotoxic effect 
of TPA to newly arisen Oua^ mutants (Table 3.19). As TPA is a membrane 
active agent,this may be a consequence of the additional stresses
p
placed on the membranes of Oua cells, already selectively disadvantaged 
by trypsinisation. This apparent interaction between trypsinisation and
p
TPA may also affect the recovery of TG mutants in the respreading-type
protocol used in 3.5. However, there is no evidence to suggest that
this is important to the results obtained for TPA in the CHO-Kl/TG^ system,
p
Of the different mutation assay systems examined the Oua system
(3.3) appeared to be the most valuable for use in subsequent studies.
It provided a fully validated protocol for CHO-KIA cells in which a 
mutagenesis enhancing activity for TPA could be reliably detected when 
either MNNG or MNU was used as the initiating mutagen. It also offered 
other advantages to mutagenesis enhancing activity studies. Oua^ mutations 
were assessed in an in situ protocol, which is less susceptible to 
external influences such as trypsinisation, and less manipulation of 
the cells was required.
p
For these reasons this Oua system was used to investigate the 
mechanism of in vitro mutagenesis enhancement by tumour promoters in 
CHO-KIA cells and other Chinese hamster cell lines.
Cell culture conditions have been reported to influence the in 
vitro activity of TPA (Nagasawa and Little, 1981). They have also been
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implicated to explain the discordant results obtained for TPA by diff­
erent laboratories (Emerit and Cerutti, 1981). With growing evidence 
for the involvement of free radicals in tumour promotion, the free-radical 
scavenging potential of cell culture medium has been of interest. By 
examining the influence of culture conditions on the mutagenesis enhancing 
activity it was hoped to obtain an indication of the mechanism(s) of 
this enhancing activity in CHO-KIA cells and other cell lines. The 
influence of free radical scavenging agents in the culture medium on muta­
genesis enhancing activity of TPA and other promoters was examined using
p
the Oua system.
The sulphydryl compounds L-cysteine and glutathione (GSH) have 
been shown to protect cells in culture from the DNA damaging effects 
of X-rays and radiomimetic chemicals (Sasaki and Matsubara, 1977; Raj 
and Heddle, 1980). Glutathione also has an important role in the intra­
cellular defence against free radicals produced during normal metabolic 
processes and at times of oxidative stress (Meister and Anderson, 1983).
Cell culture conditions had a profound influence on the mutagenesis 
enhancing activity of tumour promoters in CHO-KIA cells. For TPA (4.3), 
the presence of L-cysteine was essential to the enhancing activity of 
this agent on MNNG-induced mutation of CHO-KIA cells (Tables 3.7, 4.2, 
and 4.3b). When L-cysteine was absent from the culture medium (Tables
4.1 and 4.3a) or replaced by GSH (Table 4.4) TPA had no effect on MNNG 
mutagenesis. This absolute requirement for L-cysteine is in contrast 
to the results of Perchellet et al. (1985). These workers have found 
that the addition of L-cysteine (4 x 10 ^ M) to the culture medium of 
mouse kératinocytes prevented the induction of ODC activity associated 
with TPA treatment of these cells. The mutagenesis enhancing activity 
of TPA was mutagen specific, confirming previous observations from 3.3.3. 
TPA did not enhance EMS-induced mutation of CHO-KIA cells to Oua^,
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irrespective of culture conditions (Tables 3.10 and 4.5). Culture 
conditions did not influence the cytotoxicity or mutagenicity of TPA 
alone, or the effects of TPA on mutagen-induced lethality.
In contrast, a mutagenesis enhancing activity could only be detected 
for the free radical generating compound BZP in the absence of L-cysteine, 
for cells grown in EMEM (4.4). This is consistent with this medium having 
the lowest free radical scavenging potential of those studied (Keck 
and Emerit, 1979). Thus, a free radical mechanism of mutagenesis enhance­
ment can be detected by alterations of culture conditions. As would be 
expected for this type of mechanism of mutagenesis enhancement the 
activity of BZP was not mutagen specific. In the absence of L-cysteine,
BZP enhanced both MNNG- (Table 4.8) and EMS-induced (Table 4.10a) Oua^ 
mutation in CHO-KIA cells. In these experiments, and essential to its 
definition as a true mutagenesis enhancing agent, BZP at a concentration 
of 1.5 yg/ml was neither toxic to control or mutagen-treated CHO-KIA 
cells, nor mutagenic at the Oua^ locus.
The small, though not significant, increase of MNNG- and EMS-induced
Oua^ mutations of CHO-KIA cells grown in EMEM + LC (Tables 4.9 and 4.10b)
by BZP may be due to insufficient protection of the cells by a
-4concentration of 2 x 10 M L-cysteine. In FIO medium, a more complex 
cell culture medium, MNNG mutagenesis was not increased by BZP (Table
4.7).
At a non-toxic and non-mutagenic concentration, 0.6 yg/ml, HCHO 
exhibited a similar profile of MNNG-mutagenesis enhancement as observed 
for TPA. A mutagenesis enhancing activity for HCHO was only detected 
when L-cysteinewas present in the culture medium (Table 4.11). This 
suggests that there may be similarities in the mechanism of mutagenesis 
enhancement for both TPA and HCHO.
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In CHO-KIA an in vitro mutagenesis enhancing activity could not be 
detected for the linear alkanes n-decane (Table 4.13), n-dodecane (Table 
4.14) or n-tetradecane (Table 4.15), irrespective of culture conditions.
This is in contrast to their reported mutagenesis enhancing activity 
in V79 cells (Lankas et al., 1978). The linear alkanes may act as tumour 
promoters by altering membrane functions (Horton et al., 1976), and a 
similar mechanism may account for their mutagenesis enhancing activity 
in V79 cells. By comparing the results obtained for the linear alkanes 
and TPA in CHO-KIA cells it can be inferred that the effects of TPA on 
MNNG mutagenesis are not simply due to a general perturbation of membrane 
activity.
The in vitro mutagenesis enhancing activity of the linear alkanes 
in V79 cells parallels their in vivo tumour promoting activity in mouse 
skin (Sice, 1966). This has been used to support the proposal that the 
detection of in vitro mutagenesis enhancing activity may provide a much-needed 
rapid screening test for compounds with tumour promoting properties 
(Lankas et al., 1980). However, it is apparent from these present studies 
that the in vitro mutagenesis enhancing activity of promoters in CHO-KIA 
cells does not parallel their in vivo promoting activity. These present 
studies also indicate that promoting agents may exhibit cell line 
specificity for their in vitro activities, similar to the organ and 
species specificity observed for these agents in vivo (Table 1.1).
This cell line specificity of tumour promoters was examined using 
other Chinese hamster cell lines. For both V79 and CHO cells mutation 
to Oua^ can be quantified using exactly the same in situ protocol as 
that used for CHO-KIA cells (Bradley et al., 1981; Hsie et al., 1981).
Any results obtained can therefore be directly compared to the • 
observations in CHO-KIA cells.
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Prior to mutagenesis studies in these cell lines the cytotoxicity 
of the mutagens to be used was assessed. Both V79-379A and CHO(S) cells 
were extremely sensitive to the cytotoxic effects of MNNG when treated 
as single cells. Depending upon the culture medium the D^^ value for 
MNNG in V79-379A cells ranged from 0.011 yg/ml - 0.03 yg/ml (Figs. 5.1a 
and 5.1b). The reported D^^ values for other V79 cells obtained under 
similar conditions are 0.74 yg/ml (Chu et al., 1968) - 1.03 yg/ml 
(Peterson et al., 1979). For CHO(S) the D^^ value for MNNG was 
0.011 yg/ml (Fig. 5.2) compared to the value of 0.44 yg/ml obtained by 
Kao and Puck (1968). The reason(s) for the extreme sensitivity of these 
cells remains to be elucidated. However, it was not due to the 
degradation or contamination of the MNNG used throughout these studies. 
The UV absorption spectrum for the MNNG used throughout showed no 
observable differences from that of a newly acquired batch of MNNG (see 
Appendix).
The toxicity of EMS towards single-plated V79-379A cells was also 
assessed (Fig. 5.1c). The D^^ value for EMS treatment was 0.49 mg/ml.
This compares to values of 1.5 mg/ml and 1.2 mg/ml obtained by Arlett 
et al. (1975) and Peterson et al. (1979), respectively, for V79 cells 
under similar conditions. V79-379A cells are therefore more sensitive 
to the cytotoxic effects of both MNNG and EMS than CHO-KIA cells treated 
under similar conditions.
In initial mutagenesis experiments TPA (1 yg/ml) seemed to be toxic 
to both control and MNNG-treated V79-379A cells (Tables 5.1 - 5.3), under 
all culture conditions. This is in contrast to the results of other 
workers using V79 cells (Lankas et al., 1977, 1980; Trosko et al., 1977), 
and may have been caused by initial handling problems encountered with 
this cell line. The trypsinisation conditions were very difficult to
220
establish for V79-379A cells and different requirements were necessary 
for cells grown in different culture media (see Table 2.2). In a sub­
sequent experiment TPA was not toxic to either control or EMS-treated 
V79-379A cells (Table 5.4).
In agreement with the results of Thompson et al. (1980) TPA was 
not toxic to either control or MNNG-treated CHO(S) cells (Table 5.5).
TPA alone was not mutagenic at the Oua^ locus in either V79-379A or 
CHO(S) cells.
In agreement with the observations of Lankas et al. (1977), and 
despite its apparent cytotoxic effects, TPA did enhance gene mutation 
at the Oua locus in V79-379A cells. In contrast to the results observed 
in CHO-KIA cells under similar conditions, this mutagenesis enhancing 
activity of TPA in V79-379A cells was neither mutagen specific nor 
dependent upon culture conditions (5.2). TPA enhanced both MNNG- (Tables
5.1 - 5.3) and EMS-induced (Table 5.4) Oua^ mutation of V79-379A cells. 
Furthermore, the presence of L-cysteine was not required for this enhancing 
activity on MNNG mutagenesis. This suggests that the mechanism of muta­
genesis enhancement by TPA in CHO-KIA and V79-379A cells may be 
different and cannot be explained by the use of different experimental 
protocols.
In CHO(S) cells TPA did not enhance MNNG-induced mutation to Oua^, 
despite the presence of L-cysteine in the culture medium (Table 5.5).
The lack of a mutagenesis enhancing activity for TPA in this cell line 
is in agreement with that reported by Thompson et al. (1980) in CHO cells. 
However, it is possible that this lack of activity may be due to a 
mutagen concentration effect previously observed in CHO-KIA cells
(3.3).
It has been proposed that themutagenesis enhancing activity of 
tumour promoters in mammalian cells in vitro is an experimental artefact
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(Lasne et al., 1980; Thompson et al., 1980; Kinsella, 1981). This stems 
from a number of observations that promoting agents inhibit cell-cell 
communication between cells in culture. The first evidence that tumour 
promoters could inhibit intercellular communication was obtained 
independently by Yotti et al. (1979) and Murray and Fitzgerald (1979). 
Since which time promoter-mediated inhibition of cell communication has 
been observed in many types of cultured cells, including human cells, 
by means of metabolic cooperation (Trosko et al., 1982; Lawrence et al.,
1984), electrical coupling (Enomoto et al., 1981; Yamasaki et al., 1983) 
and dye transfer methods (Fitzgerald et al., 1983; Enomoto and Yamasaki, 
1985a).
Of particular importance to the in vitro mutagenesis enhancing 
activity of promoters Eire the observations that at very low concentrations 
TPA and other promoting agents enhanced the recovery of TG^ V79 cells
3cocultured with high densities of wild type (TG ) cells in selective
3medium (Yotti et al., 1979; Trosko et al., 1982). At the TG cell 
densities used, in the absence of the promoters, the TG^ cells were 
rendered phenotypically normal as a result of metabolic cooperation and 
therefore unselectable in TG-containing medium.
Between cells in contact metabolic cooperation is thought to be 
mediated through specialised membrane structures, gap junctions (Gilula 
et al., 1972; Azarina et al., 1974). These are the likely sites for the 
transfer of ions, metabolites and other molecules between normal and 
mutant cells. For V79 cells, freeze fracture studies have demonstrated 
that TPA almost completely eliminated existing gap junctions, and prevented 
the formation of new structures (Yancey et al., 1982).
The mutagenesis enhancing activity for TPA observed in CHO-KIA cells 
is unlikely to result from an inhibition of metabolic cooperation. In
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the Oua system this was established by a number of observations. Neither 
the mutagen specificity of the enhancing activity (3.3) nor the profound 
influence of the culture conditions (4.3) would be expected if TPA or 
the other tumour promoters exerted their effects in this manner in this 
cell line. In addition, the enhancing activity of TPA increased with 
a decrease in CHO-KIA cell survival, when lower densities of cells would 
be expected at mutant selection.
The results of a reconstruction experiment for CHO-KIA cells (3.3.5) 
showed that the colonial recovery of Oua cells in the presence of 
2 X 10^ wild-type cells increased by approximately 20% in the presence 
of either TPA or DMSO. However, a similar increase (approximately 16%) 
in the recovery of Oua colonies in the presence of untreated wild-type 
cells, over that in their absence, has been reported previously for 
CHO-KIA cells (Dewdney, 1982). This was presumed to reflect a feeder 
layer effect whereby a large number of wild-type cells facilitated the 
colonial growth of Oua^ cells. Neither TPA nor DMSO interfere with this 
form of cellular communication.
It is also unlikely that inhibition of metabolic cooperation can 
account for the enhancement in the incidence of TG mutants at days 5 
and 7 of expression following TPA exposure of MNNG-treated CHO-KIA cells 
(Fig. 3.7). In reconstruction experiments performed independently with 
two different CHO-Kl subclones it has been shown that when cells are
5respread in TG-containing medium at less than 3 x 10 cells/90 mm dish
p
cell density had no effect on the recovery of TG mutants (Chasin, 1973; 
O'Neill et al., 1977). As in the TG^ experiments reported above (3.4)
5the cell density was 1.5 x 10 cells/90 mm dish the possibility of 
metabolic cooperation was therefore assumed to be eliminated.
CHO, the parental cell line of CHO-Kl, has only a limited capacity 
for metabolic cooperation (Corsaro and Migeon, 1975). This implies that
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CHO-Kl cells likewise do not engage in this form of intercellular comm­
unication to any great extent. The absence of TPA mutagenesis enhancing 
activity in CHO(S) cells reported in these present studies (5.3.2) further 
supports a mechanism other than an inhibition of metabolic cooperation 
to explain the effects observed in CHO-KIA cells. Interestingly, TPA 
has been reported to slightly enhance metabolic cooperation between TG 
CHO mutants and high densities of wild-type CHO cells (Warren et al., 
1981). This may explain the slight, though not significant, decrease
p
in MNNG-induced mutation of CHO(S) cells to Oua in the presence of TPA 
(Table 5.6).
In contrast to CHO cells, metabolic cooperation has been repeatedly 
demonstrated between normal and mutant V79 cells (Yotti et al., 1979; 
Warren et al., 1981; Trosko et al., 1982). Thus, the mutagenesis 
enhancing activity of tumour promoters in V79 cells could result from 
an inhibition of metabolic cooperation. The results observed for V79-379A 
cells in this present study (5.2) support this as the probable mechanism 
of action of TPA in this cell line. The mutagenesis enhancing effect 
of TPA in V79-379A cells was neither mutagen specific nor dependent upon 
culture conditions. Also in a reconstruction experiment (5.2.4) TPA 
enhanced the recovery of Oua^ colonies in the presence of wild-type 
V79-379A cells (Table 5.5). This inhibition of metabolic cooperation 
by TPA was almost complete, as the recovery of Oua^ colonies was similar
Sin the presence or absence of Oua V79-379A cells following TPA 
treatment (56.2% v 63%, Table 5.5). Similar results are reported for 
TPA enhancement of TG^ mutant recovery in the presence of high densities 
of TG^V79 cells (Yotti et al., 1979). These observations are in 
agreement with those of Yancey et al. (1982) that TPA almost completely 
eliminates gap junctions in V79 cells. Differences in the ability of
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CHO-Kl and V79 cells to engage in metabolic cooperation may explain the 
contrasting mutagenesis enhancing activity of the linear alkanes in these 
cell lines.
Although considered an experimental artefact in vitroj the inhibition
of cell-cell communication by tumour promoters may be relevant to their
in vivo promoting activity. The ability to inhibit metabolic cooperation 
R Sbetween TG and TG V79 cells has been correlated with in vivo tumour 
promoting ability (Trosko et al., 1982). In addition, Kalimi and Sirsat 
(1984) have recently reported a decreased number of gap junctions in 
TPA-treated mouse skin. As many malignant tumours in vivo are deficient 
in gap junctions (Weinstein et al., 1976), these observations suggest 
that promoter-mediated inhibition of cellular communication may permit 
the release of initiated cells from normal growth restraints. That the 
synthetic diacylglycerol, OAG (see 1.6), also inhibits metabolic co­
operation (Enomoto and Yamasaki, 1985b) implies that this effect of 
phorbol diesters may be mediated through binding with their specific 
membrane receptors.
While the mutagenesis enhancing activity of TPA in V79-379A cells 
may be an "experimental artefact", the enhancing activity of TPA in CHO-KIA 
cells appears to be a real effect. However, for this cell line some 
mechanism of action must explain the mutagen specificity (3.3) and the 
influence of culture conditions (4.3). Three genuine mechanisms, distinct 
from effects on metabolic cooperation, have been suggested which might 
explain the mutagenesis of enhancing activity of tumour promoters:
1) induction of the expression of latent mutations;
2) inhibition of DNA repair; and
3) disturbances of oxidative metabolism.
The induction of latent mutations by TPA is less mechanistically specific 
than the other two. This hypothesis envisages that not all mutagen-
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induced primary DNA lesions are expressed as mutations and that TPA and 
other tumour promoters act to activate these unexpressed mutations.
This hypothesis is compatible with the characteristic capability of TPA 
to enhance mutation long after the occurrence of DNA damage. However, 
in CHO-KIA cells the enhancing activity of TPA was dependent on the early 
presence of the tumour promoter (3.3.4), which eliminates this as the 
mechanism of action of TPA in this system.
DNA repair is a mechanism by which a cell protects itself against 
mutagenic agents. The activated forms of most mutagens are capable of 
interacting covalently with cellular DNA (Miller, 1970) and most normal 
cells have enzyme systems to remove these bound mutagens (Hart et al., 
1978). Short sections of single-stranded DNA containing lethal or 
mutagenic lesions can be repaired by an error-free excision mechanism. 
During this, damaged DNA is excised, by the actions of endonucleases 
and exonucleases, and then replaced with the correct sequence of nucleo­
tides, by a process involving DNA polymerase and ligase activities. In 
mammalian cells this error-free excision repair process is detectable 
by the removal of pyrimidine dimers from DNA or the occurrence of un­
scheduled DNA synthesis (UDS) in synchronised cell populations (Auerbach, 
1976). Studies with bacterial and mammalian cell mutants have demon­
strated that an absence of, or a reduction in DNA excision repair 
capacities leads to enhanced mutagenesis (Witkin, 1969; Hart et al., 
1978). Defective repair of damaged DNA has been related to carcino­
genesis with the finding that cells from patients with the hereditary 
"cancer-prone" disease Xeroderma pigmentosum demonstrate a virtual 
absence of UDS following UV radiation (Setlow et al., 1969).
Gaudin et al. (1971, 1972) observed that TPA inhibited DNA 
excision repair in human lymphocytes following 254 nm UV irradiation.
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Similarly, TPA has been shown to inhibit the removal of pyrimidine 
dimers from the DNA of UV (254 nm) irradiated HeLa cells, and to augment 
UV inactivation of this cell line (Teebor et al., 1973). In human amnion 
cells TPA also inhibits UV-induced UDS (Trosko et al., 1975). Thus, it 
may be that tumour promoters act to enhance mutagenesis by an inhibition 
of excision repair of mutational and/or premutational lesions in damaged 
DNA.
The possibility that the inhibition of excision repair, or other
DNA repair processes, is responsible for the enhancement of mutagenesis
by tumour promoters has been cast in to doubt .TPA was able to elicit
R Rincreases in both TG and Oua mutation frequencies in V79 cells for 
up to 3 weeks after mutagen treatment (Trosko et al., 1977; Lankas et 
al., 1980). DNA repair in mammalian cells is essentially complete within 
the first 24 hr following the occurrence of DNA damage (Trosko and Yager, 
1974 ).
In CHO-KIA cells, however, an inhibition of DNA repair may, in 
part, explain the mutagenesis enhancing activity of TPA, which was 
dependent on the duration of the promoter treatment (3.3.4). TPA was 
only effective as a mutagenesis enhancing agent when presented to MNNG- 
treated cells during the first 15 hr of mutation expression (Table 3.12). 
This is the time during which the majority of DNA repair (70 - 90%) in 
mammalian cells is effected (Edenberg and Hanawalt, 1973; Trosko and 
Yager, 1974).
The inhibition of DNA repair need not be a mechanism of muta­
genesis enhancement exclusive to the tumour promoters. The non-promoting 
DNA repair inhibitors caffeine and 3-aminobenzamide have been reported 
to enhance induced-mutations in mammalian cell assays (Roberts and 
Sturrock, 1973; Schwartz et al., 1985). However, these are non-specific
227
DNA repair inhibitors, and also enhance the cytotoxicity of mutagens 
in these systems. As would be expected if the promoter had a non-specific 
effect on DNA repair, TPA enhanced the inactivation of CHO-KIA cells 
following exposure to 313 nm (Fig. 6.4) and 365 nm UV (Fig. 6.5). The 
importance of DNA damage to the lethal effects of these wavelengths is 
uncertain. At a wavelength where DNA damage is known to be of prime 
importance to cell inactivation (254 nm) TPA did not enhance UV-induced 
lethality (Fig. 6.3). Also, TPA did not enhance the cytotoxic effects 
of any of the mutagens in CHO-KIA cells (3.3.2 and 3.3.3). Thus, the 
effect of TPA is specifically directed at inhibition of the repair of 
mutational or premutational DNA lesions.
There is accumulating evidence from in vivo and in vitro studies 
that active oxygen species play a role in tumour promotion (Cerutti,
1985). Exogenously generated oxygen free radicals have also been reported 
to enhance in vitro transformation of initiated C3H/10T% cells 
(Zimmerman and Cerutti, 1984) and to possess weak mutagenic and clasto- 
genic activities in CHO cells (Phillips et al., 1984; Sofuni et àl., 
1984). DNA damage caused by induced free radicals may be reflected in 
vitro as a mutagenesis enhancing activity.
A direct free radical mechanism of action for the mutagenesis 
enhancing activity of TPA in CHO-KIA cells seems improbable. L-cysteine, 
present in culture medium, protects CHO-KIA cells against the enhancing 
activity of the free radical generating compound BZP (Tables4.7 - 4.10). 
Conversely, the presence of L-cysteine is specifically required for the 
mutagenesis enhancing activity of TPA to be observed (4.3). Also, a 
direct free radical mechanism of mutagenesis enhancement should not be 
mutagen specific. As BZP enhanced the incidence of both MNNG (Table
p
4.8) and EMS-induced (Table 4.10) Oua mutations in CHO-KIA cells, this
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further supports a direct free radical mechanism of mutagenesis enhancement 
for BZP.
That the mechanism of mutagenesis enhancement in CHO-KIA by BZp 
and TPA are different is in agreement with recent observations in vivo 
and in vitro. Reiners et al. (1984) have found that strains of mice 
refractory to promotion by TPA responded to BZP promotion, indicating 
that BZP may possess a more general promoting activity than TPA. While 
in cultured JB6 mouse epidermal cells retinoic acid, the potent 
inhibitor of Stage II tumour promotion (see 1.4), inhibits BZP-induced 
transformation but not that induced by TPA (Gindhart et al., 1985). In 
this study the range of concentrations, 10  ̂M - 10  ̂M, over which BZP 
induced transformation included the concentration employed in CHO-KIA 
studies (4.4 ).
However,the involvement of free radicals in the mutagenesis enhancing 
activity of TPA cannot be entirely eliminated. It has been proposed that 
the free radicals, known to be produced by cells in response to TPA 
treatment, do not induce genetic damage directly, but mediate their 
effects by an indirect mechanism (Emerit and Cerutti, 1981, 1982). A 
clastogenic factor, comprised of free arachidonic acid (AA) together 
with peroxides and aldehydes, produced by the action of free radicals 
on cellular membranes, is imperative to this mechanism (Fig. 7.1). It 
is the DNA damage induced by this clastogenic factor which may be 
manifest as mutagenesis enhancement.
There are similarities, with respect to culture conditions, between 
the mutagenesis enhancing activity of TPA (4.3) and HCHO (4.5). It 
appears that the aldehydic component of a clastogenic factor induced 






















Fig. 7.1 Model of membrane mediated DNA damage.
Phorbol diesters can stimulate the arachidonic acid (AA) cascade and 
vi-a the prostaglandins (PG) and the AA-hydroperoxides (HPETE) produce 
active oxygen and aldehydes. Alternatively, they can produce active 
oxygen and lipid hydroperoxides (LOOH) by an oxidative burst. 
Extracellular lipid hydroperoxides plus aldehydes may act as a 
clastogenic factor causing DNA damage directly in the stimulated cell 
or indirectly in the surrounding tissue.
CO cyclooxygenase, LO lipooxygenase, OX oxidase, PL phospholipase.
(Adapted froig Cerutti and Amstad^ 1983),
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The mutagenesis enhancing activity of HCHO has been investigated 
in human bronchial epithelial cells (Grafstrom et al., 1985). In that 
system HCHO enhanced MNU mutagenesis by specifically inhibiting the action 
of 0^ methylguanine-DNA-methyltransferase (MT, E.C. 2.1.1.66). This is 
the repair enzyme present in many baoterial and mammalian oells 
responsible for the removal of the premutagenic 0^ methylguanine (O^MeG) 
lesion induoed by MNU and other alkylating agents (Samson and Cairns,
1977; Craddook et al., 1982). HCHO oould inhibit the repair of O^MeG 
by several different meohanisms. MT has a oysteine moiety at its aotive 
site (Pegg, 1983) and aldehydes readily bind to oysteine. Aldehydes suoh 
as malondialdehyde, formed by lipid peroxidation during olastogenio faotor 
formation (Fig. 7.1) oould also aot to inhibit the removal of O^MeG by 
binding to the aotive site of MT (Grafstrom et al., 1985).However, as 
CHO oells do not possess MT activity (Goth-Goldstein, 1980), this cannot 
explain the mechanism of mutagenesis enhancement by either HCHO or TPA. 
Alternatively, HCHO and other aldehydes react directly with media 
components suoh as oysteine to produce oyolio compounds (Fig. 7.2).
Similar cyclic compounds have been reported to inhibit enzyme funotions 
in baoteria (Kay and Gronhund, 1969), and Grafstrom et al. (1985) have 
proposed that they may also inhibit DNA repair enzymes in mammalian oells. 
This would explain the influenoe of oulture oonditions on the mutagenesis 
enhancing activity for both HCHO (4.5) and TPA (4.3) in CHO-KIA oells.
Suoh an inhibition of DNA repair funotions would also explain the influenoe 
of the duration of promoter treatment on the aotivity of TPA in these 
oells (3.3.4). The mutagen oonoentration should be important in suoh 
a meohanism, as a higher dose of mutagen will induoe greater numbers of 
premutagenio lesions to be exoised from DNA. TPA activity in CHO-KIA 





^ C H  NH
/ \ . /
R = H thiazolidine-4- 
carboxylic acid
Fig. 7.2 Reaction of cysteine with aldehydes producing thiazolidine 
compounds.
(Taken from an oral presentation given by R.C. Grafstrom to the 
Fourth International Conference on Environmental Mutagens, Stockholm, 
1985.)
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The nature of the DNA lesion whose repair is inhibited during TPA 
treatment may be inferred from the mutagen specificty of this activity.
In CHO-KIA cells TPA specifically enhanced the mutagenesis of MNNG and 
MNU (3.3.3) which indicates that an 0-alkylation lesion in DNA may be 
important in this process. S^l alkylating agents (see 1.7.2), typified 
in this present study by MNNG and MNU, react relatively more extensively 
at 0-atom sites in DNA then do S^2 agents e.g. M'.MS (Lawley, 1974). The 
borderline S^l/2 compound EMS fills an intermediate role, but does not 
appear to produce the specific lesion enhanced by TPA in sufficient 
amounts for this activity to be exhibited.
The induction of 0^ alkylG in DNA has been correlated with the 
mutagenicity of alkylating agents in mammalian cells (Heflich et al., 
1983; Kaina et al., 1983). However, there is evidence to suggest that 
at least one other DNA lesion, o"̂ alkylthymine (O^MeT), may also be 
responsible for some of the mutagenic effects of alkylating agents 
(Abbott and Saffhill, 1977; Fox and Brennand, 1980). An inhibition of 
the repair of this minor DNA lesion may explain the effects of TPA.
There is no direct evidence to indicate that CHO cells possess
4a repair enzyme for 0 MeT excision. H)wever, although they do not possess 
MT activity, CHO cells have been shown to exhibit an inducible adaptive 
response (Samson and Schwartz, 1980), similar to that associated with 
MT activity in bacteria (Samson and Cairns, 1977). Waldstein et al.
(1982) have also reported a limited capacity for MNNG-treated CHO cells 
to remove 0-methyl lesions from their DNA. The presence of an inducible
40 MeT repair enzyme has been implicated to explain similar adaptation 
responses in V79 cells (Fox and Carlton,1984), which also lack MT 
activity (Warren et al., 1979). Thus it is possible that CHO-KIA cells
4may possess an 0 MeT repair enzyme.
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This mechanism of mutagenesis enhancement is dependent on the 
production of a clastogenic factor in CHO-KIA through an interaction 
between TPA and cell membranes (Fig. 7.1). Two observations suggested 
that these effects of TPA could be membrane mediated in CHO-KIA cells:
a) TPA induced changes in the morphology of CHO-KIA cells, although 
it did not affect other growth parameters (2.8.10); and
b) in the multiple drug-resistance marker assay (3.5) TPA was toxic
R Rto Oua CHO-KIA mutants (Table 3.19). Oua mutants are known to be
sensitive to the membrane activity of trypsin (Arlett, 1977a).
Additionally, TPA is a membrane active compound (see 1.2), and 
it is becoming increasingly apparent that a large number of biological 
ef fects of TPA can be mediated through interactions with cell membranes 
(see 1.6). The effects of TPA on the inactivation of CHO-KIA cells foll­
owing UV irradiation (Chapter 6) further support a membrane activity 
of TPA in these cells.
From action spectra studies with cultured cells, it is apparent 
that the lethal effects of UV radiations are mediated by different lesions 
at different wavelengths (dagger, 1985). In the far-UV region (< 290 nm) 
DNA damage is almost certainly responsible for cell inactivation (Coohill, 
1984). In this UV region the cytotoxicity of the radiations correlates 
with the induction of DNA photoproducts, most particularly pyrimidine 
dimers, for a number of cell culture systems (Todd et al., 1968; Rothman 
and Setlow, 1979). While DNA lesions are undoubtedly involved in cell 
inactivation by mid- (290-320 nm) and near-UV (320-400 nm) radiations 
(Webb, 1977; dagger, 1981), it is apparent that damage to other cellular 
components is also of importance. Studies in bacteria (Moss and Smith, 
1981; Kelland et al., 1983a, 1984) and in yeast (Ito and Ito, 1983) have 
suggested that the cell membrane may be the target site for some of the
234
lethal damage induced by these UV radiations. This was concluded because 
following mid- and near-UV irradiation cells either became more sensitive 
to other membrane damaging events (Moss and Smith, 1981; Kelland et al., 
1983a) or leaked essential intracellular components into their culture 
media (Ito and Ito, 1983; Kelland et al., 1984). The former rationale 
was used to assess the membrane activity of TPA, by exposing CHO-KIA 
cells irradiated with far-, mid- and near-UV to TPA (1 pg/ml) in the 
plating medium (6.3). TPA enhanced cell inactivation by 313 nm (Fig.
6.4) and 365 nm (Fig 6.5) UV but not that following 254 nm UV (Fig. 6.3), 
while having no effect on unirradiated cells. The lack of effect at 
254 nm is in contrast to that of Dewdney (1982), who found that TPA 
mildly sensitized CHO-KIA cells to inactivation by 254 nm UV. However, 
in that study the cells were trypsinised immediately prior to TPA 
exposure, which may explain their sensitivity.
Although in all experiments the cells were irradiated under 
essentially the same conditions, the irradiation times in the 313 nm 
and 365 nm experiments were considerably longer than those at 254 nm.
The observed differences could therefore have been due to the prolonged 
holding of CHO-KIA cells in PBS, common to 313 nm and 365 nm experiments. 
When this was investigated in a sham-irradiation experiment (6.4), TPA 
had no effect on the survival of non-irradiated CHO-KIA cells held for 
up to 210 mins in PBS, a time longer than that used for experiments.
The results obtained in irradiation experiments must therefore represent 
a true synergistic action of TPA on UV irradiated CHO-KIA cells.
TPA enhanced the lethal effects of 313 nm UV to a greaterextent 
than 365 nm UV (Table 6.2). This observation indicates that far from 
being a transition region, as proposed by dagger (1985) mid-UV may in 
fact possess a unique action of cell lethality.
235
The response of cells in vitro to mid - UV has been associated 
with the release of agents derived from membrane phospholipids. 313 nm 
UV has been shown to induce the release of prostaglandins (PG) and 
arachidonic acid (AA) from the membranes of cultured C3H/10T% mouse 
fibroblasts (De Leo et al., 1984) and human kératinocytes (De Leo et 
al., 1985). In these cell systems the release of AA following UV 
irradiation was rapid and could be inhibited by dexamethasone. As this 
steroid inhibits the activity of the membrane enzyme phospholipase Â , 
this has led to the proposal that mid-UV photons interact directly with 
cell membranes to activate this enzyme (De Leo et al., 1985). The effects 
induced in C3H/10T% cells by 313 nm are similar to those observed 
following treatment of these cells with phorbol diesters (Mufson et al., 
1981), which also specifically activate phospholipase A^ (Ocuhi and Levine, 
1978b; Galey et al., 1985). The enhancement of 313 nm UV-induced inactiv­
ation by TPA in CHO-KIA cells may represent the combined action of these 
two agents at the cell membrane. While the enhancement of 365 nm UV-induced 
cell lethality probably represents a less specific UV membrane effect 
together with this specific action of TPA.
Unfortunately, parallel mutagenesis enhancing studies with TPA 
and UV of specific wavelength were not possible due to technical 
constraints. The large numbers of cells required for mutagenesis studies 
cannot be irradiated in suspension using the optical bench arrangement 
in Fig. 6.1a. Large numbers of cells can be irradiated attached to 
T/C dishes, but sources of monochromatic light are, as yet, unavailable 
for this method of irradiation.
The interaction between TPA and UV, particularly at 313 nm, suggests 
that a clastogenic factor may be induced in CHO-KIA cells by TPA. 
Therefore, the mutagenesis enhancing activity observed for TPA in the
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CHO-KIA/Oua^ system may be wholly due to a particular set of experimental 
conditions.
The activation of phospholipase A^ and the subsequent production 
of a clastogenic factor in cells treated with TPA may be mediated through 
the specific phorbol diester receptors (Cerutti and Amstad, 1983). In 
CHO-KIA general membrane perturbations, such as those induced by linear 
alkanes, do not lead to an enhancement of mutagenesis. Therefore, the 
enhancing effects of TPA in these cells might be mediated through such 
a receptor interaction. CHO, and presumably CHO-Kl cells do possess
3reversible HPDBu binding sites (Shoyab et al., 1980). The negative 
results for TPA in CHO(S) cells (Table 5.5) may, therefore, be simply 
explained by the mutagen concentration effect, observed in CHO-KIA 
cells (3.3). The extreme sensitivity of CHO(S) cells to the toxic effects 




The V79 and CHO cell lines maintained for these studies are 
extremely sensitive to the toxic effects of MNNG (see 5.2.1 and 5.3.1), 
when compared with the results obtained for similar cells treated under 
similar conditions by other workers (Kao and Puck, 1968; Roberts et al., 
1971; Peterson et al., 1979). Throughout the present studies a single 
batch of MNNG (Sigma Chemicals Lot no. 470-0143) was used. It was possible 
that this may have degraded or become contaminated with other toxic 
compounds during storage. A fresh batch of MNNG was thus obtained from 
the same supplier (Sigma Chemicals Lot no. 112F-0003). The purity 
of these two batches was then compared using a spectrophotometric 
method and a parallel toxicity study was undertaken using single-plated 
CHO-KIA cells.
The ultraviolet absorption spectrum for MNNG should exhibit two
maxima at 280 nm and 400 nm (Gichner and Veleminsky, 1982). The molar
-4 -1 -1extinction coefficients at these maxima are 1.77 x 10 M cm and 
167.9 M ^cm ^, respectively (La Folia et al., 1972). Upon decomposition 
the peak at 400 nm disappears, and the 280 nm peak is replaced by one 
at 260 nm corresponding to the absorption maxima for N-nitrourea (La 
Folia et al., 1972). The absorbance at 400 nm is linear with increasing 
MNNG concentration and is usually used to measure the stability of MNNG.
The purity of the MNNG batches was assessed by the spectrophot- 
metric method of La Folia et al. (1972). For each batch a solution was 
prepared in DDH^O in the usual way at a concentration of 500 vig/ml 
(see 2.4.1). A portion of each was sterilised by filtration through 
0.2 ym pore size Millex-GS filter unit (see 2.2.1), and stored at -20°C
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protected from light. This was used in the parallel toxicity study.
Ultraviolet and visible absorption spectra (200 - 600 nm) were 
measured on a Perkin Elmer 500S automatic spectrophotometer for MNNG 
solutions in matched, stoppered qusirtz cuvettes. For both batches, a 
similar absorption spectrum was observed and the absorption maxima 
detected for MNNG at final concentrations of 5 yg/ml and 500 yg/ml 
are given in Figs. A.la and b. Over the wavelengths scanned (200 - 600 nm) 
no other absorption maxima were observed. Particularly no peak at 
260 nm, indicative of MNNG degradation, was observed for either batch.
The absorption spectra obtained are in agreement with that given by 
La Polla et al. (1972).
Using the molar extinction coefficient at 400 nm the concentration 
of MNNG can be calculated. For the two batches tested the MNNG concen­
trations are given in Table A.I.
Table A.I. MNNG concentrations calculated from absorbances at 400 nm 
for different batches of MNNG.
MNNG batch Absorption Absorbance MNNG concentration
maximum(nm) (yg/ml)
470-0143 398 0.536 469
112F-0003 399 0.554 485
The toxicity of MNNG was examined in single-plated CHO-KIA cells 
grown in FIO medium following the method used previously (see 3.4.1). 
The dose-response curves obtained from these studies for each batch 
of MNNG are given in Figs. A.2a and b. Both curves are superimposable 

















































treated with MNNG (Lot 47C-0143) redrawn from Fig. 3.1a. The values
are 0.024 pg/ml from Fig. A.2a and 0.022 pg/ml from A.2b. The value
for single-plated CHO-KIA cells treated with MNNG interpolated from 
Fig. A.2c is 0.02 pg/ml.
The results from these investigations indicate that there are no 
obvious differences between the two batches of MNNG examined. The 
extreme sensitivity of the V79 and CHO cell lines must therefore be 
due to other factors.
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